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ABSTRACT 
FLUORESCENCE DETECTION OF BIOLOGICAL THIOLS AND AXIALLY 
CHIRAL BODIPY DERIVATIVES & 
ALTERNATIVE METHODOLOGIES FOR SINGLET OXYGEN GENERATION 
FOR PHOTODYNAMIC ACTION  
SAFACAN KÖLEMEN 
PHD IN MATERIALS SCIENCE AND NANOTECHNOLOGY 
SUPERVISOR: PROF. DR. ENGİN UMUT AKKAYA 
SEPTEMBER, 2014 
Calorimetric and luminescent detection of biological thiols namely cysteine (Cys), 
homocysteine (Hcy) and glutathione (GSH) have attracted great interest due to the 
their biological significance. There are many reported fluorescent probes for Cys and 
Hcy, however selective probe designs for GSH remained elusive. We represented in 
thesis (Chapter 3) a BODIPY based selective fluorescent probe for the in vitro 
detection of GSH in cancer cell lines. Photodynamic therapy (PDT) is one of the 
promising and developing treatment modality for certain indications. Therapeutic 
action is achieved by the generation of cytotoxic singlet oxygen (SO). Most critical 
compartment of SO production pathway is the sensitizer molecule. In order to get 
effective inter-system crossing, which is highly needed for singlet oxygen 
generation, common strategy is to incorporate heavy atoms on sensitizers. However, 
presence of heavy atoms increases the dark toxicity that is not desired in clinical 
applications. In Chapter 4, we are introducing a new concept for activatable heavy 
atom free sensitization of PDT by designing novel orthogonal BODIPY derivatives 
and detailed computational analysis of this new concept. While dealing with 
orthogonal BODIPYs, we synthesized for the first time two axially chiral BODIPY 
derivatives and characterized the enantiopure products, which holds great promise 
for enantioselective sensing applications (Chapter 5).   PDT has two major problems, 
which are light penetration depth of the incident light and the hypoxia. These two 
restrictions are addressed in chapter 6, by combining gold nanorods and aromatic 
endoperoxides.  
Keywords: GSH probe, axial chirality, photodynamic therapy, singlet oxygen, gold 
nanorods/endoperoxides 
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ÖZET 
BİYOLOJİK TİYOLLERİN FLORESAN TAYİNİ VE AKSİYAL KİRAL BODIPY 
TÜREVLERİ & FOTODİNAMİK ETKİ İÇİN ALTERNATİF YOLLAR İLE 
SİNGLET OKSİJEN ÜRETİMİ 
SAFACAN KÖLEMEN 
MALZEME BİLİMİ VE NANOTEKNOLOJİ, DOKTORA 
TEZ YÖNETİCİSİ: PROF. DR. ENGİN UMUT AKKAYA 
EYLÜL, 2014 
Biyolojik tiyoller sistein (Cys), homosistein (Hcy) ve glütatyonun (GSH) floresan 
moleküler ajanlar ile tayin edilmesi, bu tiyollerin taşıdıkları biyolojik rollerden ötürü 
çok büyük önem arz etmektedir. Literatürde yer alan pek çok çalışmada Cys ve Hcy 
tayini için dizayn edilmiş ajanlar bulunabilmektedir. Ancak GSH için seçici floresan 
moleküler görüntüleme ajanları çok az sayıdadır. Bu tez kapsamında GSH’ın kanser 
hücre kültürleri içerisindeki tayini seçici olarak BODIPY tabanlı floresan boya 
yardımı ile yapılmıştır (Bölüm 3). Fotodinamik terapi (PDT) fazlaca umut vaat eden 
ve gelişmekte olan bir kanser tedavi yöntemidir. PDT kapsamındaki terapatik etki 
zararlı singlet oksijen (SO) üretimi ile gerçekleşmektedir. SO üretimi sırasında yer 
alan parçalardan en önemlisi duyarlaştırıcı moleküldür. SO elde edilmesi için gerekli 
olan sistemler arası geçişin sağlanabilmesi için sıklıkla uygulanan dizayn prensibi 
duyarlaştırıcı molekülü ağır atomlar ile modifiye etmektir. Ancak ağır atomların 
varlığı duyarlaştırıcının uyarıcı ışık olmaksızın toksik etki göstermesine neden 
olmaktadır. Bu doğrultuda bölüm 4’te yer alan çalışmalarda ağır atom içermeyen ve 
sadece kanserli hücrede aktifleşebilen yeni duyarlaştırıcı dizaynları ve ortaya 
çıkarılan yeni konseptin detaylı teorik çalışması sunulmuştur. BODIPY kimyası 
üzerinde yürüttüğümüz çalışmalar sonunda ilk kez aksiyal kiral özelliğe sahip 
BODIPY türevleri tasarlamış, sentezlenmiş ve karakterize edilmiştir. PDT 
mekanizmasının iki önemli problemi mevcuttur. Bunlar uyarma ışığının dokulardan 
kısıtlı bir miktarda geçiş yapması ve hipoksiyadır. Bölüm 6’da altın nanoçubuklar ve 
aromatik endoperoksitler yardımı ile bu sorunlara çözüm sunulmaktadır.  
Anahtar Kelimeler: GSH ajanı, aksiyal kiral, fotodinamik terapi, singlet oksijen, altın 
nanorod/endoperoksit      
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CHAPTER 1 
 
1. INTRODUCTION 
 
Cancer appears to be one of the most challenging health problems faced by large 
amount of people all around the world. Number of patients is expected to reach more 
extended life spans in the coming years. State-of-the-art diagnostic tools and 
treatments must emerge in order to have more effective results, decreased 
invasiveness, fewer side effects and more patient compliance with respect to the 
conventional methods (chemotherapy and radiotherapy).  
Conventional imaging methods for diagnosis applications mostly rely on contrast 
agents. These agents emit signal continuously regardless of target cell (“always on”). 
As a natural consequence of this, sensitivity cannot be achieved sufficiently due to 
the low target to background signal ratios. At that point, molecular optical imaging 
by means of fluorescent probes arises as a good alternative. These probes can be 
designed in such a way that they become active only under certain conditions 
(“turned on”). Thus, signal from well-designed probe can only be detected after 
selective interaction between target cells and probe that increases the specificity and 
selectivity. This improves target to background ratio and provides opportunity for 
detection of even very small tumours. Furthermore, molecular fluorescence imaging 
offers simple and cheap instrumentation as well as real time analysis. 
Design, synthesis and characterization of molecular fluorescent probes, which are 
selective to various diseases marker is the key of targeted fluorescent imaging. At 
that point, BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) dyes with their 
high fluorescence quantum yields/absorption coefficients, tunable 
absorption/fluorescence peaks, ease of synthetic methods and various sides for 
functionalization were most widely employed in fluorescence imaging studies during 
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the last decade. Therefore, in chapter 3, we introduced a BODIPY based glutathione 
selective turn-on fluorescent probe. Levels of biological thiols such as cystein (Cys), 
homocystein (Hcy) and glutathione (GSH) in living systems are known to be 
important parameters in health and sickness. Since their presences are vital for the 
maintenance of cellular redox status and alterations in their levels is linked to a 
number of debilitating diseases, probes that respond to these thiols by color change, 
emission wavelength change, or both are highly valued. Additionally, level of GSH 
in cancer cells is 2-50 fold higher than health cells, which makes GSH a promising 
target for cancer diagnosis. A vast amount of examples in which Cys and/or HCY are 
selectively detected and monitored appeared in the literature, however there are only 
few examples for GSH probes. This is the result of limited design principles for bio-
thiols detection, which are mainly based on Michael addition, cyclization and 
cleavage of the disulfide bond. Structural differences between GSH and other two 
bio-thiols make GSH monitoring a challenging task. In chapter 3, for the purpose of 
selective GSH sensing, we thought that two binding sites on a probe are essential. 
We modified the BODIPY core with a crown ether moiety at meso position. Crown 
moiety is the modulation site for photo-induced electron transfer (PET) and it is a 
very well known binding site for the ammonium end of the GSH. In addition to that 
we incorporated a nitro styryl group on the BODIPY core in order to create a thiol-
binding site. In this work, we have shown that selectivity for reaction-based probes 
can be improved by applying additional photophysical manipulation sites.  
Photodynamic therapy (PDT) is a promising candidate for treatment of certain 
malignant (skin, head and neck, gastrointestinal, gynecological cancers), 
premalignant (actinic keratosis), and nonmalignant (psoriasis, AMD-age related 
macular degeneration) indications since it offers non-invasive and activatable 
therapy alternatives. PDT utilizes light, sensitizer and molecular oxygen to cause 
cancer cell death via apoptosis or necrosis.  The therapeutic action is taking place 
upon the generation of cytotoxic singlet oxygen through excitation of a particular 
chromophore (sensitizer) followed by an energy transfer to the dissolved oxygen in 
tumor tissues.  
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One of the most substantial parts of the PDT designs is the choice of sensitizer. An 
effective sensitizer should hold some unique characteristics such as low toxicity in 
the absence of light, high extinction coefficients, photostability, amphiphilicity and 
biocompatibility. More importantly, a sensitizer should have high triplet quantum 
yield such that transition of an excited electron from singlet excited state to triplet 
excited (inter-system crossing (ISC)) takes place smoothly. Common strategy for 
achieving efficient ISC is to decorate sensitizers with heavy atoms such as iodine and 
bromine. However, presence of heavy atoms increases the dark toxicity of 
sensitizers. We have been interested in finding out some possible different ways of 
achieving increased intersystem crossing (ISC) without incorporating heavy atoms in 
order to minimize dark toxicity for photodynamic therapy applications, turning our 
attention to the excited state properties of the sensitizers. In chapter 4, we are 
introducing a new excited state concept, which we named it as doubly substituted 
tetra radical state (DS-TR) by realizing orthogonal arrangement of BODIPY 
monomers. DS-TR character of S1 was shown to have a strong correlation with 
S1→T1 ISC yielding 1O2. 
Detailed study of DS-TR excited state was also provided by π-extended BODIPY 
derivatives in Chapter 4. Near-IR absorption, desired for potential photodynamic 
therapy applications, was not pursuable for bis-chromophores by the standard 
strategy of π -extension, as DS singlet states are destabilized. Decreased exchange 
coupling in π -extended cases appears to be responsible for this destabilization. On 
the other hand, by using the accumulated knowledge of excited state configurations 
and triplet photosensitization, we further improved our new concept through 
activatable heavy-atom free PDT sensitization. There is no doubt that targeted 
sensitizers increase the therapy efficacy and decrease the side effects. To do so, we 
extended the π-conjugation on the orthogonal dimer core, which removes the DS-TR 
picture and makes our sensitizer inactive. In the presence of GSH only, a cancer 
marker, double bond is reduced and the conjugation is broken that yields effective 
charge transfer mediated ISC. The detailed results of this project have been given in 
chapter 4.   
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While we were dealing with orthogonal BODIPY dimers for PDT applications, we 
recognized the potential of our dimers for atropisomerism. Synthesis, separation and 
detection of chiral molecules are at the heart of drug discovery studies. If a chiral 
molecule do have fluorescence property than its application areas can be expanded. 
For instance, fluorescence enantioselective sensing is one of the most up-to-date and 
improvable topics among the optical sensing studies due to its potential as a simple 
detection tool in chiral assays. This detection is quite important for drug discovery, 
biological labeling, catalysts, and understanding the mechanism of molecular 
recognition in biological systems. There are number of fluorescent sensors for 
recognition of chiral amines, carboxylic acids, alcohols and amino acids. Especially 
biologically important hydroxy acids and amino acids have been attracting much 
interest.  
Rich BODIPY chemistry allows us to design, synthesize and characterize axially 
chiral BODIPY derivatives. In chapter 5, we presented the first example of 
atropisomeric BODIPY derivatives with persistent chirality due to multiple methyl 
group clashes. Circular dichroism studies clearly demonstrate successful separation 
of the two enantiomers. The orthogonally linked BODIPY compounds have been 
demonstrated to have interesting photophysical properties but also we show that they 
can be isolated as atropisomeric chiral compounds.  
In chapter 6, I switched my attention back to PDT concept. On the way of fight 
against cancer, nanotechnology that combines life science, medicine, electronics and 
biomaterials is a good choice of weapon. As a result of increasing nanotechnology 
based biomedical applications and out coming new properties, there is a growing 
interest to use inorganic nanoparticles in cancer treatments. Nanomaterials can be 
used in various therapies (Photothermal, photodynamic therapies), ultrasensitive 
detection of cancer markers, imaging techniques as contrast agents, carriers for drug 
delivery, control release, and regenerative medicine. Among possible nanomaterials, 
gold nanoparticles have many advantages and unique properties that make them 
suitable for therapy, diagnosis and theranostic (therapy + diagnosis) applications. 
Biocompatibility, bioinertness, presence of tunable surface plasmon resonance peak, 
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which covers almost all of the electromagnetic spectrum, well establish surface 
chemistry for easy functionalization (targeting), compact size and insignificant 
toxicity are some of the well known properties of gold nanoparticles. It is important 
to note that; localized surface plasmon resonance (LSPR) wavelength of a gold 
nanoparticle can be tuned by simply adjusting the size and the shape of the 
nanoparticle during the chemical synthesis. For instance gold nanorods have red 
shifted LSPR peaks that span through near-IR region, which make them highly 
suitable for biomedical studies. Gold nanorods like other types of gold nanoparticles 
can be heated by external factors such as light (near IR). In fact, since these 
nanoparticles can be targeted to the tumor tissue, this heating alone is being 
considered as a viable treatment modality (photothermal therapy).  
Applicability of PDT is severely limited by two major factors, penetration depth of 
the excitation light and hypoxia (low oxygen concentration) in tumor tissues. In 
chapter 6, we tried to address these restrictions by combining aromatic 
endoperoxides and gold nanorods. Our primary goal is to deliver the principal 
cytotoxic agent of photodynamic therapy, singlet oxygen, directly by thermal 
decomposition of otherwise stable endoperoxides, which are located on gold 
nanorods and observe cell death due to the thermal and singlet oxygen effects. Near-
IR excitation mediated temperature rise on the surface of gold nanorods triggers the 
thermal decomposition and release of trapped singlet oxygen from endoperoxides. 
Thus, this design is not using heat as an end product as in the case of classical 
photothermal therapy. This project, which is a radical rewriting of the photodynamic 
therapy concept, is poised to revamp photodynamic therapy, offering potential 
solutions for major problems hitherto blocking broader clinical applications.  
 
 
 
 
  6 
CHAPTER 2 
 
2. BACKGROUND 
 
2.1. Fluorescent Molecular Sensors 
2.1.1. General Information 
A sensor is a device, which yields a measurable output (signal) upon interacting with 
matter or energy.1 Sensors are considered only as macroscopic devices (such as pH 
electrode or thermometer) until the beginning of the nineties.1 Followed by the 
increased recognition of nanotechnology in sensing applications, properly designed 
molecules are also appeared to be suitable candidates. Today we have an accepted 
and well-known term molecular sensor, which is a molecule that signals the presence 
of an analyte by some physical output.  Signaling mechanism of molecular sensors 
basically involves selective interaction of a molecule with an analyte of interest, 
which forms measurable form of energy that can be detectable with various simple 
spectroscopic techniques such as optical tools (e.g., UV, visible, fluorescence), or 
electrochemical methods (e.g., cyclic voltammetry). Optical sensors utilize light-
based detection of analytes and are considered to be useful in practical applications 
because of their high sensitivity, low cost, and simplicity of instrumentation.1 One 
type of the optical sensing is the calorimetric sensor, which involves the color 
change (shift in absorbance spectrum) upon interaction with an analyte. Second and 
more promising method is to sense analyte concentrations with fluorescent signal 
transduction and these types of molecular sensors can be referred as fluorescent 
sensors. In these type of sensors, photophysical mechanisms that control the 
response of a molecular probe mainly include photo-induced electron transfer (PeT), 
photo-induced charge transfer (PCT), excimer/exciplex formation, Förster resonance 
energy transfer (FRET), and aggregation-induced emission (AIE).2 These 
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mechanisms will be discussed briefly in the section 2.3. 
Fluorescent molecular sensor design strategies mostly involve three main 
approaches:3 (i) binding site-signaling subunit, (ii) displacement approach, and (iii) 
chemodosimeter designs. In the case of first principle, a molecular sensor contains 
covalently bonded binding site(s) that is selective to a certain analyte and an optical 
signaling sub-unit in such a way that the interaction of an analyte with the binding 
site triggers electronic modulations in the optical signaling unit in the form of 
fluorescence (emission) change. Second modality (the displacement approach) 
suggests non-covalent interaction of the binding and signaling sites. Molecular 
ensemble between these two units is destroyed upon coordination of an analyte to the 
binding site causes displacement of the binding moiety that yields detectable optical 
changes. Chemodosimeter designs are realized by the chemical reactions on a 
molecular probe with specific analytes (a cation, an anion or a molecule) resulting in 
fluorescence alterations. It involves irreversible bond breaking or formation. Recent 
studies in the field reveal novel approaches that involve the use of nanoparticles in 
combination with molecular probes.   
 
Figure 1. Tsien’s Ca2+ probe.4 
Fluorescent molecular sensor development has evolved into an attractive field of 
study after Tsien’s pioneering study4 on fluorescent Ca2+ detection in 1980 (figure 
1), followed by large number of promising examples emerging at a steady pace with 
worldwide participation in this endeavor.5 Major application areas of fluorescent 
molecular sensors are real time imaging of biological systems/processes and medical 
diagnosis.6 It is known that living organisms and their environment are composed of 
elements, ions and molecules, which are constantly forming network of chemical 
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reactions including acid-base chemistry, electron transfer, metal-ligand interactions 
and catalytic transformations.6 A molecular level understanding of these processes 
and detection of rich array of analytes (e.g., ions, molecules) that living organisms 
provide are real challenges, but also provides great opportunity for researchers to 
investigate biological systems in their own medium and create new tools especially 
for medical diagnosis. Towards addressing these challenges, molecular imaging 
(sensors) offers powerful modality for real time monitoring of living samples with 
high resolution, quick response and selectivity.  
2.1.2. Overview of Fluorescence 
 
Figure 2. The Jablonski diagram. 
It is important to review fluorescence concept before getting in to detail with 
fluorescent molecular probes. The absorption of light by a molecule results in 
excitation of one electron from ground electronic state (S0) to one of the higher 
vibrational levels of a singlet-excited state. In a very short time, excited electron 
relaxes back to lowest vibrational level of the excited state (S1). There are several 
pathways for an electron to release its stored energy after reaching to S1 state. It can 
turn back to its ground state by releasing heat only (non-radiative path) or by 
emitting light, which is known as fluorescence. In addition to these, if the molecule 
contains suitable modifications and has sufficiently long-lived excited state lifetime, 
an electron in the singlet excited state can pass to lower energy triplet excited state 
(inter-system crossing). Relaxation from excited triplet electronic level to ground 
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state by emitting photons is named as phosphorescence. Time for fluorescence to 
occur is around nano or microseconds (10-9 - 10-6 s), on the other hand 
phosphorescence is more time consuming process (10-3 - 102 s) since it involves 
several transitions.7 Possible deactivation pathways for an excited electron are 
summarized in the Jablonski diagram (figure 2). One should note that emission 
wavelength of a molecule is always located at longer wavelengths than absorption 
wavelength due to the rapid decay of an excited electron to lowest vibrational level 
S1 (figure 3). This phenomenon is called as Stokes’ shift7 and it is counted as one of 
the positive characteristics of fluorescent molecular sensors. 
 
Figure 3. Stokes shift. 
2.1.3. Fluorescent Probes 
Fluorescence is well-accepted optimum signaling mechanism for optical molecular 
sensors due to some superior properties as mentioned before. Most important 
characteristic of fluorescent probes (fluorophore) is their extreme sensitivity due to 
Stokes’ shift that provides different wavelengths for excitation and emission. Thus, 
analyte detection can be realized by low or almost zero background signals. 
Fluorescence signal can detect analytes even at picomolar concentrations, whereas 
with chromogenic probes can detect concentrations as low as micromolar levels (one 
million times higher).8 It is also important to note that, presence of Stokes’ shift by 
itself is not sufficient to diminish background signal at some cases. For instance, 
biological samples have their own autofluorescence signals up to 600 nm. Probes 
absorbing/emitting at longer wavelengths of electromagnetic spectrum mostly 
overcome these interferences. So appropriate fluorescent sensors for biological 
studies should have optimized wavelength range between 600-900 nm so called 
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therapeutic window.9 Upper limit of this scale is arranged according to water 
absorption. Thus it is possible to monitor and analyze morphological details in 
tissues with subcellular resolution both in vitro and in vivo by using non-invasive 
fluorescence sensing tools. Biochemistry and molecular biology applications such as 
medical diagnosis, DNA sequencing and bioassays regularly take advantage of 
fluorescent molecular sensors in daily life practices. Another useful property of this 
optical method is the widespread availability of instrumentation that requires 
minimal maintenance. An additional advantage of fluorescence sensing is that 
detection of analytes can be performed via time resolved measurements. 
Basic requirements for a fluorescent molecular probe can be summarized as follows;1 
(i) the binding site must have high selectivity for the analyte of interest (ii) there 
must be signal transduction mechanism between probe and analyte (iii) sensor-
analyte conjugate should be bio-compatible and stable in physiological medium (iv) 
out-coming signal should not be affected by environmental factors (e.g., pH and 
fluorescent quenchers) (v) irradiation and detection instrumentation have to be user 
friendly and cheap. It must be emphasized that it is really hard task to combine all of 
these properties in one probe and requirements may differ according to end-use of a 
molecular senor. 
There are many fluorophores, which are employed in fluorescent detection of certain 
analytes. Endogenous molecules are an important class. For instance, aromatic amino 
acids including phenylalanine and tyrosine are weakly emissive compounds.10 
Tryptophan (Trp) shows the highest fluorescence among amino acids at 353 nm 
under UV excitation with fluorescence quantum yield of 0.13.11 Trp can be used to 
monitor protein folding and ligand binding processes as well as it can be included in 
FRET12 and PeT13 applications. Other and maybe the most popular naturally 
occurring fluorescent dye is porphyrin, which has tunable absorption and emission 
peaks through visible and red region.   
Synthetic small molecules such as cyanine, fluorescein, perylene, coumarin, 
BODIPY and rhodamine are well known and extensively studied fluorescent probes 
(figure 4), which are applied in many applications including anion, cation and 
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biologically relevant molecules detection, food analysis, environmental monitoring, 
medical diagnosis and many other disciplines.14 
 
Figure 4. Molecular structures of common fluorescent probes. 
For all of these probes, it is possible to tune absorption and emission wavelengths, 
however coumarin dyes mostly known as UV probe whereas fluorescein and 
rhodamine derivatives are well recognized by their strong emission at near-IR region. 
Suitable chemical modifications that can be done on these dyes favor the 
incorporation of analyte binding side according to particular purposes. Different 
classes of dyes show unique properties. For instance coumarin dyes have very large 
Stokes’ shift, which makes them suitable for biological applications. Most popular 
coumarin dyes are heteroatom substituted ones. Fluorescein dyes after their first 
synthesis in 187115 have widely been used in chemosensor designs. It has very high 
fluorescence quantum yield, water solubility and it also possesses versatile 
modification sides for many different applications. However, this class of dyes have 
very high rate of photo-bleaching and pH sensitivity. On the other hand, rhodamine 
dyes, another well-studied fluorescent probes offer very low pH sensitivity and 
tunable absorption/emission peaks.16 Cyanine dyes are constructed with two 
polymethine chains between nitrogens. They are intensively used as DNA stains and 
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membrane sensors.17 Intramolecular chain twisting makes cyanine dyes flexible and 
alters their fluorescence properties. Fluorescent probes based on perylene dyes have 
strong absorption in visible range and high fluorescent quantum yield but difficult 
derivatization restricts their wide application.18 BODIPY dyes will be discussed in 
the following section separately since they will show up extensively throughout this 
dissertation.   
2.2. BODIPY Dyes 
BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) dye was synthesized for the 
first time accidently in 1968 while Treibs and Kreuzer were trying to react 2,4-
dimethylpyrrole with acetic anhydride in the presence of BF3.OEt2.19 After 17 years, 
in 1985 Hauglang and Kang reported the fluorescent characteristics of BODIPY 
dyes.20 Since then BODIPY dyes have been well recognized as fluorescent molecular 
sensors and employed intensively for bio-labeling applications.21-23 
 
Figure 5. Molecular structures of BODIPY and its precursors. 
BODIPY core can be obtained after two consecutive steps.24 In general, 
dipyrromethene group is obtained by combining two pyrrole moieties with a methine 
bridge. After that, dipyrromethene unit is coordinated with a disubstituted (mostly a 
BF2 group) boron atom, which completes the formation of rigid and constrained core 
structure. Simple BODIPY core structure, its IUPAC numbering and structures for 
BODIPY precursors are given in figure 5.  
There are three different synthetic pathways for the synthesis of unsubstituted 
BODIPY dyes. According to Bruce et al. procedure,25 after the formation of 
dipyrromethane core, it is oxidized by DDQ in order to obtain dipyrromethene 
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structure followed by the addition of tertiary amine base and BF3.OEt2. Second 
pathway involves the acid-catalyzed condensation of unsubstituted pyrrole and 
pyrrole-2-carbaldehyde just before the addition of base and BF3.OEt2 complexation.26 
In the final procedure, Pene-Cabrera and co-workers introduced the palladium-
catalyzed reaction of 8-thiomethyl BODIPY and triethylsilane in the presence of 
copper(I) thienyl-2-carboxylate (CuTc) with very high yield.27 
 
Figure 6. Synthetic pathways for meso-functionalized symmetric BODIPYs. 
Symmetric BODIPY dyes with meso (8-position) functionalization are synthesized 
by acid-catalyzed condensation of excess pyrroles with aldehydes, acid chlorides or 
anhydrides in the presence of amine base and BF3.OEt2 (figure 6).28,29 When 
aldehydes are employed in condensation, initially dipyrromethane intermediate is 
formed which is then oxidized to dipyrromethene by using quinone derivatives. 
Substituted BODIPY dyes at meso position are widely used due to their 
advantageous characteristics with respect to unsubstituted analogues. They provide 
high stability, enhanced solubility in organic solvents and free functional groups for 
further modifications depending on the end-use.   
It is also possible to synthesize meso-unsubstituted symmetric BODIPY derivatives 
by the condensation of excess pyrrole derivatives (~2.2 eq) with orthoester.30 
Initially dipyrromethene intermediate is formed and afterwards base and 
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borontrifloride are added to get BODIPY skeleton. Burgess and co-workers propose 
another possible mechanism in which pyrrole-2-carbaldehyde is used together with 
POCl3 without any need for excess pyrrole.31 Synthetic pathways for both strategies 
are given in figure 7. On the other hand, in the case of asymmetric BODIPY 
synthesis, condensation of pyrrole-2-carbaldehyde with other pyrrole derivatives has 
to be carried out.32 
 
Figure 7. Synthetic pathways for meso-unsubstituted symmetric BODIPYs. 
The parent BODIPY unit has a major absorption peak (S0-S1 transition) near 500-520 
nm with moderate to high absorption coefficients (40.000 – 100.000 M-1 cm-1). One 
should also note that in the absorption spectrum of a BODIPY dye, it is very 
common to observe a weak peak at high-energy region around 370 ± 10 nm that 
corresponds to S0-S2 transition.33 A sharp and strong emission peak due to the 
relaxation of an excited electron from S1 state is mostly observed between 530-550 
nm suggesting approximately 30 nm Stokes’ shift.  BODIPY dyes have very high 
fluorescence quantum yield (φf > 0.50) and long fluorescence lifetimes (in the order 
of nanoseconds). Phosphorescence is very rare since this class of dye normally have 
very low triplet quantum yields.34 They have high thermal and photostability as well 
as physiological medium compatibility.24 
Simple BODIPY core has some drawbacks such as solubility in aqueous solution, 
absence of functional groups for further modifications and low absorbance/emission 
wavelengths for biomedical applications. These challenges can be addressed by 
suitable derivatization of the core at meso, 3-5, 1-7, 2-6 and boron center.24 Meso (8) 
functionalization is straightforward since it can be realized by just choosing the 
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appropriately substituted aldehyde or acid chloride while performing the 
condensation reaction.35 Phenyl bearing substitutions at meso position in the 
presence of methyl groups at 1 and 7 positions of the core force phenyl moiety to be 
almost perpendicular to BODIPY core, which evokes some design strategies for the 
modulation of fluorescence signal. A different approach for functionalization of the 
8-position is to replace meso-carbon atom with nitrogen that yields aza-BODIPYs.36 
Incorporation of aza-substitution pushes absorption/emission peaks into the red end 
of the visible spectrum (650-850 nm).  
2-6 positions are susceptible to electrophilic attack due to their relatively electron 
rich character. At these positions sulfonation37 (important for water solubility), 
formylation,35 nitration38 and halogenation39 reactions can be performed. While 
heavy atom introduction such as iodine and bromine quenches the fluorescence due 
to effective inter-system crossing,40 they provide sides for well-known coupling 
reactions (e.g., Suzuki, Sonagashira and Stille). 1-7 and 3-5 positions have acidic 
character and they are suitable for Knoevenagel condensation reaction.41 This type of 
condensation is quite important because it is the simplest way to get red shifted 
absorption and emission peaks by extending the π-conjugation via incorporation of 
styryl groups (figure 8). Mono-, di-, tri-, and tetrastyryl modifications seem to offer a 
greater degree of versatility as judged by the recent interest,42-45 after Akkaya group 
report.41 This clearly stems from the following facts: (i) Knoevenagel reaction of the 
3- and 5-methyls is in most cases high yielding; (ii) the reaction conditions tolerate 
the use of a variety of aldehydes with different stereo-electronic characteristics; (iii) 
strong charge donor substituents are likely to yield switchable fluorescent molecules 
with internal charge transfer characteristics useful as chemosensors and molecular 
logic gates.46,47 In addition to Knoevenagel type condensation reaction, 3 and 5 
positions when decorated with good leaving groups, they are open to nucleophilic 
aromatic substitution. According to Dehaen and Boens studies 3,5-dichloroBODIPY 
dyes can be easily modified by nucleophiles.48 Ziessel et al. reported the replacement 
of two fluorine atoms at boron center by alkoxides and aryl groups to get highly 
photo-stable and redox active BODIPY derivatives, which have been used as 
sensitizers for dye-sensitized solar cells and organic photovoltaics.49  
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Figure 8. Functionalization of 3,5 and 1,7 positions by Knoevenagel condensation reaction. 
Copyright © 2009, American Chemical Society. Reprinted with permission from ref (41).41 
BODIPY dyes were known only as bright fluorescent dyes for use in cellular 
imaging as supplied by a few commercial sources. However, especially within the 
last ten years, there has been a veritable Bodipy renaissance. This is in large part 
sparked by the new tactics24,29 in the functionalization of the BODIPY core, which 
led to the synthesis of longer wavelength absorbing/emitting fluorescent dyes,50,51 
energy transfer cassettes,52 light harvesters,53 sensitizers for solar cells,54,55 
photodynamic therapy,56,57 nonlinear optical materials,58 mesogenic materials,59 
supramolecular polymers,60 and molecular logic systems.61 
2.3. Photophysics of Sensing Mechanism 
2.3.1. Photo-induced Electron Transfer (PeT) 
An electron is excited from HOMO level of a luminophore (light absorbing 
molecule) to its LUMO upon irradiation followed by vibrational loses within the 
excited state. If there is a receptor group, which is capable of donating or accepting 
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electrons, is linked to a luminophore without any conjugation then particular orbital 
of this receptor that contains lone electron pairs can be represented as separate orbital 
(figure 9). When the energy of this orbital lies between the luminophore’s HOMO 
and LUMO, an electron transfer occurs from lone electron pair to the hole in the 
HOMO that is created after excitation takes place. This phenomenon is known as 
photo-induced electron transfer (PeT). In the case of PeT, excited electron relaxes 
back to its ground state by non-radiative path and this leads to decrease in emission 
intensity or quenching of the fluorescence. Fluorescence can be regained if lone 
electron pair is involved in binding interactions (e.g., protonation or metal binding). 
Binding lowers the energy of receptor molecular orbital due to stabilization and 
blocks the electron transfer (figure 9).  
 
 
 
 
Figure 9. Schematic representation of PeT. Copyright © 2009, Royal Society of Chemistry. 
Reprinted with permission from ref (62).62 
There is another alternative PeT mechanism, which is known as “oxidative PeT”, 
which involves the electron transfer from excited molecule to electron acceptor 
receptor. Mechanism for oxidative PeT is given in figure 10. Contrary to 
conventional PeT, now initially luminophores are mostly fluorescent at the initial 
state (exceptions do exist, e.g., Nagano et al.)63 and upon binding, it becomes almost 
non-fluorescent due to the electron transfer from LUMO of luminophore to LUMO 
of receptor. 
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Figure 10. Schematic representation of reverse-PeT. 
PeT is one of the most traditional mechanisms for turn on-off fluorescence signal 
transduction and it can be utilized for detection of various analytes by employing 
wide range of probes and receptors.64,65 Some PeT based fluorescent probe examples 
are given in figure 11. An anthracene derivative fluorophore with crown-ether 
binding side is one of the simplest and well-known examples of PeT sensors. Upon 
addition of K+ on (7), fluorescence quantum yield increases from 0.003 to 0.14.66 In 
the case of (8), polyazamacrocycle rings were used to detect Zn2+ cation by turn-on 
PeT signaling mechanism.67 Compound (9) is a BODIPY based Cu(II) probe in 
which hydrolysis of ester to alcohol takes place after recognition of the analyte that 
blocks the PeT and increases the emission intensity.68 
 
Figure 11. Some PeT based fluorescent probes. 
2.3.2. Photo-induced Charge Transfer (PCT) 
Photo-induced charge transfer (PCT) is another popular signaling mechanism for 
molecular sensors. PCT probes contain electron donor and acceptor moieties, which 
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are conjugated to fluorophore. Upon excitation charge transfer occurs from donor 
groups to acceptors that causes charge redistribution throughout the molecule. Re-
localization of electron density makes this charge transfer process highly sensitive to 
microenvironment.  It is generally accepted that interaction of analytes with receptor, 
which is an electron acceptor or donating group, results in significant amount of 
shifts in both absorption and emission spectra (figure 12).2 If the fluorophore-analyte 
interaction takes place at donor side, then electron donation capacity of donor group 
will be lowered which results in conjugation loss and blue-shift in the absorption 
spectrum. On the other hand, if the receptor is electron-withdrawing group then 
binding of analyte will improve the electron withdrawing character of probe and red-
shifted absorption will be observed. Fluorescence peaks mostly behave similarly 
with absorption spectra (exceptions do exists). PCT strategy is mostly employed in 
calorimetric sensor designs in which naked eye detection of an analyte can be 
possible due to the immediate color change.    
 
Figure 12. Schematic representation of PCT. Copyright © 2007, American Chemical Society. 
Reprinted with permission from ref (2). 
Compound (10)69 contains crown-ether (electron donating) moiety as a calcium ion 
receptor (it is also suitable for K+). Thus binding of Ca2+ results in blue shift in the 
absorption spectrum. Parent fluorophore has absorption wavelength of 463 nm, 
which is blue-shifted to 360 nm after calcium complexation. This is expected result 
for absorption but fluorescence spectrum of (10) + Ca2+ shows some interesting 
results. While shift in absorption spectrum is almost 100 nm, emission maximum is 
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only shifted 28 nm. This can be explained by redistribution of electron density. PCT 
decreases the coordination capacity of nitrogen atom on crown-ether group by 
reducing the electron density on it, which makes the crown ether moiety almost non-
coordinating. Thus fluorescence spectrum is only slightly affected since emission is 
coming out from a fluorophore with very weak or no analyte interaction. Other two 
PCT examples in figure 13 are pH sensitive BODIPY based dyes. In the case of (11), 
electron donating dimethylamino phenyl moieties were used as a receptor. Proton 
binding to the receptor causes blue shift as expected.70 Compound (12) is very 
similar to the former probe, but it contains electron accepting pyridine groups. Upon 
protonation, red shift was observed in the absorption spectrum.69  
 
Figure 13. Some PCT based probes. 
2.3.3. Fluorescence Resonance Energy Transfer (FRET) 
FRET based molecular sensors are composed of two (or more) dissimilar 
fluorophores in which one behave as a donor and the other one is an acceptor. Donor 
fluorophore is the one that absorbs/emits at shorter wavelength. Upon irradiation at 
absorption wavelength of donor, the acceptor absorbs emitted light from donor and at 
the end while donor returns back to its ground state, emission of the acceptor 
compound is detected. FRET itself is a non-radiative process. In order to have 
efficient FRET,2 (i) there has to be a spectral overlap between donor emission and 
acceptor absorbance spectra, and (ii) orientation of dipole moments of donor and 
acceptor is critical. Fluorophores are mostly linked together by non-conjugated 
linkers, thus there is no orbital overlap between two units. It is noted in literature 
that, if the distance between two fluorophores are in the range of 10-100 Ǻ, then 
FRET can be active.2 This type of signal transduction is mostly useful when a 
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fluorophore of interest has small Stokes’ shift.  
2.3.4. Excimer Formation 
Fluorophores that contain aromatic rings such as anthracene and pyrene can form 
excited state dimers upon irradiation, which is known as excimer formation. In the 
case of excited state excimer, two emission peaks are observed one corresponds to 
monomer and the second one is the result of excimer formation and located at longer 
wavelengths.69 Addition of analytes may favor or hinder the excimer structure and 
the detection can be achieved by observing the relative emission intensity ratios of 
monomer and excimer.  
2.3.5. Aggregation Induced Emission (AIE) 
Rapid development of supramolecular chemistry emerge new fluorescent sensing 
mechanisms. Aggregation induced emission (AEI) is one of the promising and new 
emerging signal transduction mechanisms. It is well known that aggregated form of 
fluorophores in solution quenches the fluorescence (aggregation induced quenching).  
For that matter, many bulky and long chains are incorporated on to the fluorophore 
to avoid this type of aggregate formation in solution. However, some compounds that 
are almost non-fluorescent in solution were shown to have enhanced fluorescence 
upon aggregation.5  
 
Figure 14. 1-methyl-1,2,3,4,5-pentaphenylsilole (13) as an AIE probe. 
This behavior was first observed by Tang et al., by using 1-methyl-1,2,3,4,5-
pentaphenylsilole (13) (figure 14).71 Compound (13) is initially non-emissive in 
ethanol, but when the water content of the solution is raised up to 90%, fluorescence 
quantum yield is found to be 0.21. With the help of other examples, it is concluded 
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that AEI is the result of restricted rotation of the aggregate form. When there is no 
aggregation, intramolecular rotation activates the non-radiative path for relaxation, 
but in aggregate form this rotation is blocked and high fluorescence can be observed. 
Most common AEI probes are derived from silole and tetraphenylethylene (TPE) 
derivatives.72 
2.4. Detection of Biological Thiols 
During the last decade, calorimetric and luminescent detection of biological thiols 
namely cysteine (Cys), homocysteine (Hcy) and glutathione (GSH) have attracted 
great interest due to the biological significance of these thiol bearing molecules. Cys, 
Hcy and GSH (figure 15) are known to be important biomarkers for various diseases 
and chronic heath conditions.  
 
Figure 15. Molecular structures of bio-thiols. 
Specifically, high cysteine concentration is clearly associated with myocardial and 
cerebral infarctions, whereas deficiency of Cys can be related with liver damage, loss 
of muscle, skin lesions, lethargy and slow growth in children.73 In addition to these 
Cys is the main thiol source for iron-sulfur clusters that are best known for their role 
in oxidation/reduction reactions of mitochondria related electron transport.74 On the 
other hand, elevated Hcy level is an indicator of arterial and venous thrombosis (e.g., 
cardiovascular disease) as well as Alzheimer’s, folate and B12 vitamin deficiency.75 
Change in plasma total Hcy (tHcy) concentration is associated with the birth 
abnormalities and cognitive impairment in the elderly.76 It is also important to note 
that intracellular concentrations of Cys and Hcy are in the level of micromolar, 
whereas plasma concentrations of these two bio-thiols are found to be 0.25mM-
0.38mM.76 GSH is one of the most abundant (1-10 mM) intracellular nonprotein 
thiols, which is composed of cysteine, glycine and glutamic acid.77 It has important 
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roles in controlling intracellular redox activities and signal transduction. More 
specifically, it appears in the oxidative stress control mechanisms to maintain the 
redox homeostasis for cell growth and function.78 In addition to its intracellular 
activities; it is directly related with cardiovascular disease and cancer such that its 
intracellular concentration is 2 to 50 fold higher in cancer cells.79  
Calorimetric and fluorescent detection strategies of bio-thiols are mostly utilized the 
strong nucleophilic character of thiols and their high affinity towards metal ions.76,80 
Accordingly, almost all of the optical sensors for bio-thiol detection comprise 
chemodosimeter approach, which is realized by the reactions between molecular 
sensors and thiols.76,81 Mechanisms of these specific reactions can be summarized as 
Michael addition, cyclization with aldehydes, cleavage of sulfonamide/sulfonate 
esters, thiol-halogen substitution and metal complex coordination.  
2.4.1. Michael Addition    
Michael addition/reaction is the nucleophilic addition of nucleophiles to α,β-
unsaturated carbonyl groups. Thiols are known to be good candidates as a 
nucleophile in this type of reaction, which makes Michael addition one of the most 
employed strategies for the detection of bio-thiols via molecular probes. In 1998, de 
Silva and co-workers introduced serious of fluorophores with maleimide receptor for 
the detection of thiols.81  
 
Figure 16. Maleimide substituted probes for bio-thiol detection. 
Michael acceptor maleimide moieties are connected to fluorophores with spacer 
groups, so compounds 14-16 are chemodosimeters (figure 16), which use PeT as a 
signal transduction mechanism. Initially probes are almost non-fluorescent due to the 
PeT, after the Michael addition of Cys and simple mercaptoethanol to the electron 
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deficient alkene group in aqueous methanol solution, PeT is blocked and 
fluorescence is restored. 
Recently, a coumarin based bio-thiols probe (17) is reported by Sun et al. in which 
nitroalkene moiety is used as a Michael acceptor group (figure 17).82 Turn-on 
fluorescence response is observed in the presence of all bio-thiols and the reaction is 
highly selective towards Cys, Hcy and GSH than other amino acids. Cys is the one 
that reacts fastest followed by Hcy and GSH due to the steric factors. Fluorescent 
enhancement is mostly due to the inhibition of PeT upon addition of thiols to the 
nitroolefin group.   
 
Figure 17. Coumarin and fluorescein based Michael addition mechanism for selective 
detection of bio-thiols. 
A similar approach is also introduced by using fluorescein based probe (18) (figure 
17).83 After the addition of bio-thiols to nitroalkene, blue shifted absorption spectrum 
and emission intensity increase (at 520 nm) in fluorescence spectrum are detected. 
These optical changes are the result of spiro ring opening after the addition of bio-
thiols. Cys showed very fast response (kobs = 2.3 min-1) with a detection limit of 0.2 
µM. High fluorescence quantum yields of probe-thiol conjugates make them suitable 
for monitoring thiols concentration in cell and zebrafish.  In Michael addition 
reactions of bio-thiols, larger and bulkier GSH mostly faces more steric hindrance 
while it is trying to reach the α,β-unsaturated carbonyl center. Accordingly, it has 
lower reaction rate and highest interaction energy compared to Cys and Hcy in most 
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of the time.  
Jung et.al. introduced that the pKa differences of three bio-thiols can be considered as 
an additional point while dealing with the reaction rates of these thiols.84 pKa values 
of Cys, Hcy and GSH are 8.30, 8.87 and 9.20 respectively. So, Cys is the strongest 
nucleophile in physiological medium (pH 7.4) with its lowest pKa value. Jung and 
co-workers utilized this set of information in Michael-type addition of Cys to (19) 
(figure 18). Turn-on fluorescent signal is observed as a result of the reaction and 
probe is also used for imaging of Cys in HepG2 cells. 
 
Figure 18. Intracellular detection of Cys via Michael addition. 
Akkaya et al., designed two BODIPY dyes (20 and 21) carrying nitroethenyl 
substituents in conjugation with the BODIPY core which yields probes that responds 
to biological thiols via change in both absorbance and emission wavelength (figure 
19).85  
While (20) has absorption maximum at 520 nm, (21) has longer wavelength 
absorption due to the π-extension as a result of Knoevenagel-type condensation 
reaction. Both probes showed very fast and sensitive responses with color changes 
and “turn-on” fluorescence. This fluorescence enhancement is at least partly due to a 
reduction in the efficiency of the PeT process upon the attack of the Cys thiol on 
probes resulting an increase in the energy level of the BODIPY centered LUMO. 
Under identical conditions, other biological thiols, such as Hcy and GSH afforded 
similar turn on fluorescence responses as well. However, the response to Cys is 
much faster than that to Hcy and GSH. Thus, by controlling the reaction time, 
exquisite selectivity for Cys can be obtained. The result is bright signaling of 
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biologically relevant thiols in the longer wavelength region of the visible spectrum 
and in aqueous solutions (in the case of 21). 
 
Figure 19. BODIPY based probes for selective Cys detection.  
 
Figure 20. A FRET based chemodosimeter. 
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Shui et al., developed a FRET based chemodosimeter with iridium (III) metal 
complex (22), which is linked to diarylazo quencher via vinyl sulfide linker (figure 
20).86 When metal complex is irradiated at 360 nm, nearby non-luminescent 
quencher absorbs emitted light at 590 nm, thus probe is initially non-fluorescent. In 
the presence of Cys and Hcy, fluorescence of metal complex is restored. This is the 
result of thiol-assisted cleavage of vinyl sulfide linkage that releases the quencher 
from probe, which blocks the FRET. The probe is also capable of detecting the 
concentration of Cys and Hcy in human blood plasma. Plasma concentration is found 
to be 0.31 mM, which is in good agreement with the theoretical range (0.25 – 0.38 
nM).  
2.4.2. Cyclization with Aldehydes  
Cyclization with aldehydes is another widely used strategy for fluorescent sensing of 
Cys and Hcy. Molecular probes containing aldehyde functional group can be 
involved in 6- or 5-membered ring formation with suitable 1,3- or 1,2-aminothiols 
like Hcy and Cys. On the other hand, larger GSH is not suitable for similar ring 
formation. Hu et al. demonstrated this approach recently. Probe (23) is a 7-
dimethylamino-1,4-benzoxazin-2-one derivative, which contains electron donating 
amino and electron withdrawing carbonyl groups (figure 21).87 Push-pull system on 
the probe offers weak fluorescence and makes (23) a good PCT type probe. In the 
presence of Cys and Hcy, absorption maximum is shifted 70 nm from orange to 
yellow and 5-fold enhancement of emission intensity is observed at 560 nm in 
CH3CN-HEPES buffer (3:7, v/v) due to the cyclization process of probe with thiol 
bearing molecules Cys and Hcy at carbonyl side. Probe is also used to monitor bio-
thiols in living cells.  
 
Figure 21. Coumarin based detection of bio-thiols via cyclization mechanism. 
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2.4.3. Conjugate Addition & Cyclization 
Wang et al. designed a fluorescein based fluorescent probe that utilizes conjugate 
addition and cyclization processes together (figure 22).88 When small bio-thiols (Cys 
and Hcy) are introduced to chemodosimeter (24), they are added on acryloyl moiety 
followed by the cleavage of the ester bond due to the cyclization that forms 
fluorescein core, which is highly emissive. When incubation time of thiols with the 
probe is limited to 10 min, (24) is highly selective towards to Cys. In the absorption 
spectrum, upon addition of Cys in EtOH-phosphate buffer (pH 7.4, 2:8, v/v), a 
shifted peak at 490 nm is detected.   
 
Figure 22. Conjugate addition and cyclization approach for Cys detection. 
2.4.4. Cleavage of Sulfonamide and Sulfonate Esters    
Nucleophilic substitutions of phenols and amines in the presence of thiols have been 
used in many bio-thiol detection studies. One example is the Jiang and co-workers 
work (figure 23) in which they introduced BODIPY based near-IR probe (25).89 
Probe is decorated with 2,4-dinitrobenzenesulfonyl moiety, which is known to be a 
good electron acceptor and reaction site for thiols. Thiol specific cleavage of 
sulfonate ester blocks the oxidative PeT mechanism. Thus, turn-on response is 
observed at 755 nm with bio-thiols in a co-solvent (CH3CN-H2O-DMSO) with a 
(24) 
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detection limit of 0.5 µM. 
 
Figure 23. Cleavage of sulfonate ester bonds with bio-thiols.  
2.4.5. Thiol-Halogen Nucleophilic Substitution 
Thiol-halogen nucleophilic substitution is an important approach for the selective 
detection of GSH, which is otherwise difficult by Michael addition or cyclization of 
aldehydes strategies as mentioned before. Yang et al. reported a fascinating example 
of thiol-halogen nucleophilic substitution method for the selective fluorescent 
sensing of GSH (figure 24).90  
 
Figure 24. BODIPY based thiol-halogen substitution. 
Chlorine on the chlorinated-BODIPY derivative (26) undergoes nucleophilic 
aromatic displacement with the thiolates of the bio-thiols. While thioether adduct, 
which is formed by GSH is stable, Cys/Hcy encounter further intramolecular 
replacement of thiolates with primary amine groups on Cys/Hcy that involves the 
formation of 5- or 6-memebered rings in the transition states. At the end, two 
products are obtained; one is the sulfur-substituted BODIPY (in the case of GSH) 
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and the second one is amino-substituted BODIPY derivative (in the case of 
Cys/Hcy). As expected these two products have different optical characteristics such 
as, in the case of Cys/Hcy, absorption and emission maxima are blue shifted (λems = 
556), whereas thioether adduct has red shifted absorption and emission spectra (λems 
= 588 nm). So, by monitoring the emission signal at 588 nm, highly selective GSH 
probe is introduced, which is also applicable in cell culture studies.  
2.4.6. Disulfide Exchange Reaction 
Disulfide exchange reaction mechanism mainly involves the cleavage of disulfide 
bond by thiols. Zhu et al. combined two 4-aminonaphthalimide probes (typical PCT-
type dye) with a disulfide linkage in their recent study (figure 25).91 Addition of 
GSH on to the probe (27) cleaves the disulfide based carbamate linker followed by 
cyclization and release of 1,3-oxathiolan-2-one, which yields two 4-
aminonaphthalimide cores. Consequently, red shifted absorption and emission peaks 
are observed. Concentration dependent titration experiment with GSH suggests 
ratiometric detection of GSH both in solution and in cancer cells. 
 
Figure 25. Disulfide exchange reaction mechanism on a naphthalimide derivative. 
2.4.7. Metal Complexation 
Chemodosimeter design strategies for the detection of bio-thiols also include 
nucleophilic displacement approach in the presence of metal ions. In order to realize 
this, thiols should have high affinity towards the particular metal ion. Tae group 
reported one interesting example about metal complexation based detection of bio-
thiols (figure 26).92 They synthesized rhodamine hydroxylamine containing 2-
  31 
deoxyribose group. Sugar functionalization has two important roles. It increases the 
water solubility and metal binding strength (e.g., towards Au+) of the probe. Initially 
rhodamine derivative (28) is non-fluorescent and has no color since (28) is in the 
spirolactam form. Tae and coworkers reported that addition of Au+ ion increases the 
emission intensity due to the ring opening reaction. In addition to that, complexation 
of Cys and Hcy with Au+-(28) conjugate further increases the fluorescence and 
shifted the color from colorless to red. Various amino acids are also employed but 
only Cys and Hcy selectively bonded to the gold ion with the help of well-known 
Au-S interaction. Detection limit of the probe for Cys is noted as 100 nM.   
 
Figure 26. Metal complexation approach for the detection of bio-thiols. 
2.5. Photodynamic Therapy 
2.5.1. General Information 
Photodynamic therapy (PDT) is a promising non-invasive treatment modality for 
certain malignant (skin, head and neck, gastrointestinal, gynecological cancers), 
premalignant (actinic keratosis), and nonmalignant (psoriasis, AMD-age related 
macular degeneration) indications.93 The therapeutic action is contingent upon the 
generation of singlet oxygen through excitation of a particular chromophore 
(sensitizer) followed by an energy transfer to the dissolved oxygen in tumor tissues. 
Thus, PDT involves three individually non-toxic components; light, sensitizer and 
molecular oxygen, which are come together to generate cytotoxic singlet oxygen. 
Singlet oxygen and other secondary products (reactive oxygen species, ROS) are 
responsible for the apoptotic and necrotic deaths of the tumor cells. Main cellular 
targets are membrane structures of the cells and organelles.94 Since all three effectors 
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must be at the same spatiotemporal coordinates for singlet oxygen generation and 
administration of the sensitizer is done by intravenously or topically around the 
diseased regions PDT has the potential to be a very localized and selective modality 
of cancer treatment. Moreover, irradiation of the tumor area in the body can be 
realized by means of flexible fiber optics. Unlike chemotherapy and radiation 
therapy, PDT does not cause serious side effects. Mechanism of PDT action and its 
effects on tumors will be discussed in the following sections.  
2.5.2. Milestones of PDT 
Light-induced therapy is traced back to more than three thousand years ago.94,95 In 
the ancient Egypt and India, light was being extensively used to treat various 
diseases such as psoriasis, rickets and vitiligo.96 At the beginning of nineteenth 
century, Oscar Raab demonstrated that when certain chemicals interact with the 
light, they are able to generate cytotoxic effects.97 In 1903, the use of light to treat 
several diseases was named as “phototherapy” by a Nobel laureate Niels Finsen.98 In 
the same year, Herman Von Tappeiner and Jesionek showed that skin tumors could 
be effectively treated with eosin dye in the presence of white light, which is then 
classified as “photodynamic action”.99 
Porphyrin is one of the most widely studied sensitizers in the mid-nineteenth century. 
W. Hausmann introduced the iron coordinated porphyrin derivative 
(haematoporphyrin) to treat paramecium and red blood cells.100 Later, a German 
physician Meyer-Betz injected a porphyrin sensitizer into his body. After walking on 
a sunny day, he reported pain and swelling. Also, he remained light sensitive for 
months. This trial is the first reported study with a PDT sensitizer on humans.101 
Richard Lipson and coworkers further improved the initial haematoporphyrin (29) 
designs (figure 27).102 They showed that administration dose of their 
haematoporphyrin derivative (HPD) is much smaller than crude haematoporphyrin 
due to the high level of accumulation of HPD in tumor sites. First in vivo study was 
reported in 1972 with porphyrins in tumor-implanted rats in which tumor growth was 
delayed for 20 days.103 Dougherty established a pioneering study in 1975 by stopping 
the tumor growth in mice completely with the help of HPD and red light.104 Clinical 
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applications were started to appear in 1976.93 Recurrent bladder carcinoma growth in 
one patient was slowed down and necrosis of the tumor cells with the help of HPD 
sensitizer was observed. Then, Dougherty and colleagues used similar approach to 
treat 25 skin cancer patients.105 Hayata et al. tried to enlarge PDT action to deeper 
cancer cells (lung tumors) but only 7% of patients were cured successfully.106 After 
1984, PDT was applied extensively to many cancer types including oesphageal, lung, 
gastric, breast, head/neck and pancreatic carcinomas.93 These studies showed that 
PDT was mostly effective in early-stage patients.94 
 
Figure 27. Molecular structures of Photofrin and Foscan. 
In 1993, partially purified form of HPD (Photofrin) (figure 27) got approval for the 
first time in Canada for prophylactic treatment of bladder cancer.94 Later, FDA and 
other worldwide agencies also approved it with extended scope (esophageal cancer, 
Barrett esophagus which is a pre-cancerous condition that may lead to esophageal 
cancer; gastric and papillary bladder cancer, cervical dysplasia and cancer, 
endobronchial cancer). There are also some other FDA approved PDT agents (table 
1) such as ALA, 5-aminolevulinic acid (skin, bladder and brain cancers) and 
Verteporfin (ophthalmic, pancreatic and skin cancers). In addition to these additional 
approved drugs in certain countries (Levulan, Metvix, Foscan (30) (figure 27), ALA 
esters - EU, NPe6 - Japan) do exist with many others in trial phases.94,107 It is highly 
possible to further increase the efficacy of PDT action in clinic by improved 
specificity, better localization and deeper light penetration. This might be achieved 
by new generation of drugs, which combine novel protocols and equipments. 
2.5.3.  Mechanism of PDT Action 
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The absorption of light by a sensitizer results in excitation of one electron from 
ground electronic state (S0) to one of the higher vibrational levels of a singlet-excited 
state. 
Table 1. FDA approved PDT drugs.93,107 
PS Structure 
Wavelength 
(nm) 
Approved Trials Cancer Type 
HPD-Photofrin Porphyrin 630 Worldwide  
Lung, 
esophagus, 
bladder, brain 
ALA-Levulan Porphyrin 635 Worldwide  
Skin, bladder, 
brain, 
esophagus 
ALA esters-
Metvix 
Porphyrin 635 Europe  Skin, bladder 
Temoporfin-
Foscan 
Chlorin 652 Europe 
United 
States 
Head and 
neck, lung, 
brain, skin 
Verteporfin Chlorin 690 Worldwide  
Ophthalmic, 
pancreatic, 
skin 
Talaporfin-Npe6 Chlorin 660 Japan 
United 
States 
Liver, colon, 
barin 
Silicon 
phthalocyanine-
Pc4 
Phthalocyanine 675  
United 
States 
Cutaneous T-
cell 
lymphoma 
Padoporfin-
Tookad 
Bacteriochlorin 762  
United 
States 
Prostate 
Motexafin 
lutetium-Lutex 
Texaphyrin 732  United 
States 
Breast 
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In a very short time, excited electron relaxes back to lowest vibrational level of the 
excited state (S1). At that point, if the sensitizer contains heavy atoms (e.g., iodine, 
bromine) or some transition metal complexes (e.g., Ru, Ir) or intramolecular spin 
convertors (e.g., C60), it is highly possible to observe inter-system crossing (ISC) 
from singlet excited state to long-lived triplet excited state.108 Furthermore, ISC can 
also be achieved with sensitizers that have low-lying n-π* transition and exciton 
coupling behaviors.109 After reaching to triplet excited states there are two possible 
reactions that can undergo at this excited state.93 First one is the reaction with a 
substrate, such as cell membrane or a molecule in which electron transfer takes place 
from excited (activated) sensitizer to form radicals. These radicals then react with the 
molecular oxygen (3O2) to yield oxygenated products like highly reactive singlet 
oxygen, 1O2. In the second type of reaction, triplet excited state energy is directly 
transferred to nearby molecular oxygen to produce cytotoxic 1O2 (figure 28). Both 
reactions are clearly oxygen dependent thus, it is reported that induction of tissue 
hypoxia (absence of molecular oxygen) limits the singlet oxygen production.93 
Generally, ratio between these two types of reactions is related with the type of 
sensitizer, its affinity towards substrate, and concentration of oxygen.  
Singlet oxygen is a highly reactive species with a short lifetime in aqueous media 
(<0.04 µs, with an approximate diffusion distance of <0.02 µm.109 So, cells that are 
close to the area of the singlet oxygen generation are the ones that are mostly 
affected. Actually, this excited state species is 94.3 kJ/mol above the ground state, 
however the transition between the triplet ground state (X3Σg-) and the first singlet-
excited state is strictly forbidden by spin, symmetry and parity selection rules.110 
Therefore, singlet oxygen cannot be produced by the direct excitation of the ground 
state molecular oxygen, so it is always generated by sensitization through energy 
transfer from sensitizers. Photosensitization and generation of singlet oxygen in this 
way, with the intermediacy of these dyes also require an efficient intersystem 
crossing between the singlet and triplet manifolds as mentioned before. Overall 
efficiency of PDT action and its cytotoxic effect are multifactorial and highly 
dependent on the type of sensitizer, administration and light exposure doses, oxygen 
availability, localization of sensitizer and the time interval between administration of 
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the sensitizer and irradiation.93     
 
Figure 28. Modified Jablonski diagram. 
2.5.4. Basic Components of PDT  
There are three major components of a PDT action; a photosensitizer, light source 
and molecular oxygen. Choice of a suitable photosensitizer (PS) is one of the most 
critical steps while generating cytotoxic singlet oxygen in PDT action. An ideal PS 
should have easy manufacturing processes with good stability and long shelf life. 
Furthermore, high absorption coefficient at longer wavelengths (600-900 nm) is 
another important requirement. At theses wavelengths (therapeutic window) it is 
known that incoming light has highest tissue penetration depth.111 It has to be non-
toxic in the absence of light, in other words it should have no dark toxicity. In 
addition to these, clearance rate of a PS from healthy cells should be rapid in order to 
avoid phototoxic side effects. For effective and safe cell penetration it has to have 
amphiphilic character. Other desirable properties of a PS are high triplet quantum 
yield for effective ISC and long triplet lifetime for efficient reactions. These are 
probably most challenging requirements, which will be discussed in detail in the 
forthcoming sections. Finally presence of targeting moieties on a sensitizer increases 
the efficacy of therapy while decreasing the dark toxicity and possible side effects.  
In clinical applications, Photofrin is the most commonly employed PDT sensitizer as 
mentioned before, however its complicated structure, low absorption coefficient and 
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low selectivity forced scientist to reveal new sensitizers. After significant efforts, 
most of the problems associated with the Photofrin such as need for high 
concentration of drug/light exposure and long-term photosensitivity was solved with 
a chlorine sensitizer, Foscan.107 Nevertheless some other complications were 
reported due to its high potency. ALA and ALA ester derivatives are also important 
class of photosensitizers with their high potential for clinical applications.107 There 
are also many other sensitizers apart from porphyrin derivatives, which have been 
used in in vitro and in vivo studies such as rose bengal, methylene blue, eosin B, 
phthalocyanine and BODIPY derivatives.108    
Light source is another critical component of PDT action. It is not just significant for 
irradiation of a PS but also deterministic for the efficiency of the therapy. It is known 
that penetration depth of blue light is very limited, whereas red and near-IR 
radiations penetrate deeper through tissues. Most effective range for irradiation is 
introduced as between 600 to 900 nm.111 Longer wavelengths are not useful since the 
energy of the light is not sufficient to initiate PDT reactions and at that wavelengths 
water and some physiological molecules start to absorb most of the incoming light. 
Mostly employed light sources are lasers and light emitting diodes (LEDs). 
Moreover, optical fibers with diffusing tips are appeared to be important class of 
light sources especially for the influential delivery of light to the tumor sites in the 
body. One should note that total light dose, light exposure time and light delivery are 
important points for clinical efficacy. Final component for the PDT action is the 
molecular oxygen as it is mentioned before. It is the major reagent of light-triggered 
singlet oxygen generation reactions.  
2.5.5. PDT Effects on Tumors        
Generation of cytotoxic singlet oxygen can trigger the tumor destruction in three 
different ways: (i) direct killing of tumor cells, (ii) tumor infarction by damaging 
tumor vasculature and (iii) activation of an immune response against cancer cells.93 
All of these three pathways are contributing to cancer cell killing process and long-
term tumor control. Almost all of the processes are related with the oxidative damage 
of 1O2. Singlet oxygen reacts with bio-molecules very rapidly. Lipid peroxidation, 
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oxidations of thiols and amines, DNA strand break and cross-linking are some 
examples for 1O2 bio-reactions. As a result of these reactions cell death is observed 
according to apoptosis or necrosis mechanisms depending on the localization of PS. 
Mitochondria localizing agents induce apoptosis, while plasma membrane localizing 
sensitizers are more likely to cause necrosis on irradiation.112 
PDT triggered photodamage can directly kill cancer cells,113 however complete 
removal of tumors cannot be achieved due to the several reasons.  Korbelik and co-
workers reported that tumor cells, which are away from the vascular supply, mostly 
survive due to the inefficient PDT action.113 Another issue is lack of molecular 
oxygen around the tumor sites due to the consumption of it during the PDT action 
and damaged vasculature as a result of PDT.114 This situation is directly restricted the 
long-term tumor response. In order to avoid hypoxia, light fluence rate has to be 
lowered or light exposure dose should be arranged carefully.  
There is no doubt that cancer cells are growing very fast and they need high amount 
of nutrients and oxygen, which is supplied by blood vessels. Thus, it should not be 
surprising to shutdown this feeding mechanism while treating cancer. In 1989, 
Barbara Hendersen showed that Photofrin caused vascular shut down around tumor 
sites, limiting nutrient and oxygen supply to the cancer cells.115 Decrease in tumor 
growth was also mentioned in the same study. Furthermore, it was shown that PDT 
induced vascular damage is the result of thrombus formation.116 Further studies on 
well-known sensitizers HPD, Photofrin and benzoporphyrin derivative (BPD) 
demonstrated that vascular endothelial growth factor was upregulated during the 
PDT action proving the vascular constriction.117 Time interval between sensitizer 
injection and light irradiation can determine the killing mechanism of tumor cells. 
For instance, if the time between the administration and light exposure is short (15 
min) then sensitizers mostly localize in the vasculatures, which causes indirect 
killing of cells due to the vasculature damage.93 
In detailed studies with cells that are exposed to PDT action, signs of some immune 
system elements such as lymphocytes, leukocytes and macrophages were detected 
suggesting the activation of immune response in the PDT-treated tissues.118 Delay in 
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tumor growth was observed in deVree’s work because of the neutrophil 
accumulation in the PDT-activated tumor cells, which triggered the immune 
response against tumor.119 Activation of immune response is counted as one of the 
most advantageous issue of PDT since conventional cancer therapies namely 
chemotherapy and radiotherapy are known as immunosuppressive treatments.     
2.6. Triplet Photosensitization for PDT: Design Principles  
The triplet state of a photosensitizer can be populated by non-radiative S1 → Tn (n ≥ 
1) transition after successful excitation, which is known as inter-system crossing 
(ISC) process. So, in order to obtain powerful triplet sensitizers, strong absorption of 
the incoming light followed by efficient ISC are highly desired. Ideal triplet state 
sensitizers should also have long-lived triplet excited state since it behaves as a 
triplet energy donor to trigger many photochemical and photophysical processes, 
which play active roles in many application areas such as PDT, photocatalytic 
organic reactions and triplet-triplet anhilation (TTA) upconversion.108 It is also 
possible to apply triplet PSs to phosphorescent imaging, electroluminescence and 
molecular sensing studies. In the following sections PDT application will be 
discussed extensively.108  
In a singlet excited state, electrons have opposite spins according to Pauli exclusion 
principle however, triplet excited state electrons have parallel spins. Thus, ISC (S1 → 
Tn or S1 → T1) is normally quantum mechanically forbidden process since it involves 
spin reversion. This is why triplet excited state is less probably observed with most 
of the chromophores upon excitation. ISC mainly involves two different spin states 
and can be realized only in some circumstances. It is generally accepted that for an 
effective ISC process, there has to be a coupling between electron spin and orbital 
angular momentum, which is named as spin-orbit coupling (SOC).120 This coupling 
favors the ISC and during SOC, energy and total angular momentum are conserved. 
Spin-orbit coupling is one of the most important interactions that make ISC possible.  
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2.6.1. Heavy Atom Effect 
Sensitizers that are decorated with atoms (figure 29), which have large atomic 
numbers, can induce effective ISC.108 If an electron is moving around a nucleus with 
highly positive charge, motion of that electron accelerates, which increases the spin 
(µS) and angular (µL) momentum. As a result, coupling between two states become 
more feasible. Heavy atom containing sensitizers are great example of SOC 
modulation. Probability of getting SOC by using nuclear-charge effect scales with 
Z4, where Z is the nuclear charge.108 Thus, as the atomic number of an atom 
incorporated on the sensitizer increases, chance to have an efficient ISC also 
increases. Most organic dyes have low triplet quantum yields, and in many recent 
candidates for photodynamic sensitizers, heavy atoms are incorporated into the 
structure as a strategy to improve spin–orbit coupling leading to facilitated 
intersystem crossing.56 While this approach seems fail-safe, incorporation of heavy 
atoms such as Br, I, Rh, Ir, Pt, Ru and Os etc. very often leads to increased “dark 
toxicity”.121  
Incorporation of transition metal complexes is a well-known strategy for heavy atom 
triggered SOC and ISC.122 However, small absorption coefficients of transition metal 
complexes in the visible region restrict their widespread usage. Thus, iodo- and 
bromo-substituted sensitizers have been more excessively employed to obtain 
effective sensitizers for PDT. Rose bengal (31) and eosin blue (32) are important 
classes of triplet PSs for generation of singlet oxygen (figure 29).  
 
Figure 29. Heavy atom mediated ISC. 
Another remarkable triplet sensitizer class is BODIPY chromophore. BODIPY dyes 
due to their unique characteristics such as high absorption coefficients, resistance to 
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photobleaching, low dark toxicity and environment insensitivity are accepted as ideal 
sensitizers and have been used extensively in PDT studies.123 Nagano and coworkers 
reported first report of BODIPY sensitizer for PDT application in 2005. They 
introduced a 2,6-Diiodo-BODIPY (33) derivative to investigate heavy atom mediated 
singlet oxygen generation on this class of dyes (figure 29).34 Fluorescence quantum 
yield is observed to be 2% indicating efficient ISC for the excited electron. (33) is 
also applied  to in vitro cancer cell successfully. 
After the first report of Nagano, red/near-IR absorbing and water-soluble BODIPY 
derivatives started to appear. Akkaya group reported a di-styryl bromo-substituted 
BODIPY derivative (34) with red-shifted absorption maximum and improved water 
solubility due to the addition oligoethylene glycol moieties (figure 30).57 Cytotoxic 
effect of (34) on cancer cell line is detected by the cell-membrane damage via 
fluorescence microscopy.  
 
Figure 30. Near-IR absorbing, water-soluble BODIPY sensitizer. 
2.6.2. Heavy Atom Free Photosensitization 
There are also some other strategies that offer design principles for the comprising of 
heavy atom free sensitizers. As mentioned above incorporation of heavy atoms 
unfortunately increase the dark toxicity of the sensitizer. Unlike traditional 
chemotherapy agents, in principle, photodynamic therapy sensitizers themselves 
should be nontoxic, either at cellular or organ levels, even at relatively high 
concentrations. This projection at least partially can be realized by the use of heavy 
atom free sensitizers. Some design principles towards realization of heavy atom free 
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sensitizers are given below. 
2.6.3. Chromophores with Low-Lying n-π* Transitions 
One of the important requirements for effective SOC is that the energy difference 
between singlet and excited states should be close enough for strong transition. If the 
electronic configurations of S1 and T1 states are same, then the energy difference 
between these two states appears to be twice of the electron exchange integral (J). 
On the other hand, in the case of n-π* transitions (charge transfer) it is reported that 
energy gap between S1/T1 is much smaller. Therefore, most of the organic 
compounds with high π-extension undergo π-π* transition which dramatically 
decreases triplet quantum yield. El-Sayed generalized this phenomenon. According 
to El-Sayed’s selection rule S1 (n-π*) → T1 (π-π*) is an allowed transition since 
angular momentum is conserved and the energy gap is small. However, S1 (π-π*) → 
T1 (π-π*) transition is forbidden. Rate constant equation for ISC is given below, 
where HSO is the probability of getting SOC and E is the energy gap between S1 and 
T1 state. This equation clearly shows once more that small energy gap is highly 
needed for effective ISC. This is a typical case for excited states, which have charge 
transfer character and a simple example of low-lying n-π* transition mediated ISC is 
benzophenone (aromatic ketone) in which ISC rate constant is very fast due the S1 
(n-π*) → T1 (π-π*) transition.108 
kISC ∝<T1|HSO|S1>2 / (ΔES1-T1)2  
Dede et al., reported an informative study on charge transfer mediated ISC very 
recently (figure 31).124 In this theoretical study, excited state of pH dependent 
quinolizinium fluorophore (35) is investigated. S1 → T1 transition (ISC) is reported 
in the deprotonated form of (35), whereas triplet state hop could not be observed 
when (35) is protonated. Detailed calculations showed that in the case of (35) 
(deprotonated) excited state charge transfer from aminophenyl moiety to the 
benzoquinolizinium ring occurs. This excitation can be referred as n-π* type of 
charge transfer transition. On the other hand in the case of protonated (35), 
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aminophenyl group is no longer a charge donor and typical π-π* type excitation is 
detected. Consequently, almost degenerate S1 and T1 states are calculated in the case 
of deprotonated (35), which favors the ISC according to El-Sayed’s rule.    
 
Figure 31. Charge transfer mediated ISC. 
2.6.4. Exciton Coupling 
Excitation of a molecule that contains identical chromophores, which are closely 
linked together without π-conjugation, results in two delocalized excited states for 
each of the single chromophore. In other words, each chromophore is excited 
separately. If one of the singlet exciton states (mostly the one at lower energy) is 
closely oriented to the triplet-excited state, then ISC can be realized.125 There are 
also some recent examples in which similar two chromophoric systems are 
introduced, however exciton coupling could not be detected (see chapter 4).   
 
Figure 32. BODIPY based exciton-coupling behavior. 
Flamigni group demonstrated an example of exciton absorption for the construction 
of heavy atom free sensitizers.126 They performed the synthesis of a dimeric 
BODIPY derivative (36) (figure 32). When the absorption spectra of dimer and its 
corresponding monomer are compared, different absorption characteristics are 
observed in the case of (36). Absorption spectrum of monomer shows a typical 
S0→S1 excitation behavior of BODIPY core around 530 nm, whereas two sharp and 
strong absorption peaks are detected in the case of dimer (36) at 381 and 534 nm. 
Presence of two singlet-excited states with different energy levels makes singlet 
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oxygen generation feasible according to exciton coupling mediated ISC. 
2.6.5. Spin Convertors  
It is a challenging task to design heavy atom free sensitizers that are able to populate 
triplet-excited state. One should optimize the chemical modifications on a sensitizer 
according to tight selection rules. Insertion of an intramolecular energy acceptor with 
intrinsic ISC character (spin convertor) to an organic molecule, which has low triplet 
quantum yield, is a promising method for designing heavy atom free sensitizers for 
PDT. A typical spin convertor is C60 moiety that can be easily coupled with 
chromophores covalently. Out coming dyads/triads can be used for 1O2 generation 
due to the effective ISC.108  
 
 
 
 
 
Figure 33. BODIPY-C60 conjugate. Copyright © 2012, American Chemical Society. 
Reprinted with permission from ref (127).127 
Zhao and coworkers reported the use of fullerene (C60) as a spin convertor in 
combination with styryl BODIPY derivatives (37) in order to introduce heavy-atom 
free PDT sensitization.127 C60 moiety has an intrinsic ISC property but by itself it is 
not an ideal sensitizer since its predominant absorption peak is located at UV region. 
C60 has a very weak additional absorption peak around 700 nm, which makes it 
suitable for intramolecular energy transfer processes when it is coupled with 
conjugated chromophores (antenna). In the case of Zhao group study, BODIPY core 
that absorbs at the visible region works as an antenna group. Upon irradiation of the 
BODIPY, excited electron in the S1 state (1.93 eV) of an antenna passes to low lying 
C60 singlet excited state (1.72 eV). After that, due to the intrinsic ISC of C60, electron 
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is transferred to triplet state of C60 and finally the electron reaches to nearby triplet 
state of antenna molecule (figure 33).        
2.6.6. Glutathione Mediated Activation of PDT Sensitizers and Low pH of 
Cancer Cells   
Targeting is an important issue while designing a PS, such that it increases the 
accumulation of the drug at the tumor site and decreases the possible side effects. 
Passive targeting is the simplest method, which is widely employed for this 
purpose.93 It can be realized due to the minimum lymphatic drainage of tumor cells. 
Because of the leaky vasculature of the tumor tissues, sensitizers can easily 
accumulate in the tumor. This process is known as enhanced permeation and 
retention (EPR). However, passive targeting is not sufficient for effective forwarding 
of PDT sensitizers through cancer cells. There has to be additional targeting elements 
in combination with EPR approach for selective therapy. PSs that are covalently 
attach to various molecules, which have great affinity towards cancer cells or to 
receptors that are expressed on tumors (e.g., monoclonocal antibodies, peptides, 
epidermal growth factors, various carbohydrates, glucose receptors and low-density 
lipoprotein) are also widely used in targeting strategies.128 It is also possible to 
control the activation/deactivation of PSs by modulating the photophysics of 
sensitizers. Initially quenched PSs can be selectively activated after photophysical 
alterations in the cancer cells with tumor related inputs such as folic acid, GSH and 
many others. For instance, singlet-singlet energy transfer or self-quenching 
mechanism can deactivate PSs before transition to triplet excited state.129 Moreover, 
PeT130 and FRET131 processes can be modulated for successful quenching of PSs. In 
addition to these, singlet oxygen scavengers can be used to trap 1O2 before its 
cytotoxic effect following ISC.132 
Among possible targeting strategies, GSH activated sensitizers have attracted 
considerable attention and appeared to be promising in recent years. As it is 
mentioned before GSH plays important roles in cellular redox activity. Synthesis of 
GSH is realized by combining its amino acid precursors (glycine, cysteine and 
glutamine) in the presence of γ-glutamylcysteine synthetase and glutathione 
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synthetase. Reduced form of GSH acts as a strong antioxidant and mostly reduced 
the reactive oxygen species, which are produced as a result of oxygen metabolism 
intracellularly. After reduction, oxidized form of GSH, which is also known as di-
sulfide form (GSSG) can be readily obtained. Glutathione reductase enzyme is 
responsible for reducing GSSG back to GSH. GSSG is transferred to extracellular 
matrix and decomposition of it takes place there, whereas GSH is an intracellular 
bio-molecule. Thus, there is a great balance between GSH and GGSG within the cell, 
which is crucial for redox reactions and maintenance of cell life cycle.133 Therefore 
extracellular amount of GSH is low, which is around micromolar levels. On the other 
hand, intracellular level is around millimolar concentrations. Reducing capacity of 
GSH regulates signal transduction mechanisms. In the case of tumor, fast growing 
cancer cells try to decrease the amount of reactive oxygen species, which are known 
to be primary reason for oxidative stress that limits the survival and proliferation of 
cells. The high level of reducing bio-molecules NADH and GSH are responsible for 
this reduction. It is also observed that cancer-promoting transcription factor such as 
MYC is highly regulated that increases the glutamine uptake, which is needed for 
GSH synthesis. As a result of this cycle, reduced GSH level is elevated in cancer 
cells (2 to 50 fold).134 Thus, incorporation of GSH selective groups on a PS or GSH 
mediated activation of a PS are powerful and extensively applied modalities to get 
targeted PDT agents.  
 
Figure 34. GSH activated phthalocyanine sensitizer.  
Dennis Ng and coworkers reported a 2,4-dinitrobenzenesulfonate substituted zinc (II) 
phthalocyanine based activatable sensitizer very recently.135 Initially compound (38) 
is weakly fluorescent because of the 2,4-dinitrobenzenesulfonate group mediated 
reverse PeT mechanism. Since PeT mechanism is a very fast transition, presence of a 
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PeT pathway blocks the ISC and PSs become de-activated. When GSH is added, 
cleavage of sulfonate ester bond terminates the PeT route and singlet oxygen 
generation takes place with bare phthalocyanine sensitizer as in the case of porphyrin 
dyes (figure 34). (38) is also applied to MCF-7 cancer cell line.  
Choi et al. introduced a nano-sized graphene oxide (GO)-sensitizer (chlorine 6) 
complex, where redox-responsive cleavable disulfide linker satisfies successful 
complexation between GO and chlorine 6. Initially conjugate is non-fluorescent and 
non-toxic even under irradiation due to the effective FRET from excited chlorine 6 to 
the GO.136 Complex is getting activated only in cancer cells (where GSH level is 
very high) after exocytosis due to the GSH mediated disulfide bond breakage. 
Released sensitizer then becomes fluorescent and phototoxic (figure 35). This 
activatable conjugate is a highly promising example for the next generation 
theranostic (therapy + diagnosis) sensitizers.  
 
Figure 35. GSH activated graphene oxide-chlorine 6 conjugate for PDT. Copyright © 2012, 
Royal Society of Chemistry. Reprinted with permission from ref (136). 
 
Low pH value of cancer cells: Hypoxia and mitochondria damage force cancer cells 
to supply their energy need by increasing the rate of glycolysis (formation of ATP 
and pyruvate from glucose in the presence of pyruvate kinase) and lactic acid 
formation.137 Consequently change in energy metabolism and ion transport processes 
cause lactic acid and pyruvate accumulation in the cancer cells, which decreases the 
extracellular pH of cancer cells to pH 6.0-6.5. 
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2.7. Axial Chirality 
It is well known that sufficient condition for an organic molecule to be chiral is that 
it has to have a non-superposable mirror image. This condition is widely satisfied 
with a single and stable stereocenter (central chirality) in most of the organic 
compounds. Presence of central chirality is adequate but not a necessary one. There 
are also some other types of chiral molecules in which there are no chiral centers 
(chirality in molecules devoid of chiral centers). In 1956, Chan, Ingold and Prelog 
introduced the term “axial chirality” in their pioneering study.138 They stated that 
three-dimensional space could also be occupied by asymmetrically around a line or a 
plane in addition to a point (or a center).  
 
Figure 36. Some common molecules with axial chirality. 
Chiral axis is typically maintained by; (i) chain stiffness of a double bond, (ii) the 
molecular framework itself, (iii) a combination of these two or (iv) hindered rotation 
around a single bond.139 Consequently, axial chirality is mostly observed in allenes, 
spiranes, alkylidenecycloalkanes, and biphenyls (figure 36).  
 
Figure 37. Schematic representation of axially chiral plane. 
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In these types of molecules, if the tetrahedron framework is stretched along its S4 
axis, desymmetrized D2d framework is obtained.139 Thus, the long axis of this 
framework can be chosen as a chiral axis (figure 37). Since the stretched tetrahedron 
has lower symmetry compared to a parent tetrahedron, it is not required to have four 
different groups around a chiral axis such that, sufficient condition for chirality can 
be written as a≠b and c≠d. This is typical case for allene derivatives 
(abC=C=Cab).139    
Circular dichroism (CD) is the primary analytical tool for the analysis and detection 
of chiral molecules.140 It depends on the differential absorption of left/right circularly 
polarized light by a chiral sample. One type of circularly polarized light is absorbed 
more than the other at particular wavelengths and CD calculates the absorbance 
difference (ΔA).  
ΔA =  AL - AR 
where AL is the absorbance of left circularly polarized light and AR is the right 
circularly polarized light. According to Beer’s law, this equation can also written as 
follow; 
Δε = (εL - εR) =ΔA / cl 
εL and εR are molar extinction coefficients of left and right circularly polarized light 
respectively, c is the concentration and l is the path length. The term molar ellipticity 
[θ]M can also be used to represent CD results. 
[θ]M = 100θ / cl 
As it is mentioned before left or right circularly polarized light is absorbed more by a 
chiral sample, thus the amplitude of one type of light is always smaller.140 When 
amplitudes of these two incoming light are combined, they form ellipsoid shape. θ is 
the angle between the long and short axes of ellipsoid. Relation between extinction 
coefficient difference and molar ellipticity is given below. 
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Δε = [θ]M / 3298.2 
2.7.1. Atropisomerism 
Axial chirality in atropisomeric (named from the Greek a meaning not, and tropos 
meaning turn) compounds is the result of a non-planar arrangement of different 
groups on both sides of the chiral plane, and enantiopure products can be isolated 
because of the restricted rotation of a single bond on that chiral axis.141 Most 
extensively studied and known atropisomeric compounds are ortho-substituted 
biphenyl derivatives in which steric factors form rotation barrier between the 
substituents.142 In figure 38, schematic representation of a biphenyl is given. When 
X≠Y and A≠B and furthermore, if the steric interactions that arise from X-A, Y-B 
and/or X-B, Y-A clashes make planer arrangement of two rings highly energetic, 
axial chirality can be obtained. Two nonplanar enantiomers can be resolved under 
suitable conditions if the perpendicular to planer interconversion about a sp2-sp2 
bond is slow enough. Christie and Kenner introduce the first example of this type of 
axial chirality in 1922.143 Later, Kuhn named it as atropisomerism in 1933.143  
 
Figure 38. Schematic representation of atropisomerism. 
Oki and coworkers generalized the suitable conditions for getting resolved 
atropisomeric enantiomers.144 It is generally accepted that, successful separation of 
two isomers is almost impossible if the energy barrier between them is low (∼85 
kJ/mol) and so interconversion is taking place very rapidly at room temperature. It is 
difficult to introduce exact free energy values for efficient separation since it highly 
depends on temperature. Some estimated values are, 93.3 kJ/mol at 300 K, 109.6 
kJ/mol at 350 K and 61.5 kJ/mol at 200 K. In addition to energy barrier requirement, 
it is noted that half-life of an enantiopure product has to be at least 1000s (16.7 min) 
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for effective and stable isolation.  
Biphenyl and binaphthyl derivatives are very common examples of sp2-sp2 single 
bond type atropisomerism. There also some other types of atropisomerism such as 
axial chirality about sp2-sp3 (9-Arylfluorenes) and sp3-sp3 
(dibenzobicyclo[2.2.2]octatriene) bonds.139 Asymmetric synthesis of atropisomers 
mostly involves well established Kharasch, Negishi, Stille and Suzuki coupling 
reactions.139   
Nomenclature of atropisomers involves some additional priority rules139 such as 
“near groups precede far groups” and priority of the substituents on each of the units 
along the axis of hindered rotation is determined separately according to Cahn-
Ingold-Prelog priority rules (figure 39). Stereochemistry of atropisomers then can be 
assigned by moving from the substituent of highest priority on the closest ring to the 
highest priority group on the other ring by tracking the shortest path. If the direction 
is clockwise then isomer is named as P (plus) or S. On the other hand anti-clockwise 
direction can be designated as M (minus) or R. Sometimes aS or aR may be used, 
where “a” stands for axial chirality, but usage of “a” is optional. Schematic 
representation of sequence rule for atropisomers is given in figure 39. In this figure, 
it is assumed that priority of A>B and X>Y.    
 
Figure 39. Nomenclature of atropisomeric compounds.  
Chiral discrimination between enantiomers is highly significant for pharmaceutical 
and food chemistry.145,146 Atropisomeric compounds, especially binaphthyl 
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derivatives have been widely employed for enantioselective sensing of chiral 
molecules such as amino acids, amines, acids and alcohols.146 Lin Pu and co-workers 
introduced one example of fluorescent enantioselective detection of α-
Hydroxycarboxylic acids.147 They synthesized a 1,1’-bi-2-naphthol(BINOL)-amino 
alcohol derivative (39) (figure 40) and isolated the S-isomer. S-(39) has two 
characteristics fluorescence peaks one at 372 nm and the other one at 448 nm. 
Longer wavelength emission is assigned to the excimer formation, whereas the other 
peak is the monomer emission. When S-(39) is treated with S- and R-phenyllactic 
acid separately, it is observed that, S-phenyllactic acid quenches the monomer 
emission and increases the excimer fluorescence, conversely R-phenyllactic acid 
enhances the monomer emission. Similar results are also obtained by using mandelic 
acid. For both cases, ratio of fluorescence intensities for monomer emission after the 
addition of R/S acids can be used to achieve enantioselective sensing of α-
Hydroxycarboxylic acids. In the case of phenyllactic acid IR/IS ratio is calculated as 
11.2, which is the highest reported value for fluorescent enantioselective detection.   
 
Figure 40. Enantioselective detection of α-Hydroxycarboxylic acids. 
2.7.2. Chiral BODIPY Dyes   
Chiral fluorophores and chromophores are highly desired as it is mentioned in the 
previous section. Thus, the synthesis of chiral BODIPY (one of the most commonly 
used fluorescent dye) derivatives has great importance since this class of dye can be 
used in various applications. Rich BODIPY chemistry offers great opportunities for 
the functionalization of the core. Ziessel et al., reported a chiral BODIPY derivative 
(40) in which boron atom is used as a chiral center (boron asymmetry) (figure 41).148 
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Dissymmetrization at boron is achieved by the selective oxidation of methyl group at 
3-position and replacing one of the fluoride atom by naphthalene derivative. 
Enantiomers are isolated by chiral high performance liquid chromatography (HPLC) 
and presence of enantiopure products are detected by circular dichroism (CD) data. 
 
 
 
 
Figure 41. Boron asymmetry on a BODIPY dye. Copyright © 2010, American Chemical 
Society. Reprinted with permission from ref (148).148 
Daub and Rurack introduced a binaphthalene-BODIPY conjugate (41) for 
fluorescent chiral discrimination of optically active phenylethylamine (PEA).149 In 
the presence of base, deprotonation of hydroxy groups causes effective PeT, which 
decreases the emission intensity of BODIPY at 542 nm. When (41) is treated with R-
/S-PEA, decrease in fluorescence intensity is more pronounced in the case of S-PEA 
due to the better association of it with (41) suggesting enantioselective detection of 
an optically active base.  
 
Figure 42. Molecular structure of binaphthalene-BODIPY conjugate. 
After our first report150 on atropisomeric BODIPY derivatives (see chapter 5), during 
the preparation of this dissertation, Hall et al., revealed new axially chiral BODIPY 
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dyes (42, 43, 44) (figure 43).151 They modified the meso-position of the BODIPY 
core with an aryl substitution and 1- / 7-positions of the core with methyl groups in 
order to hinder the rotation of single bond at meso-position. In addition to that, ortho-
position of the meso-aryl and 2- / 6-positions of the BODIPY core are decorated with 
chemically differentiable groups to dissymetritized the axis of hindered rotation. 
Enantiopure products are separated by chiral HPLC.    
 
Figure 43. Axially chiral BODIPY derivatives. 
2.8. Polycyclic Aromatic Endoperoxides 
It is obvious that the chemical reactivity of singlet oxygen is different than the triplet 
ground state oxygen such that, it can undergo addition reactions to form 
endoperoxides. Many polycyclic aromatic compounds including naphthalene and 
anthracene can trap singlet oxygen, and some of these resulting endoperoxides 
(EPOs) exhibit an interesting feature, which is the release of singlet and/or triplet 
oxygen in the excited state upon warming or light irradiation.152 The first example 
discovered was the case of rubrene in 1926, which is followed by the studies on 
9,10-diphenylanthracene.152 Further investigations showed that in some instances 
(e.g., 1,4-dimethoxy-9,10-diphenylanthracene), the dissociation to produce singlet 
oxygen can take place at room temperature.152 In accordance with this feature, water-
soluble naphthalene endoperoxide derivatives have been prepared and employed as 
singlet oxygen carriers and source in biological environment by several research 
groups.153 It is now clear that by different substitution patterns, it is possible to 
control the rate and temperature of thermal decomposition process of polycyclic 
aromatic endoperoxides that suggests promising utilization on many application 
areas. 
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2.8.1. Preparation of Endoperoxides  
Most of the aromatic endoperoxides themselves are prepared by photosensitized 
oxygenation, which involves [4+2] cycloaddition of 1O2.154 Due to the electrophilic 
nature of 1O2, the reactivity of aromatic hydrocarbons with 1O2 increases with 
electron density of the hydrocarbons involved. Incorporation of electron donating 
substituents on the reaction site of 1O2 dramatically increases the rate constant of the 
addition reaction in the order H < C6H5 < CH3 < OCH3.152 For example, 
unsubstituted naphthalene does not react with 1O2, whereas it is possible to observe 
endoperoxide formation with 1-methyl naphthalene.152 Another structural effect on 
reactivity is the number of fused ring. Investigations on anthracene, tetracene and 
pentacene showed that as the fused ring number increases, reactivity increases by 
about 2 fold.155 
In addition to electronic effects, steric factors also play an important role in 
determining the reaction rate. For instance, in the case of [2,2] paracyclophane diene, 
phenyl rings are distorted in such a way that reaction with singlet oxygen can take 
place easily.156 1,8-dimethyl anthracene is another interesting example, in which 
steric strain between two methyl moieties is relaxed in the excited state suggesting 
high reactivity.152 Unlike Diels-Alder cycloadditions however, there is a significant 
solvent dependence in reaction rates. The cycloaddition reaction of singlet oxygen 
rate increases 100-fold from cyclohexane to DMF, and becomes even faster in water 
with water-soluble analogs.152 
 
Figure 44. Synthesis of aromatic endoperoxides. 
The suggested mechanism for the [4+2] cycloaddition of singlet oxygen to the 
aromatic compounds is very similar to the classical Diels-Alder type reactions but 
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with little alterations. Recent studies revealed that singlet oxygen addition to the 
aromatic ring is a concerted, single step reaction, which exhibits strong charge 
transfer from the aromatic organic donor to singlet oxygen (figure 44).157 During the 
reaction a reversible intermediate conjugate between aromatic ring and oxygen is 
formed in the singlet state. This conjugate has a significant charge transfer character 
due to the electrophilicity of singlet oxygen. After the formation of intermediate 
state, one can obtain the aromatic endoperoxide through concerted mechanism or 
charge-transfer mediated ISC may takes place that switches the intermediate 
conjugate to the triplet state and at the end molecular oxygen 3O2 is dissociated. 
2.8.2. Thermolysis of Endoperoxides    
In the dissociation of endoperoxides upon heating, in principle there are two primary 
pathways, cycloreversion, leading to the substrate and O2 (in either triplet or singlet 
state) and cleavage of the peroxide bond, which is often accompanied by 
rearrangements or decomposition to hydroxyketones or quinones (figure 45).158  
 
Figure 45. Thermolysis pathways for aromatic endoperoxides. 
Activation enthalpy values for cycloreversion are directly affecting the ratio between 
cleavage and cycloreversion. Figure 46 represents some activation parameters for the 
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thermolysis of several aromatic endoperoxides.152 Activation enthalpy for 
cycloreversion increases from simple benzene to substituted naphthalene and 1,4-
substituted anthracene derivatives and then 9,10-substituted anthracenic 
endoperoxide. Thus, it is clear that cleavage strongly compete with the 
cycloreversion process in the case of compounds similar to those. 
Recent studies showed that incorporation of aromatic moieties to the bridgehead 
position of aromatic EPOs favors the cycloreversion process.152 For thermal 
cycloreversion decomposition pathway, there are also two possible mechanisms. In a 
concerted cycloreversion, singlet oxygen is produced quantitatively. On the other 
hand, homolytic cleavage involves ISC and leads both molecular and singlet oxygen. 
Turro and coworkers introduced that 1,4-substituted aromatic endoperoxides (45, 46, 
47) decomposes singlet oxygen in a high yield, whereas 9,10-substituted ones (48) 
produce 1O2 and 3O2 (figure 46).158 As mentioned before, there are many examples in 
the literature in which naphthalene and anthracene derivatives have been employed 
as reversible singlet oxygen carriers in both organic and aqueous solutions.152 
 
Figure 46. Activation parameters for the thermolysis of various aromatic endoperoxides and 
singlet oxygen generation yields. 
Some examples are given in figure 47 and 48. In addition to small molecules, 
polymeric endoperoxides have also been prepared as well, for example, naphthalene 
derivatives are successfully grafted on a chloromethylated styrene divinylbenzene 
beads, or polymerization of methyl substituted vinylnaphthalene.159 
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Figure 47. Formation and decomposition of naphthalene based endoperoxides. 
 
Figure 48. Temperature dependence of anthracene (51) thermolysis. Copyright © 2008, 
Elsevier. Reprinted with permission from ref (160). 160 
2.9. Gold Nanorods 
Richard Feynman in his famous talk, which is entitled as “There is a plenty of room 
at the bottom” at American Physical Society Meeting at Caltech on 1959, introduced 
a new, fascinating and promising field with its potential application areas and 
impressive recommendations to the scientific community.161 This talk was approved 
to be the pioneering attempt for initiating the small-scale science, which is so called 
“nanotechnology” today. He started to present his new point of view by asking a 
remarkable question: “Why cannot we write the entire 24 volumes of the 
Encyclopedia Britannica on the head of a pin?” This was actually a good starting 
point, which strictly explains how small he meant when he was talking about small-
scale science. From that day to today, nanotechnology have been receiving extensive 
attention. Nanoparticles are one of the significant contributors to the field due to their 
attractive application areas such as biomedical technologies, catalytic activities, 
optoelectronic devices and plasmon-enhanced spectroscopies.  
It is very well known that the type and the pathway of free electron motion are 
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directly affecting the physical and chemical properties of a matter in most cases, 
highlighting the importance of the type and shape of the materials (figure 49). 
Detailed studies revealed that when the electrons are confined in a very small 
nanometer scale (1-100 nm), in other words as the size of a matter change from bulk 
to nano-scale; its properties (electronic, optical and catalytic) are dramatically 
changing due to the restricted electron motion, suggesting new and promising 
application areas.162 This is mostly the result of large surface area-to-volume ratio 
and quantum confinement effect (for 2-10 nm nanoparticles, where the size is 
comparable or smaller than the Bohr radius) in sufficiently small materials. This 
phenomenon is also valid for transition metal nanoparticles including gold 
nanostructures. The electron confinement in nanostructures of gold results in 
characteristic properties such as enhanced optical transition probabilities, 
confinement-induced shifts of energy levels and nonlocal dielectric responses.163 As 
a result of these properties, gold nanoparticles in the form of sphere, core-shell, cage 
and rod have been intensively studied and attracted great interest.164  
One of the most intriguing properties of gold nanoparticles is the ability to induce 
localized surface plasmon oscillations of conduction band electrons by confining the 
incoming photons in a small area. As a result of this confinement, the amplitude of 
the light wave increases by orders of magnitude (increase in electric field), which 
results in several potential applications including optical imaging, photothermal 
conversion, Rayleigh and enhanced Raman scattering.165 It is important to note that; 
localized surface plasmon resonance (LSPR) wavelength of a gold nanoparticle can 
be tuned by simply adjusting the size and the shape of the nanoparticle during the 
chemical synthesis. At that point, gold nanorods (NRs) are quite favored since these 
rod-like nanoparticles have two distinct LSPR peaks, which are longitudinal and 
transverse and former can be tuned by chemical synthetic methodologies across a 
broad range, covering visible and near-IR region of electromagnetic spectrum (figure 
49). This tuning is mostly realized by the control of the aspect ratio and varying the 
head shape of the nanorods.165 In addition to strong and controllable LSPR peak, 
gold NR has some other promising characteristics such as 
biocompatibility/bioinertness, ease of functionalization and compact size, which 
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makes it suitable for imaging, therapy and theranostic studies.164 These applications 
of Au NRs have been pursued extensively during the last decade.  
2.9.1. Preparation of Gold Nanorods         
Michael Faraday obtained gold nanocrystals in 1857 by reducing gold chloride in the 
presence of phosphorous for the first time.164 After this initial report, many 
techniques including chemical/electrochemical reduction, photochemical reduction 
and some other different physical methods have been introduced for the synthesis of 
gold nanoparticles (nanospheres, nanorods, nanoplates, nanocubes, nanoshells, and 
nanocages).164 For the growth of gold NRs, there are basically two methods, which 
are bottom-up and top-down approaches, and some other different physical methods 
have been introduced for the synthesis of gold nanoparticles (nanospheres, nanorods, 
nanoplates, nanocubes, nanoshells, and nanocages).164  
 
Figure 49. Comparative LSPR peaks of nano-sphere, shell and rod. Copyright © 2010, John 
Wiley and Sons. Reprinted with permission from ref (166).166 
Popular bottom-up techniques for the synthesis of gold NRs are wet-chemical,167 
electrochemical,168 solvothermal,169 microwave-assisted,170 and photochemical 
reduction171 methods in the presence of several reducing agents including ascorbic 
acid, sodium borohydride and 1-2 nm gold clusters. In addition to these, some 
directive templates are included in the synthesis in order to achieve growth along one 
direction. Most common templates for this purpose are cationic ammonium 
surfactants, among which cetyltrimethylammonium bromide (CTAB) is commonly 
employed.172 CTAB-like surfactants have two major roles; (i) they prevent the 
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aggregation of nanorods and (ii) direct the longitudinal growth of rods by forming 
micelle.  
In general, chemists prefer to use bottom-up, wet chemical seed-mediated growth in 
which gold salts are reduced in the presence of CTAB. This method is quite useful 
since it yields almost mono-disperse, uniform and high yield (yield in nanorod 
synthesis represents the ratio between the number of rod-like structures to the total 
number of gold nanocrystals in solution) nanorods.164 
 
Figure 50. Preparation of gold NRs according to El-Sayed’s seed mediated synthesis. 
Copyright © 2009, John Wiley and Sons. Reprinted with permission from ref (164)164 
Seed-mediated growth was introduced by El-Sayed and Murphy independently.167,173 
In a typical procedure (figure 50), initially, seed solution that contains 1-2 nm small 
gold nanoparticles are prepared by reducing chloroauric acid (HAuCl4) in the 
presence of cold sodium borohydride (NaBH4) in a aqueous CTAB solution. Then, 
small amount of seed solution is introduced to the growth solution, which is prepared 
separately by reducing HAuCl4, Au (III) to Au (I) with ascorbic acid in the presence 
of AgNO3 again in aqueous CTAB solution. Au (I) ions further reduced to Au (0) by 
added seed to form gold nanorods. One of the most important contributors of growth 
solution is AgNO3 since Ag (I) ions are thought to bond selectively to the {110} face 
of the gold nanocrystals during the growth, which favors the deposition of gold 
atoms on {100} face that causes the longitudinal growth and rod-like shape. 99% 
nanorod yield can be achieved by using seed-mediated growth. Moreover, this 
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Although the bottom-up methods can give nearly mono-
disperse Au nanorods with small diameters and high uniformity,
they suffer from several disadvantages that hinder the potential
device applications. First, selective placement of Au nanorods
at desired locations on substrates by the bottom-up methods
has been very difficult owing to the random nature of the
reduction of Au ions and the deposition of Au atoms in reaction
solutions. Second, the shape and size of Au nanorods vary
among different batches, even though the growths follow the
same procedures. This variation will affect their optical and
catalytic properties and applications. Third, there are extreme
difficulties in placing Au nanorods into large-area, ordered
arrays with the bottom-up methods. Top-down approaches are
therefore developed as a complementary means to the prepara-
tion of Au nanorods. Top-down methods have the merit of
producing homogeneous Au nanorods with controlled particle
geometries and regular inter-particle arrangements, which is
valuable for quantitative characterization as well as device
applications.
There are mainly two types of top-down methods for the
preparation of Au nanorods. The first refers to the removal of
gold from pre-deposited Au films according to pre-designed
patterns using focused ion beam or various etching techniques.61–63
The remaining structures are composed of Au nanorods located
at pre-determined sites. The second type of top-down methods
employs lithography techniques to make masks. A layer of gold
is then deposited on the substrate that is covered with the mask
through physical methods, such as thermal, electron-beam
evaporation, or sputtering. Au nanorods are obtained after
the lift-off process. The sizes of the nanorods fabricated using
the top-down methods are usually limited by the resolution of
lithography techniques. For example, traditional photolitho-
graphy can only produce nanostructures with sizes in the range
of several hundred nanometers due to the diffraction limit of
light. Electron-beam lithography is the most commonly used
technique for the fabrication of Au nanorods with smaller sizes.
Nowadays, state-of-the-art electron-beam lithography systems
can produce Au nanorods of diameters ranging from B10 nm
to several hundred nanometers.64 However, the top-down
methods are usually time-consuming and have high cost, which
makes them impractical for the fabrication of Au nanorods on
large scales. In addition, the nanorods obtained from vacuum
deposition techniques are usually composed of polycrystalline
nanoparticles, which will degrade their plasmonic properties due
to the electron scattering at the grain boundaries. These short-
comings prevent the top-down methods from practical device
applications and limit them mostly to fundamental research.
2.2 Shape and size tuning
One of the great challenges in materials science is the fine
tuning of the size and shape of nanostructures in a controlled
manner. This is very important not only in the rational design
of nanomaterials but also for their applications, because many
optical, electronic, and catalytic properties of nanomaterials are
strongly dependent on their shapes and sizes. For example, one
of the most intriguing plasmonic properties of Au nanorods is
that their longitudinal plasmon wavelength exhibits a nearly
linear dependence on their aspect ratio.7 Moreover, even for Au
nanorods with the same aspect ratio, the plasmon resonance
properties are also strongly dependent on their head shape.
During the past fiv years, tremendous progress has been
made on the shape and size tuning of Au nanorods. Most of
them are based on the bottom-up methods, because such tuning
usually occurs at scales of several to tens of nanometers, which is
below the resolution limits of most top-down techniques.
By using the seed-mediated growth method together with
Fig. 1 Schematic illustration of the seed-mediated method for the growth of Au nanorods.
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growth method offers high control on size and shape of the nanorod product by 
careful adjustments of amount of surfactant and reagents, the pH of the solution, 
temperature, and the structure of seeds. Aspect ratio can be varied between 2.4 to 
8.5, which directly affects the plasmonic properties. For instance, by just changing 
the concentration of AgNO3, it is possible to change the length and aspect ratio of the 
nanorod. Furthermore, low amount of ascorbic acid yields dogbone-like rod 
structures. As in the case of almost all synthetic methodologies, there are also some 
drawbacks of this method.164 First of all, it is impossible to control the location of 
added gold nanocrystals to the rod during the growth, since gold salts are randomly 
reduced. Secondly, the size and the shape of the rods vary in each experiment even if 
the same procedure is applied.  
Top-down approaches for the synthesis of gold NRs involve removal of gold from 
pre-deposited gold film by using focused ion beam or some etching techniques, 
Second method is to use lithographic methods. Electron-beam lithography is the 
most applied one in which 10-100 nm rods can be obtained.164        
2.9.2. Functionalization of Gold Nanorods 
CTAB coated gold nanorods have to be functionalized with suitable 
organic/inorganic moieties for better stability under different conditions and to get 
functional reaction sites for further modifications according to desired end-use.174 
While performing the synthesis of gold NRs, dissolved bromide ions adsorbed on the 
surface of nanorod, which causes electrostatic interaction between positively charged 
ammonium end of the CTAB and bromide on the rod surface. This interaction forms 
the inner layer. Hydrophobic alkyl groups do not like to interact with water, thus an 
additional CTAB layer is formed in which ammonium end is pointing outside and 
hydrophobic tail is located inside. Consequently, presence of bilayer structure makes 
the surface of nanorod positively charge and it becomes stable in aqueous solution.175 
This bilayer can be broken if the concentration of the CTAB on the surface is lower 
than the critical micelle concentration and/or some other reagents with very high 
affinity toward gold is added.  
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Affinity of thiols towards gold is mostly utilized in functionalization of gold 
nanorods. Small molecules containing thiol as a functional group are not desired 
since they are not able to overcome the large attractive force between NRs. Thiol-
substituted high molecular weight polymers such as poly(ethylene glycol)s (PEGs) 
are more suitable for thiol-gold bonding chemistry.164 In general, functionalization 
with thiol molecules is realized at the two ends of the rod, suggesting that CTAB 
concentration is higher at the center.176 Modification of NRs with thiol terminated 
PEGs makes NRs more biocompatible and enhances their retention time in biological 
medium. Moreover, PEGlyation prevents the aggregation of rod in aqueous solvent 
and polar environments such as alcohols, acetone, dimethylformamide (DMF), 
dimethyl sulfoxide (DMSO) and phosphate buffer saline (PBS).164 Disulfides and 
dithiocarbamates can be also used to functionalize the surface of NRs. Polymers 
containing bifunctional groups also useful for further modification of gold NRs.177 
There are some other approaches different than Au-thiol bond chemistry including 
electrostatic, antibody-antigen interactions and DNA sequence recognition.164 For 
instance negatively charge polyelectrolytes (e.g, polystyrenesulfonate and 
polyacrylic acid) and proteins can be employed through electrostatic adsorption.178  
2.9.3. Plasmonic Properties and Photothermal Conversion     
It is mentioned before that collective oscillation of the conduction band electrons 
upon excitation of gold nanorods is responsible for the well-defined LSPR peaks of 
these nanostructures. Localization of incoming electromagnetic waves in a region 
that is very close (100 nm) to the surface, is one the unique characteristics of the 
metal nanoparticles. This property yields large electric field enhancements, 
extremely high absorption and photothermal conversion abilities. 
Desymmetritization of gold nanospheres as in the case of gold NRs dramatically 
changes the plasmonic behavior of the nanoparticles. Gold NRs with their cylindrical 
geometries offer different directions and path lengths for conduction electron to 
move around. As a result, NRs have two characteristic LSPR peaks, a longitudinal 
and a transverse peaks.164,165 In the former one, electron oscillations take place along 
the length direction and since the pathway is much longer, longitudinal LSPR peak is 
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located at longer wavelengths of the electromagnetic spectrum. Transverse mode is 
the result of transverse electron oscillations as the name implies and can be observed 
at the blue side of the longitudinal peak around 500 nm. Adjustment of the aspect 
ratio during the wet-chemical synthesis of NRs determines the absorption 
wavelength of longitudinal peak (600-1100 nm) (figure 51). 
 
 
 
 
Figure 51. Control of plasmonic properties by adjusting the aspect ratio of NRs. Copyright © 
2013, Royal Society of Chemistry. Reprinted with permission from ref (165) 165 
In gold nanoparticles absorbed energy is relaxed back through thermalization with 
the lattice, which generates heat as a result of plasmon resonance decay. This 
temperature increase on the surface of gold nanoparticles and surrounding medium 
have been recognized as a promising methodology for various applications such as 
photothermal therapy, gene/drug release and drug delivery.165 Gold NRs are also 
suitable for photothermal conversion with additional features. NRs have strong 
absorption behaviors with controllable and tunable LSPR peaks that can be shifted to 
the red region, where tissue penetration depth is high and absorption of organic 
tissues is low. Thus, NRs are one of the most striking candidates as a photothermal 
conversion agent for biomedical applications. Photothermal conversion process 
constantly compete with the radiative and other non-radiative decays, thus for 
effective conversion, plasmonic properties and geometry of the rods have to be 
adjusted carefully. It is shown that photothermal conversion efficiency increases as 
the match between incoming laser wavelength and the longitudinal plasmon 
wavelengths of nanoparticle increases.179 This is related with the better excitation of 
the rod under these conditions. In addition to the wavelength match, geometry of the 
rod is also significant for photothermal conversion. Theoretical and experimental 
studies revealed that radiative decay is reduced in rods with small particle volume 
the size of 200 particles was measured to obtain the average
size and the size distribution.
Results
Figure 1 (curve labeled as seed) shows the visible
absorption of the seed solution a few min after prepara-
tion. Based on the TEM images, the particle size in this
solution is less than 4 nm. By introducing 12 µL of the
5-min-aged seed solution to a growth solution, the NRs
start to grow. Figure 1 shows the visible spectra at
different stages of this process. Our results show that
if the citrate-capped seed is used in a growth solution
containing silver ions, φ and star-shaped nanoparticles
are formed. In addition, the distorted NRs formed have
a larger width in the middle than that at the ends,
similar to the results reported in ref 16. When the
CTAB-capped seed is used instead, these shapes are not
formed. The NRs formed have the shape and structure
that has been originally reported10 and is shown later
in Figure 6a-c.
In the case of citrate-capped seeds, upon increasing
the silver ion content in the growth solution, the
concentration of the nonrod-shaped particles increases
drastically so that three plasmon bands associated with
three different dimensions of these particles would
dominate the overall shape of the spectrum. For sur-
factant-capped seeds, we have been able to decrease the
amount of spherical particles almost to zero. More
importantly, we have been able to control the length of
the NRs by varying the silver ion content in the growth
solution. Figure 2a shows the effect of adding identical
growth solutions to 50-300 µL of 0.004 M AgNO3
solution. It can be seen that by increasing the silver
concentration, the longitudinal plasmon band redshifts
and its intensity increases. Size distribution measure-
ments confirm that the aspect ratio of NRs increases
as shown in Figure 2b. In all the samples the fraction
of the gold nanospheres is less than 1%.
The effect of the silver ion content is not always to
increase the aspect ratio of NRs. Figure 3a shows that
by increasing the concentration of the AgNO3 in the
growth solution tomore than 0.00012M (300 µL of 0.004
M), the length of the NRs starts to decrease. The
negative effect of the silver ions in higher concentration
is probably due to their interaction with the bromide
counterion of the surfactant monomers, which will be
discussed later. A similar effect on the growth of NRs
is seen for gold ions, which is shown in Figure 3b. Our
Figure 1. UV-visible spectrum of growth of a gold NR
solution right after seed addition. The length and population
of the NRs increase to a certain limit. The CTAB-capped seed
spectrum (less than 4 nm in size) also is seen in the lower
wavelength of the spectrum.
Figure 2. (a) Visible spectra of 5 identical growth solutions
in which the silver content increases from sample no. 1 to 5.
By controlling the Ag ion concentration, the length of the NRs
can be adjusted. (b) The aspect ratios of NRs obtained from
size measurements show an increase, which confirm the
results of part (a).
Figure 3. (a) Increase in the concentration of silver ions first
increases then decreases the average aspect ratio of the NRs.
(b) Similar effect is observed for HAuCl4. At high concentra-
tion, the decrease in size could be related to the enhanced
interaction of silver and gold ions with the surfactant coun-
terions. The error bars represent the range that was obtained
for each point after five trials.
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that causes effective photothermal conversion. On the other NRs with large particle 
volume showed reduced photothermal conversion. Furthermore, Choi and coworkers 
introduced correlation between concentration of NRs and photothermal conversion. 
They showed that as the concentration of rods increases, large temperature gradient 
occurs, indicating better conversion at high concentrations.180  
It is really a great challenge to know the heat generation and temperature distribution 
on gold nanoparticles precisely, which is important for applications in which 
localized heating is needed (tissue repair, catalysis). Quidant et al. recently reported 
a thermal microscopy technique to overcome this obstacle.181 This method utilizes 
the molecular fluorescence polarization anisotropy in order to image the heat 
distribution on a single gold NR. Results showed that heat distribution around NRs is 
almost uniform. However, resolution of this technique is not sufficient enough, thus 
improvements are highly needed.  
 
Figure 52. Selective photothermal therapy of cancer cells with anti-EGFR/Au. At 80 mW 
cancer cells (HSC and HOC) are injured while there is no effect on healthy cells (HaCat) 
Copyright © 2006, American Chemical Society. Reprinted with permission from ref (183).  
Photothermal therapy (hyperthermia) is one of the most studied outcomes of 
photothermal conversion that is satisfied by metallic nanoparticles. It is a viable 
approach, which microwaves, ultrasound, radiofrequency and lasers are used in 
accordance with gold nanoparticles to initiate heating at a region of cancer.182 Upon 
heating that raises the local temperature above 40oC causes tumor cell deaths 
(without any conjugated drugs) by necrosis/apoptosis, denaturation of enzymes, 
promoting functional changes in DNA and RNA.  
In vivo photothermal studies require deeper penetration of incoming light through 
  66 
skin and tissues. This causes the modification of gold nanoparticles in such a way 
that the SPR peak is shifted through the near-IR (NIR) region of the spectrum. Thus, 
gold NRs are promising structures and widely used in hyperthermia due to their 
physicochemical characteristics. El-Sayed et al. demonstrated that the NIR excitation 
of gold nanorods, which are modified with anti-EGFR antibodies, resulted in 
theranostic affect (both imaging and selective photothermal therapy).183 Results 
showed a clear distinction between healthy and cancer cells (figure 52). After the 
imaging of tumor region by the scattering light from NRs, irradiation was performed 
with Ti: sapphire laser (800 nm) and malignant cell death occurred at half the energy 
required to damage healthy cells.  
 
Figure 53. Schematic illustration of gold nanorods-PDT complex for NIR imaging and PDT. 
Copyright © 2011, American Chemical Society. Reprinted with permission from ref (184).  
Gold NRs mediated photothermal therapy has been also used in combination with 
PDT. Choi et al. designed a gold nanorod – PDT complex for NIR imaging and 
cancer therapy (figure 53).184 In the case of complex formation between PDT drug 
and gold, fluorescence emission and singlet oxygen generation are quenched due to 
the high absorption capacity of NRs. In other words, initially PDT agent is very close 
to the gold nanorod, which favors the energy transfer from PDT sensitizer to nanorod 
upon irradiation. Thus, initially there is no fluorescence and phototoxicity effect. 
After intracellular uptake of the PDT-gold conjugate at tumor sites, PDT agent is 
released from the gold nanorods, which causes emission enhancement and singlet 
oxygen generation. To sum up, in this recent article tumor sites are identified and 
PDT action took place that yielded 79% reduction of the tumor growth. 
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CHAPTER 3 
 
3. Selective Fluorescence Sensing of Glutathione 
Using a Bifunctional Probe 
This work is partially described in the following publication: 
Işık, M.; Guliyev, R.; Kolemen, S.; Altay, Y.; Senturk, B.; Tekinay, T.; Akkaya, E. 
U. Org. Lett., 2014, 16, 3260. 
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3.1. Objective 
In this work,185 a selective probe for glutathione was designed and synthesized.  The 
design incorporates spatial and photophysical constraints for the maximal emission 
signal.  Thus, pHs, as well as the intracellular thiol concentrations, determine the 
emission signal intensity, through a tight control of charge transfer and PeT 
processes. The probe works satisfactorily inside the Human breast adenocarcinoma 
cells, highlighting GSH distribution in the cytosol. 
3.2. Introduction 
Chemosensor development has evolved into an attractive field of study, with a large 
number of promising examples emerging at a steady pace with worldwide 
participation in this endeavor.186-188 Most successful probes or chemosensors emerge 
through modulation of photophysical processes operational for the selected 
chromophore. The modulation can be the result of a reversible association (e.g., 
ligand-metal ion), or a chemical conversion of the probe in the presence of a targeted 
analyte. Rational design of selectivity on the other hand, would benefit tremendously 
by the judicious incorporation of multiple structural and electronic handles on the 
signal transduction process. 
Biological thiols namely cysteine (Cys), homocysteine (Hcy) and glutathione (GSH) 
are known to be important parameters in health and disease states as mentioned in 
the chapter 2.74 Consequently, a great deal of recent effort has been placed on 
developing sensors and probes for each and every one of these three species.  The 
substantial progress made in the field has been reviewed recently by Yoon and co-
workers.80 It is an interesting side note that a probe selective for GSH remained 
elusive until recently.90,189 Commercially available probes have acknowledged 
deficiencies such as the need for UV excitation (o-phthaldialdehyde, naphthalene-
2,3-dicarboxaldehyde, ThiolTracker Violet), high background signal, nuclear 
accumulation of the adduct (Monochlorobimane) and non-selective reactions in all 
cases. 
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In our works focusing on advancing new strategies and/or tactics in sensing and 
signalling,190 we found BODIPY dyes to be particularly useful and amenable to 
modification in accordance with any design requirements.24,32 Their impressive 
spectroscopic properties (quantum yield, extinction coefficient, tunability) coupled 
with the ease of modulation of these properties through, among other photophysical 
processes, photoinduced electron transfer191 (PeT) and internal charge transfer192 
(ICT) made them a favorite among similar fluorophores. In designing a selective 
GSH sensor, we also noted that sensing of thiols is mostly based on their strong 
nucleophilic character, apparent even in aqueous solutions.193 Conjugate addition 
reactions, altering the spectroscopic properties of the probe is a very common theme 
encountered in a large number of molecular sensor designs.194 Our goal was to target 
GSH specifically, and we thought that could be achieved by incorporating an 
additional recognition site for the N-terminal ammonium group found in GSH. The 
structure of our target molecule is shown in figure 54.  
 
Figure 54. The structure and the signal modulation sites of the target probe.  The distance 
between the terminal amine and the thiol suggests a much better match for GSH and the 
probe, than the other two biological thiols. Copyright © 2014, American Chemical Society. 
Reprinted with permission from ref (185). 
We also thought the emission signal of the probe could be further modulated by the 
protonation state of the azacrown amine moiety which would alter the rate of PeT.   
The quenching in meso-dialkylaminophenyl substituted BODIPYs is most likely a 
combination of ICT and PeT processes, the former being more apparent in less polar 
organic solvents. For use in polar or aqueous solvents, rationally designed probes 
  70 
based on PeT modulation in BODIPY dyes are abound, and Nagano group has 
reported many, with significant potential.63,195  
3.3. Results and Discussion 
The target molecule was synthesized in a couple of straightforward steps (figure 55) 
starting from corresponding aza-crown substituted benzaldehyde. Formylation121 of 
the 2-position of the BODIPY core, followed by nitromethane condensation, yielded 
the desired product. It is very well known that electron donating and withdrawing 
substituents alter both the ground state and excited state properties and result in 
larger changes in dipole moment on excitation.  Thus, (Dye 1) shows a red-shifted 
absorbance with maximum at 518 nm (figure 56) and it is essentially non-fluorescent 
(φfl < 0.01). A control reaction with mercaptoethanol causes an enhancement of the 
emission intensity with a concomitant blue shift (-20 nm) in the absorption spectrum 
(figure 56). Biological thiols (Cys, Hcy and GSH) also react similarly. Selected 
photophysical data are presented in table 2. 
 
Figure 55. Synthetic route for the synthesis of GSH probe (Dye 1). Copyright © 2014, 
American Chemical Society. Reprinted with permission from ref (185). 
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Figure 56. Absorbance spectra of (Dye 1) (8.0×10-6 M) and (Dye 1) + Thiols (200 
equivalents) at pH 6.0 in 60% MES Buffer (30 mM) / 40% MeCN and at pH 7.4 in 60% 
MOPS Buffer (30 mM) / 40% MeCN. Copyright © 2014, American Chemical Society. 
Reprinted with permission from ref (185). 
Table 2. Selected photophysical parameters for the (Dye 1) and its conjugate adduct. 
 
probes 
λabs
a (nm) εmaxa 
(M-1cm-1) 
λems
a 
(nm) 
fwhm (cm-1) ϕfb (%) 
Dye 1 518 76,000 522 1590 <1 
Dye 1 + GSH   
(pH 6.0) 
505 68,000 522 1523 24 
Dye 1 + GSH  
(pH 7.4) 
505 68,000 522 1505 2 
a In buffered aqueous-acetonitrile (60:40) solutions. b Quantum yields were determined in 
reference to Rhodamine 6G (0.95 in ethanol). 
Thus, we felt confident that the first criterion for the putative GSH sensor namely, 
reactivity towards thiols and thus transforming the probe so that the typical green 
emission of an unaltered BODIPY core could be enhanced, was satisfied.  This is a 
result of diminished conjugation and charge withdrawal, as initially the nitroethenyl 
substituent is in conjugation with the BODIPY core, and on reaction with a thiol, the 
nitro group becomes isolated from the BODIPY π- system, due to the formation of 
the thioether adduct.  1H NMR data (figure 57) strongly corroborates with the 
emission intensity changes, providing clear evidence for the conjugate addition. 
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Figure 57. Partial 1H-NMR (in CD3OD, 298 K) spectra depicting the changes on GSH 
conjugate addition to the (Dye 1): The adduct was isolated by preparative HPLC following a 
room temperature reaction of the probe and GSH in aqueous acetonitrile. Trans-coupled 
protons disappear in the product, and the azacrown peaks show a more spread out cluster of 
peaks, suggesting an emergence of non-covalent, non-symmetric interaction. Copyright © 
2014, American Chemical Society. Reprinted with permission from ref (185). 
It is also evident that, if there is any difference between the biological thiols in terms 
of the intensity of the emission signal, it should be most likely due to the relative rate 
of the reactions, perhaps in competition with any side reactions.  Thus, unless there 
are other built-in structural selection criteria, cysteine and homocysteine should react 
faster than the larger/bulkier nucleophile GSH, and for shorter reaction (incubation) 
periods, they should generate larger emission responses.  
Next, we tested the response of the probe to three biological thiols in aqueous 
solutions. We carried out the first set of experiments in pH 7.4 buffered aqueous 
solutions.  When the reactions are complete, we observed a turn on of fluorescence 
emission (figure 58, right), together with a blue shift, just as it was in the case of 
simpler thiol, mercaptoethanol. However, when the reactions were repeated in 
slightly acidic solutions mimicking the typical pH values for tumor tissues (pH 6.0), 
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in accordance with our design, the results showed a very clear-cut preference for 
GSH for the strongest emission signal (figure 58, left).  
 
 
Figure 58. Emission response to biological thiols at two different pH values, 7.4 (left, 60:40, 
30 mM MES buffer/acetonitrile) and 6.0 (right, 60:40, 30 mM MOPS buffer/acetonitrile). 
Small change in pH causes more than 5-fold increases in emission intensity for the GSH – 
(Dye 1) adduct. For Cys and Hcy, the change is approximately 2.5 fold. The concentrations 
of the thiols and other amino acids (Gly, His, Ile, Leu, Met, Phe, Pro, Ser, Thr, Tyr, Val) 
were 1.6 mM and the (Dye 1) concentration was 8.0 µM. Excitation was at 500 nm, with 5 
nm slit-widths. Copyright © 2014, American Chemical Society. Reprinted with permission 
from ref (185). 
Selectivity at pH 6.0 was further established in a series of measurements including 
number of amino acids and the three biological thiols (figure 59).  Non-thiol amino 
acids showed no response, and selectivity at actual intracellular concentrations of 
three biological thiols was spectacular. Two conclusions can be drawn from these 
results, the steric fit of the protonated ammonium group at the N-terminal is optimal 
in GSH, and since the other two thiols, Cys and Hcy, are shorter and they cannot 
provide an ammonium group reaching the N-phenylazacrown receptor as the second 
recognition site (figure 54), once the thiol adduct is formed. The second more 
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important result is the PeT modulation: the N-phenylazacrown is a strong PeT donor. 
Its protonation would stop or slow down PeT leading to strong enhancement of the 
emission (off-on type). However, our expectation based on the pKa data of the 
aromatic amines, was such that the aromatic amine moiety should not be protonated 
to a significant extent at even pH 6.0, so no clear enhancement should be seen in the 
case of Cys or Hcy. We also performed titration experiments with increasing GSH 
concentration. As expected blue shift in absorption and turn-on response in 
fluorescence were observed (figure 60).   
 
Figure 59. Selective emission response of the (Dye 1).  Blue bars correspond to the emission 
enhancement ratios (Io being the emission intensity of the probe) when biological thiols are 
introduced at their respective intracellular concentrations79,196,197 in aqueous medium (60:40, 
pH 6.0, 30 mM MOPS buffer/acetonitrile) with 8.0 µM (Dye 1) concentration.  Red bars 
show the emission enhancement when all analytes are introduced at 1.6 mM, in the same 
solvent system and probe concentration.  Excitation was at 500 nm, emission data at 522 nm 
(I and I0) were used in calculations. Copyright © 2014, American Chemical Society. 
Reprinted with permission from ref (185). 
In addition, the protonation state would not be in any way linked to the thiol reaction. 
In GSH however, N-terminal ammonium is in the right place for an effective ion- 
dipole and H-bonding interactions, which would change in the pKa of the azacrown 
amine, and thus it will be protonated to larger extent at pH 6.0. We did not want to 
leave this issue as simple conjecture, and synthesized two control compounds to 
check this experimentally. (Dye 2) is a simple phenylazacrown substituted BODIPY 
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and (Dye 3) has nitroethenyl Michael acceptor and an amine function (figure 61).  
These two compounds are to serve as negative controls of our design.   
 
Figure 60. Electronic absorption and emission spectra of (Dye 1) (8.0 µM) in 30 mM 
MES:CH3CN (60:40, v/v, pH=6.0, 25 °C) in increasing GSH concentrations (0 to 500 eq.). 
Excitation wavelength is 500 nm. Copyright © 2014, American Chemical Society. Reprinted 
with permission from ref (185). 
 
Figure 61. Following synthetic route was pursued to get (Dye 3). Copyright © 2014, 
American Chemical Society. Reprinted with permission from ref (185). 
To our delight, control (Dye 2) showed essentially no response to either moderate 
change in pH (7.4 to 6.0) or to the thiols (figure 62, left). Control (Dye 3) also as 
expected, showed only a small enhancement in emission on reaction with thiols, with 
small discrimination in terms of signal intensity, but PeT from the 
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dimethylaminophenyl substitituent showed no signs of change within the pH range 
mentioned (figure 62, right). 
 
Figure 62. The structures of control BODIPY (Dye 2) and (Dye 3).  (Dye 2) has a binding 
site for ammonium moiety, but no reactive group for thiols. (left)  (Dye 3) is thiol reactive, 
but it does not have a site for ammonium recognition. (right) Dye concentrations were 8.0 
µM, and the biological thiols were introduced at 1.6 mM. Aqueous buffer solutions were 
used as solvents, for pH 7.4 (60:40, 30 mM MES buffer/acetonitrile) and for pH 6.0 (60:40, 
30 mM MOPS buffer/acetonitrile). Excitation was at 500 nm, with 5 nm slit-widths. 
Copyright © 2014, American Chemical Society. Reprinted with permission from ref (185). 
The control experiments prove that the designed (Dye 1), has a strong steric 
differentiation between the GSH and the other two biologically relevant thiols, more 
so at pH 6.0.  pH 6.0 versus pH 7.4 responses are important as pH difference in this 
range is one of the characteristics separating tumors from healthy tissues. GSH is 
known to be present at highly elevated concentrations in tumor cells compared to 
healthy tissues.79 
Finally, we wanted to demonstrate the feasibility of the designed probe for GSH 
imaging in intracellular medium using cell cultures.  Figure 63 shows time-lapse 
images of (Dye 1) incubated cells. Within 2 hours, strong green emission of the GSH 
adduct is clearly visible in the cytosol of the cells. Considering intracellular 
concentrations of all biological thiols, the green emission is clearly resulting from the 
reaction with intracellular GSH. As a control to eliminate the possibility of the 
contribution of non-specific reactions (with other biological thiols, including 
proteins) to the generated emission signal, we performed an inhibition experiment 
(Figure 63). Buthionine sulphoximine (BSO) is a known selective inhibitor198 of γ-
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glutamylcysteine synthetase (γ-GCS).  HUVEC cells pre-treated with the inhibitor 
showed very low residual emission compared to untreated cells on staining with 
(Dye 1). 
 
Figure 63. Time-lapse confocal microscopy pictures of Human breast adenocarcinoma cells  
(MCF-7) cells incubated with (Dye 1) at 0.5 µM (a: 0 min, b: 1 min, c: 120 min).  d, e, 120 
min, fluorescence, optical images and f: merged image. Human umbilical vein endothelial 
cells (HUVEC) cells pre-treated with 5 mM BSO (g), DIC image (h), merge (i). The 
selective inhibition of GSH synthesis reduces fluorescence emission from the cells to a very 
low level, attesting the selectivity of the designed probe. Copyright © 2014, American 
Chemical Society. Reprinted with permission from ref (185). 
3.4. Experimental Details 
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX 400 
spectrometer using CDCl3 as the solvent. Chemical shifts values are reported in ppm 
from tetramethylsilane as internal standard. Spin multiplicities are reported as the 
following: s (singlet), d (doublet), m (multiplet). HRMS data were acquired on an 
Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS. UV-Vis Absorption 
spectra were taken on a Varian Cary-100 spectrophotometer. Fluorescence 
measurements were conducted on a Varian Eclipse spectrofluorometer. Flash column 
chromatography (FCC) was performed by using glass columns with a flash grade 
silica gel (Merck Silica Gel 60 (40–63 µm)). Reactions were monitored by thin layer 
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chromatography (TLC) using pre-coated silica gel plates (Merck Silica Gel PF-254), 
visualized by UV-Vis light and DNP stains as appropriate. All organic extracts were 
dehydrated over anhydrous Na2SO4 and concentrated by using rotary evaporator 
before being subjected to FCC. N-(4-Formylphenyl)-aza-18-crown-6190 and 
compound (4)199 were synthesized following reported literature procedures. All other 
chemicals and solvents were supplied from commercial sources and used as received. 
HPLC Separation of Dye 1-GSH adduct: Analytical and preparative HPLC 
separations of (Dye 1) + GSH adduct were performed on Agilent Technologies 
HPLC-1200 Series with multi-wavelength detector (MWD) and Agilent 
Technologies Preparative HPLC-1200 Series with diode array detector (DAD). In the 
case of analytical separation Agilent Technologies Zorbax Eclipse XDB-C18 
analytical 4.6 x 150 mm 5-micron column was employed and for preparative 
separation Agilent Technologies PrepHT XDB-C18 preparative Cartridge 21.2 x 150 
mm 5 micron column was used. For analytical resolution, adduct was dissolved in 
distilled water (%0.1 TFA), filtered and injected to the column. The flow rate was 1 
mL/min and UV detection wavelengths were 250, 370 and 520 nm. This separation 
was performed on a 4.6 x 150 mm column. Only one injection was done (10μL). In 
the case of preparative resolution of adduct, again it was dissolved in distilled water 
(%0.1 TFA), filtered and injected to the column. The flow rate was adjusted as 20 
mL/min and UV detection wavelength was 505 nm. This separation was performed 
on a 21.2 x 150 mm column. In preparative separation 5 injections were done (5 
mg/injections, 2000μL/injections), in order to get reasonable amount of the pure 
adduct. 
Electronic absorption and fluorescence spectroscopy experiments: Unless 
otherwise noted, all absorption and fluorescence spectra were recorded upon the 
addition of 200 equivalents (1.6 mM) of analytes on to 8 mM of the probe (1) or dyes 
(2), and (3). Each mixture (dyes + analytes) were incubated at room temperature for 
15 hours prior to spectrophotometric measurements. All data were collected in 
aqueous solutions (buffer-acetonitrile, 60:40). The pH was adjusted to 7.4 and 6.0, 
using 30 mM of MES and MOPS buffers, respectively and then diluted with 
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acetonitrile as the co-solvent. 
Detection Limit Calculation: Fluorescence titration experiments were conducted 
with increasing GSH concentrations. Slope of the emission intensity versus GSH 
concentration graph were calculated. In addition to that emission spectrum of (Dye 
1) without GSH was taken seven times and the standard deviation of the emission 
intensity was detected. Finally detection limit was calculated according to given 
formula below; where s is the standard deviation of 7 blank measurements and m is 
the slope of the emission intensity versus GSH concentration graph. 
Detection limit = 3s/m 
According to formula, detection limit was found to be 3.58 µM. 
Cell Culture Studies: Human breast adenocarcinoma cells (MCF-7) were grown to 
confluence at 37 oC under 5% CO2 in Dulbecco’s Modified Eagle Serum (DMEM) 
containing 1% penicillin/streptomycin, 10% fetal bovine serum (FBS) and 2 mM L-
glutamine. The cells were seeded in 24-well plates at 5x103 cells/well. After a 24 h 
incubation period, the cells were treated with 0.5 µM of (Dye 1) at 37 oC for 2h in a 
humidified incubator. Cells were washed three times with phosphate-buffered saline 
(PBS), fixed with 4% paraformaldehyde in PBS, covered with mounting medium and 
stored at -20 oC. In order to show that the probe specifically interacts with GSH, The 
cells (HUVEC) were we treated with buthionine sulphoximine (BSO), an inhibitor of 
GSH biosynthesis. After 24 h of treatment with 5 mM BSO, cells were stained with 
0.5 µM of dye. The samples were analyzed with Zeiss LSM-510 confocal 
microscope with an oil-immersion 63x objective lens. An argon laser of 488 nm 
wavelength was used with NFT 515 filter. Cell culture studies were done in Dr. 
Turgay Tekinay group at Bilkent University, UNAM, Ankara, Turkey. 
Synthetic Details: 
Synthesis of (Dye 2):  
Trifluoroacetic acid (TFA; 57µL, 0.75 mmol) was added dropwise to a vigorously 
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stirring solution of N-(4-Formylphenyl)-aza-18-crown-61,2 (1102 mg, 3.0 mmol) and 
2,4-dimethylpyrrole (627 mg, 6.6 mmol) in 350 mL Ar-deaerrated dichloromethane 
(DCM). The resulting red solution was stirred at room temperature in the dark for 1 
day. p-Chloranil (738 mg, 3.0 mmol) was then added in one portion and reaction was 
stirred for an additional hour. Diisopropylethyl amine (DIEA) (9.0 mL) was then 
added dropwise to this mixture over a period of 15 min, and the resulting dark brown 
solution was allowed to stir for an additional 15 min. BF3•OEt2 (9.0 mL) was then 
added dropwise over a period of 15 min., and the resulting dark red solution was 
allowed to stir further for 2h at rt. The slurry reaction mixture was washed with water 
(3 × 300 mL) and dried over anhydrous Na2SO4. The solvent was evaporated and the 
residue was purified by silica gel flash column chromatography (FCC) using 
CHCl3:MeOH (95:5) as the eluant. Compound (2) was solidified as a dark orange 
solid (790 mg, 45% yield).1H NMR (400 MHz, CDCl3) δ 7.01 (d, J = 8.4 Hz, 2H), 
6.75 (d, J = 8.4 Hz, 2H), 5.96 (s, 2H), 3.81 – 3.51 (m, 24H), 2.54 (s, 6H), 1.49 (s, 
6H). 13C NMR (100 MHz, CDCl3) δ 154.6, 148.4, 143.2, 132.2, 128.9, 121.8, 120.8, 
111.9, 70.9, 70.8, 70.7, 68.6, 51.3, 43.5, 14.7, 14.5.MS (TOF-ESI): m/z: Calcd: 
585.3191 [M-H]+, Found: 585.3365 [M-H]+, ∆=29.72 ppm. 
 
Synthesis of (3):  
POCl3 (1 mL) was added dropwise to a vigorously stirring anhydrous DMF (1 mL), 
which was kept in ice bath under N2. Resulting pale yellow viscous liquid was 
allowed to stir at room temperature for additional 30 min. To this, 1,2-dichloroethane 
(DCE) (50 mL) solution of (Dye 2) (585 mg, 1.0 mmol) was then slowly introduced 
and the resultant brown solution was heated at 60 °C for 3 h. (Attention: 60 °C is 
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critical to get mono-formylated product (3) as the major, side product (di-formylated 
BODIPY) formation was observed otherwise at higher temperatures.) Reaction was 
cooled to room temperature, and poured into ice-cold sat’d NaHCO3 solution. This 
mixture was extracted with DCM (100 mL portions) and dried over anhydrous 
Na2SO4. Solvent was evaporated in vacuo and compound was purified by silica gel 
FCC using DCM:MeOH (98:2) as the eluent. Product 3 was obtained as dark brown 
waxy solid with a green luster (521 mg, 85% yield). 1H NMR (400 MHz, CDCl3) δ 
9.98 (s, 1H), 6.97 (d, J = 8.8 Hz, 2H), 6.76 (d, J = 8.8 Hz, 2H), 6.11 (s, 1H), 3.71 – 
3.63 (m, 24H), 2.78 (s, 3H), 2.56 (s, 3H), 1.75 (s, 3H), 1.53 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ 185.9, 160.6, 155.8, 148.9, 147.4, 145.2, 142.8, 134.7, 130.6, 128.8, 
126.1, 123.6, 120.6, 112.0, 70.84, 70.77, 70.66, 68.4, 51.2, 25.6, 15.3, 15.0, 12.9, 
12.0. MS (TOF-ESI): m/z: Calcd: 613.3135 [M-H]+, Found: 613.3324 [M-H]+, ∆= 
30.81 ppm. 
 
Synthesis of( Dye 1):  
NH4OAc (3.8 mg, 0.049 mmol) was added to a nitromethane (5 mL) solution of 
compound (3) (300 mg, 0.49 mmol) and the solution was left to stir at 90 oC for 5 
days. Product formation was monitored with TLC using DCM:MeOH (99:1) as the 
eluant. At the end of reaction, nitromethane was removed in vacuo and obtained 
crude mixture was subjected to silica gel FCC using DCM:MeOH (99:1) as the 
eluent. Product (1) was obtained as a wine-red waxy solid (288 mg, 89% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.07 (d, J = 13.7 Hz, 1H), 7.37 (d, J = 13.7 Hz, 1H), 7.03 
(d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.6 Hz, 2H), 6.15 (s, 1H), 3.82 – 3.64 (m, 24H), 2.71 
(s, 3H), 2.62 (s, 3H), 1.62 (s, 3H), 1.57 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 
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213.7, 160.6, 153.8, 148.9, 147.4, 145.3, 144.3, 140.3, 134.3, 131.6, 131.2, 129.0, 
123.6, 120.6, 112.0, 70.91, 70.84 , 70.71 , 68.5, 51.2, 15.4, 15.0, 13.8, 13.3, 1.0. MS 
(TOF-ESI): m/z: Calcd: 656.3193 [M-H]+, Found: 656.3240 [M-H]+, ∆= 7.16 ppm. 
 
Synthesis of (5): 
POCl3 (1 mL) was added dropwise to a vigorously stirring anhydrous DMF (1 mL), 
which was kept in ice bath under N2. Resulting pale yellow viscous liquid was 
allowed to stir at room temperature for additional 30 min. To this, 1,2-dichloroethane 
(DCE) (50 mL) solution of compound (4) (367 mg, 1.0 mmol) was then slowly 
introduced and the resultant brown solution was heated at 60 °C for 3 h. (Attention!: 
60 °C is critical to get mono-formylated product (5) as the major, side product 
formation was observed otherwise at higher temperatures.) Reaction was cooled to 
room temperature, and poured into ice-cold sat’d NaHCO3 solution. This mixture 
was extracted thrice with DCM (100 mL portions) and dried over anhydrous Na2SO4. 
Solvent was evaporated in vacuo and compound was purified by silica gel FCC using 
DCM:MeOH (98:2) as the eluent. Product (5) was obtained as dark brown waxy 
solid with a green luster (335 mg, 85% yield). 1H NMR (400 MHz, CDCl3) δ 10.04 
(s, 1H), 7.07 (d, J = 8.7 Hz, 2H), 6.82 (d, J = 8.7 Hz, 2H), 6.15 (s, 1H), 3.06 (s, 6H), 
2.84 (s, 3H), 2.62 (s, 3H), 1.79 (s, 3H), 1.56 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 
185.99, 160.68, 156.01, 150.97, 147.39, 145.20, 128.66, 123.56, 112.45, 77.32, 
77.00, 76.69, 40.27, 15.22, 15.00, 12.97, 11.92. MS (TOF-ESI): m/z: Calcd: 
394.1980[M-H]+, Found: 394.1917 [M-H]+ , ∆= 15.98 ppm. 
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Synthesis of (Dye 3): 
NH4OAc (3.8 mg, 0.049 mmol) was added to a nitromethane (5 mL) solution of 
compound (5) (193 mg, 0.49 mmol) and the solution was left to stir at 90 oC for 5 
days. Product formation was monitored with TLC using DCM:MeOH (99:1) as the 
eluant. At the end of reaction, nitromethane was removed in vacuo and obtained 
crude mixture was subjected to silica gel FCC using DCM:MeOH (99:1) as the 
eluent. Product (Dye 3) was obtained as a wine-red  solid (194 mg, 90% yield). 1H 
NMR (400 MHz, CDCl3) δ 8.07 (d, J = 13.7 Hz, 1H), 7.37 (d, J = 13.7 Hz, 1H), 7.11 
– 7.01 (m, 2H), 6.82 (d, J = 8.8 Hz, 2H), 6.16 (s, 1H), 3.07 (s, 6H), 2.72 (s, 3H), 2.62 
(s, 3H), 1.61 (s, 3H), 1.57 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 160.63, 153.69, 
151.05, 147.48, 144.37, 140.36, 134.27, 131.15, 128.79, 123.62, 120.91, 112.36, 
77.34, 77.02, 76.71, 40.22, 15.29, 15.00, 13.78, 13.21. MS (TOF-ESI): m/z: Calcd: 
437.2039 [M-H]+, Found: 437.1973 [M-H]+, ∆= 15.09 ppm. 
 
3.5. Conclusion 
In conclusion, we have shown that selectivity for reaction-based probes can be 
improved by applying additional photophysical constraints.  In this work, this was 
made possible by the simultaneous modulation at two different sites, as the adduct 
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was generated.  While the probe discussed here required a co-solvent (acetonitrile) 
for better solubility, the idea described in this work is perfectly transferable to other 
fluorophores and even to other reactions to be used in sensory systems.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  85 
 
CHAPTER 4 
 
4. Activatable Heavy Atom Free Sensitizers for 
Photodynamic Therapy Application 
The discussions on this chapter are partially based on the following publications: 
Cakmak, Y.; Kolemen, S.; Duman, S.; Dede, Y.; Dolen, Y.; Kilic, B.; Kostereli, Z.; 
Yildirim, L. T.; Dogan, L.; Guc, D.; Akkaya, E. U. Angew. Chem. Int. Ed., 2011, 50, 
11937. 
Duman, S.; Cakmak, Y.; Kolemen, S.; Akkaya, E. U.; Dede, Y. J. Org. Chem., 2012, 
77, 4516. 
Kolemen, S.; Işık, M.; Kim, K. M.; Kim, D.; Geng, H.; Buyuktemiz, M.; Zhang, X.; 
Dede, Y.; Yoon, J.; Akkaya, E. U 
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4.1. Singlet Oxygen Generation by Using Heavy Atom Free 
Orthogonal BODIPY Derivatives 
4.1.1. Objective 
S0, S1, and T1 states of various orthogonal 8,8’ and 8,2’ bis-BODIPYs were utilized 
as heavy atom free photosensitizers for O2 (1Δg) generation, and studied by multi-
reference quantum chemical approaches. S0→S1 excitation characteristics of certain 
bis-BODIPYs are shown to be radically different than the parent BODIPY 
chromophore. Whereas a simple HOMO→LUMO type single substitution perfectly 
accounts for the BODIPY core S1 state of certain orthogonal bis-BODIPYs are 
described as a linear combination of doubly substituted (DS) configurations that 
yield four electrons in four singly occupied orbitals (tetra-radical, TR). DS-TR 
character of S1 was shown to have a strong correlation with S1→T1 ISC yielding 1O2 
and this was also proved experimentally through synthesis followed by 
characterization including phosphorescence measurements, use of trap molecules and 
cell culture studies; leading to a series of orthogonal dimers of BODIPY 
chromophore with remarkable singlet oxygen efficiencies without incorporation of 
heavy atoms.  A new path for rational development of efficient photosensitizers is 
revealed.  
Near-IR absorption, desired for photosensitizers, did not look viable for bis-
chromophores by the standard strategy of π-augmentation, as DS-TR singlet states 
are destabilized presumably via decreased exchange coupling in π-extended cases. 
Although red-shifting the absorption wavelength to enter the therapeutic window 
does not seem attainable for orthogonal bis-BODIPYs, modifications in the 
chromophore cores are promising in fine-tuning the excitation characteristics and 
suggested as future synthetic directions. 
4.1.2. Introduction 
Broader acceptance of PDT by the medical community and applicability is hampered 
by the restricted photophysical characteristics of the porphyrin derivatives. This 
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situation sparked a worldwide search for novel sensitizers leading to new 
compounds, some holding more promise than others.112,200 The primary cytotoxic 
agent involved in the photodynamic action is singlet oxygen, the efficient generation 
of which is linked invariably to the intersystem crossing (ISC) efficiency of the 
excited sensitizer. Most organic dyes have low triplet quantum yields, and in many 
recent candidates for photodynamic sensitizers, heavy atoms are incorporated into 
the structure as a strategy to improve spin–orbit coupling leading to facilitated 
intersystem crossing.201 While this approach seems fail-safe, incorporation of heavy 
atoms such as bromine, iodine, selenium, and certain lanthanides very often leads to 
increased “dark toxicity”.202 We have been interested in trying to find alternative 
ways of achieving increased intersystem crossing without the use of heavy atoms to 
minimize dark toxicity, turning our attention to the excited state properties of the 
sensitizers. 
Designing efficient photoinduced 1O2 generators requires that any existing operative 
fluorescence cycle of the fluorophore, which is through the S0 → S1 → S0 states, has 
to be perturbed so as to minimize or shutdown the S1 → S0 deactivation, and switch 
to the triplet surface once S1 is accessed. A general design principle for a favourable 
S1 → T1 hop from an electronic structure viewpoint would in principle, require the 
structural and electronic compatibility of S1 and T1 states to surpass that of S1 - S0 
pair. Once multiple electronic states come into play, quantum mechanical 
calculations providing a detailed understanding of the electronic structure are 
extremely helpful. Multi-configurational self-consistent field (MCSCF) techniques 
are the state of the art computational chemistry tools when near degeneracies and 
excited states are considered. These methods may not reach chemical accuracy (±2-3 
kcal/mol) for computing total energies, but are crucial for a qualitatively correct 
description of the excited states and are capable of providing conceptually complete 
picture of the photophysics taking place. Therefore, we mainly employed a popular 
variant of MCSCF techniques; the complete active space SCF (CASSCF) method in 
combination with relatively large basis sets and different active spaces. 
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4.1.3. Results and Discussion 
Our calculations on the parent BODIPY core showed that natural orbital occupancies 
of S1 state do describe an open-shell singlet with essentially double (>1.9) or zero 
(<0.1) electrons for all orbitals except HOMO and LUMO that are singly occupied 
(figure 64).  
 
Figure 64. Frontier molecular orbitals. HOMO (left) LUMO (right), of the parent BODIPY 
core at B3LYP/6-31G(d,p) level of theory. Surfaces are plotted at 0.2 a.u. Copyright © 2011, 
John Wiley and Sons. Reprinted with permission from ref (121). 
It is no surprise to observe a fluorophore with low triplet quantum yield to have an 
excited state possessing only two orbitals with single occupancy, hence to achieve 
our goal of efficient switching to the triplet manifold, we have to access to excited 
states different from the ones built by simple HOMO → LUMO transitions. Among 
multiply excited configurations, doubly substituted ones are particularly important in 
enhancing S1 - T1 coupling as shown by the seminal work of Salem and Rowland203 
and the following work by Michl.204 Thus, the substitutions should invoke 
simultaneous two electrons excitation from the ground state, guiding us to search for 
molecules with a pair of degenerate or near-degenerate occupied frontier orbitals 
correlating with a similar virtual (unoccupied) pair and pointing out a design 
principle of orthogonal dimeric chromophores. This foundation has two important 
features: (i) orthogonal placement prevents mixing of the π-systems of the two 
subunits leaving us with two essentially undisturbed chromophore cores. (ii) Upon 
irradiation, both cores are almost equally likely to undergo a HOMO → LUMO 
electron transfer (referring to the original monomer MOs) yielding an excited state 
mainly comprised of double substitutions. 
Our previous involvement with BODIPY dyes led us to seek ways to implement 
these design considerations using these dyes. BODIPY dyes are exceptional 
fluorophores with amazing versatility29 and rich chemistry.24 Heavy atom 
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functionalized BODIPY dyes showed some promise as potential sensitizers for 
photodynamic activity.123 It is also interesting to note that a few years ago, dimeric 
(albeit non-orthogonal) BODIPY derivatives were reported126 with peculiar 
properties linked to exciton coupling between the chromophores. We believe 
orthogonality to be an important distinction in our design (figure 65).  
 
Figure 65. Orthogonal BODIPY designs. Copyright © 2011, John Wiley and Sons. 
Reprinted with permission from ref (121). 
Orthogonality is secured by the strategic placement of the methyl substituents, 
resulting in a dihedral angle very close to 90o for the two BODIPY cores.  
Orthogonal arrangement of the BODIPY units was also experimentally verified by 
the X-ray diffraction structure (figure 66) of the compound (3). The calculated 
energy differences (2.96, 2.97 eV) remaining very close to HOMO – LUMO gap of 
Bodipy core (3.10 eV) further support our claim of Bodipy cores remaining 
essentially unperturbed in the dimeric form.  Thus the orthogonal dimer should 
possess the desired features sought in the excitation process. 
 
Figure 66. Structures of the dimeric Bodipys. a) X-ray diffraction structure of the orthogonal 
8,2’ dimer (3). b) Optimized geometry of orthogonal 8,8’ dimer (6) at CAS(6e in 6o)/cc-
pVDZ level. Dihedral angle between the two Bodipy units is very close (± 0.5o) to 90o in 
both dimers. Copyright © 2011, John Wiley and Sons. Reprinted with permission from ref 
(121). 
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Spatial orthogonality is decisive on the excitation properties of (3), (6) and (7) as it 
prevents the π -mixing among cores and maintains two essentially undisturbed 
chromophores almost retaining their monomeric orbital energies and electron density 
distributions. With the survival of BODIPY core levels in the dimer, its S0→ S1 
excitation should then be composed of the inherent HOMO→LUMO transitions of 
both monomers. Realization of this feature allows us to envisage the S0→ S1 
excitation to mainly include double substitutions from the reference wave function as 
depicted in figure 67 via construction of a conceptually useful valence bond (VB) 
wave function for S1. 
 
Figure 67. Building up bis-BODIPY S1 wave function. MO energies are 
for the 8,8′ dimer (6). In the S1 state, only the leading configurations 
are shown, and minus signs to restrain antisymmetry are intentionally 
excluded for clarity. Copyright © 2012, American Chemical Society. Reprinted with 
permission from ref (227). 
The general view demonstrated in Figure 67 is verified by the computed excited-state 
MO plots and NOONs as well as the details of the multi-configurational expansion 
given in Figure 68. The effect of constructing the S1 wave function from essentially 
unperturbed monomeric states is clearly visible on NOONs since the sum over all 
five configurations in Figure 67 for S1 (after normalization in the basis of the five 
configurations) yields a single electron in each of the four MOs, provided that the 
five configurations are essentially equally weighted. Four electrons in four molecular 
orbitals in an overall singlet coupled fashion, as confirmed by the NOONs of the 
CASSCF wave functions, is the basis for the TR designation. Moreover, distributions 
of the SOMOs for S1 are found to be linear combinations of the HOMO and LUMO 
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of isolated BODIPY cores, a feature predicted to be an outcome of spatial 
orthogonality of monomers.  
 
Figure 68. Left: (Top) BODIPY HOMO and LUMO. (Bottom) Frontier orbitals and natural 
orbital occupation numbers of S1 states of dimers (3) and (6). Right: Leading configurations 
of S0, S1, and T1 CASSCF wave functions for (3) and (6). Copyright © 2012, American 
Chemical Society. Reprinted with permission from ref (227). 
The DS-TR natures of (3) and (6) are repeatedly observed at CASSCF levels 
employing varying numbers of active electrons and orbitals and with different basis 
sets, suggesting DS-TR to emerge as a qualitative and simple descriptor for S1 states 
of the dimers. Facile 1O2 production by (3) and (6) despite the absence of high 
nuclear charge atoms suggest that ISC is invoked via a specific electronic structure 
pattern as the general view of 1O2 generation includes an effective hop of the 
photosensitizer to the triplet surface. We attribute ISC-promoted 1O2 production by 
(3) and (6) to the DS-TR nature of S1 states, as doubly substituted singlets are 
reported to better couple with triplets.203,204 Similarly, charge separation, yielding 
facile access of excited dyads to the triplet manifold, implies the significance of 
zwitterionic (charge separated) excited states in ISC dynamics. 
As a result, functionalization of the BODIPY core orthogonally, by a second 
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BODIPY is the key to switching to the triplet manifold. Based on these clearly 
encouraging computational results, we were highly motivated towards the synthesis 
of a series of orthogonally linked dimeric BODIPYs.  The synthesis procedure for 
compound (3) is quite straightforward, especially in view of recent contribution to 
BODIPY chemistry by Jiao and co-workers.35 The parent compound (1) was 
formylated through Vilsmeier reaction (figure 69). The BODIPY framework was 
then constructed around the formyl carbon using standard BODIPY chemistry. The 
absorption spectrum of the product showed a single band centered around 506 nm, 
not much different than the parent compound. Organic solutions of the orange 
colored compound were noticeably lacking detectable fluorescence emission under 
ambient or hand-held UV lamp irradiation, an indication of competing excited state 
process(es) in action. Recent progress in the derivatization of BODIPY dyes also 
allowed us to synthesize two different and more symmetrical, 8,8’ orthogonal dimers 
as well. Thus, recently reported205 8-formyl-BODIPY derivative was transformed 
into orthogonal dimers (6) and (7), using standard protocols (figure 69). A list of 
relevant photophysical parameters for the sensitizers is placed in table 3. It is 
interesting to note that for the dimers (6) and (7), significant fluorescence emission 
quantum yield is preserved, opening the possibility for a dual use as therapeutic and 
imaging agents. 
 
Figure 69. Synthesis of the target photosensitizers. a) POCl3, DMF, ClCH2CH2Cl, 50oC; b) 
2,4-dimethylpyrrole, trifluoroacetic acid (TFA), CH2Cl2, p-chloranil, Et3N, BF3·OEt2; c) 
TFA, CH2Cl2, p-chloranil, Et3N, BF3·OEt2. Copyright © 2011, John Wiley and Sons. 
Reprinted with permission from ref (121). 
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We surmised that a comparative study of compounds (1), (3), (6) and (7) would be 
instructive. First, we attempted to detect singlet oxygen phosphorescence at 1270 nm 
in chloroform for all four compounds excited with xenon-arc source at their 
respective absorption peaks, detection was done with a near IR sensitive detector. 
When excited at equal absorptivity concentrations for all compounds, dimer (3) 
yielded the strongest singlet oxygen phosphorescence emission (figure 70) at the 
signature wavelengths (peaking around 1270 nm), dimers (6) and (7) also showed 
phosphorescence peaks, but with somewhat reduced intensity.   
Table 3. Comparative spectroscopic properties of BODIPY compounds. 
    Compound λabsa/nm λemsa/nm φf τa/ns φΔe 
1 509 514 0.80[d] 5.2 - 
3 514 527 0.03[a,b] 2.5 0.51 
6 515 588 0.31[a,c] 10.9 0.46 
7 542 605 0.49[a,c] 5.0 0.21 
a In CHCl3. b In reference to Fluorescein in 0.1 M NaOH solution excited at 496 nm. c In 
reference to Rhodamine 6G in EtOH excited at 480 nm. d In EtOH. e Singlet oxygen 
quantum yield was determined with respect to Methylene Blue (0.57 in Dichloromethane)206. 
 
 
Figure 70. Singlet oxygen phosphorescence with sensitization from BODIPY derivatives: (3) 
(blue), (6) (black) and (7) (red), (1) (green) in CHCl3 at equal absorbances (0.2) at the peak 
wavelength of their respective absorbances. Copyright © 2011, John Wiley and Sons. 
Reprinted with permission from ref (121). 
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On the other hand, no such emission was observed with compound (1) (figure 70). 
Non-halogenated BODIPY dyes having low intersystem crossing efficiency, is a well 
established fact,202 indeed that is at least part of the reason for their bright 
fluorescence and photostability. While integral areas under the phosphorescence 
emission peak is a measure of singlet oxygen quantum yield, we opted for more 
quantitative assessment of singlet oxygen quantum yields using 1,3-
diphenylisobenzofuran as a trap molecule and with Methylene Blue as the reference 
compound (Methylene Blue has a singlet oxygen quantum yield of 0.57 under the 
conditions of the study in dichloromethane206) (figure 71). Excitation of the dyes was 
carried out by irradiation at the respective absorbance peak wavelengths with 
monochromatized light source, at a fluence rate around 30 µW/cm-2.  The quantum 
yield for singlet oxygen generation for (3) is 0.51 in dichloromethane, much higher 
than all non-halogenated BODIPY dyes and many other organic chromophores and 
photosensitizers, under comparable conditions.  The other BODIPY dimers (6) and 
(7) also showed respectable singlet oxygen quantum yields of 0.46 and 0.21, 
respectively. 
 
Figure 71. Comparative singlet oxygen generation experiment. Absorbance decrease of 
DPBF at 414 nm with time in dichloromethane in the presence of BODIPY photosensitizers: 
(3) (black), (6) (blue), (7) (red) and reference photosensitizer methylene blue (green). 
Copyright © 2011, John Wiley and Sons. Reprinted with permission from ref (121). 
For further demonstration of singlet generation capacity and photocytotoxicity of the 
most active dimeric dye (3), we carried out a cell culture assay with cancer cell lines. 
To that end, we prepared a micellar formulation of the 8,2’-orthogonal dimeric dye 
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using Cremophor-EL. The size distribution of the micelles was determined using 
electrophoretic light scattering. The size distribution reveals a median size of 100 nm 
for the micellar constructs.  Micelle embedded dye retained high levels of singlet 
oxygen generation capacity as revealed by another singlet oxygen trapping 
experiment, this time in aqueous media, using a water soluble anthracene derivative 
(2,2'-(Anthracene-9,10-diylbis(methylene))dimalonic acid) (figure 72). 
 
Figure 72. Singlet oxygen generation experiment in aqueous solution. Decrease in 
Absorbance spectrum of trap molecule (anthracene derivative) in the presence of 1.69 µM 
compound (3) in phosphate buffer saline (PBS). Details are given in singlet oxygen 
measurements part. Copyright © 2011, John Wiley and Sons. Reprinted with permission 
from ref (121). 
Experimental verification of photocytotoxicity was carried out as follows: varying 
concentrations of the dimeric dye in Cremophor-EL micelles were incubated with 
K562 human erythroleukemia cells within a standard culture medium at 37 oC in a 
humidified incubator containing 5% CO2. Cells were irradiated with the green LED 
source for 4 hours, followed 44 hours of incubation in dark.  The control group was 
incubated in dark, under otherwise identical conditions. The cell viabilities were 
determined using standard MTT assay. The results are shown in figure 73.  Even at 
very low concentrations of dyes (as embedded within micelles) significant decrease 
of cell viability was observed (green bars in figure 73) with a remarkable EC50 of 50 
nM. No statistically significant change was observed when the cells were kept in 
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dark, in the presence of same concentration of the photosensitizer (3) (black bars in 
figure 73).  
Photocytotoxicity was also revealed (figure 74) using confocal microscopy with two 
fluorescent probes of cell viability (acridine orange and propidium iodide).  Cells 
incubated with the sensitizer (3) in dark show no changes as revealed by differential 
staining with the neutral and cell permeable acridine orange. These cells appear 
bright green under excitation at 488 nm.  Cationic propidium iodide stains these cells 
only when membrane integrity is compromised; this happens only when both green 
LED irradiation and the sensitizer are acting on the cells.  The use of excess 
propidium iodide results in red fluorescence in dead cells, or in cells dying via either 
apoptotic or necrotic pathways. 
 
Figure 73. Photocytotoxicity of the sensitizer (3) as demonstrated by MTT assay. Cell 
suspensions (K562, human erythroleukemia cells) were seeded in 96-well flat-bottom plates 
and varying concentrations of the sensitizers were added into each well. Cells were kept 
either in dark, or under illumination with a green (520 nm) LED array at 2.5 mW/cm2 
fluence rate for a period of 4 h at 370C in a humidified incubator containing 5% CO2. 
Copyright © 2011, John Wiley and Sons. Reprinted with permission from ref (121). 
Exploring the properties of these bis-BODIPYs further, in order to delineate the 
causes, extent, and control of this interesting electronic structure motif, is extremely 
important as the substantial 1O2 generation yield in this new class of heavy atom free 
photosensitizers is linked to the extraordinary nature of S1 state. Potential clinical 
applications are easily envisioned and were previously our major concern for (3) and 
(6), however numerous questions regarding electronic structure of the S1 state, such 
as the breadth of the orthogonality principle and control of excitation properties 
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under structural perturbations required further studies. Although general principles 
for regulating the frontier orbital levels are available,207 strategies for fine-tuning 
orthogonal bis-BODIPYs to operate at longer wavelengths of the therapeutic window 
(620-850 nm) are desired. Currently it is unclear how to generalize the no-heavy 
atom ISC approach to bis-BODIPYs in general and/or to any orthogonal bis-
chromophore. Comparison of the orthogonal bis-chromophore approach with heavy 
atom incorporation is also expected to provide new insights. 
 
Figure 74. Photocytotoxic activity of the dimeric BODIPY (3) visualized via confocal 
microscopy. Cell suspensions (K562, human erythroleukemia cells) were seeded in 24-well 
plates.  a, Cells in Control 1 (upper plates) wells were incubated in dark for 24 hours; b, 
Cells in Control 2 wells (second row plates) were incubated with 500 µl/well Cremophor-EL 
solubilized (3) (at a final concentration of 164 nM) and kept in dark for 24 hours in the same 
incubator, c, Cells in Control 3 well were illuminated for 4 h without the sensitizer and 
incubated for a further 20 h in dark at the incubator. d, Cells in Control 4 (bottom row of 
plates) well  were illuminated for 4 h after addition of 164 nM (3) and incubated for a further 
20 h in dark at the incubator. Cells in wells were collected after 24 h and imaged at 40x 
magnification. Live cells are preferentially stained with acridine orange (AO, green) (a), 
whereas dead cells are preferentially stained with the dye propidium iodide (PI, red) due to 
increased cellular permeability (b). Copyright © 2011, John Wiley and Sons. Reprinted with 
permission from ref (121). 
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Effect of Orthogonality on S1 State: Structural orthogonality is argued to be the 
key, in accessing DS-TR S1 states, in the above view. This was further verified by 
the following computational experiment regarding the effect of relative positions of 
the two chromophore cores on excitation characteristics. Selecting the inter-plane 
angle as the transformation coordinate as shown in figure 75, and fixing all the 
remaining internal coordinates at their equilibrium values, CASSCF wave functions 
of the S1 state were optimized for the corresponding conformations. Simple BODIPY 
core without any methyl groups was used instead of tetra-methyl BODIPY core as 
the methyl groups in the latter introduce huge steric effects even at small deviations 
from orthogonality. The one-electron density matrix for the S1 states of 
corresponding conformations revealed that DS-TR nature of S1 does not survive at 
small inter-plane angles and the classical HOMO→LUMO type SS excited state is 
generated at near planarity, where the π-systems start to mix significantly. Hence 
spatial orthogonality of the two monomers is central to generating a DS-TR S1 state. 
 
Figure 75. Effect of inter-plane angle (θ) variation on S0→S1 excitation characteristics (DS-
TR/SS). Copyright © 2012, American Chemical Society. Reprinted with permission from ref 
(227). 
Synthesis and Spectroscopic Properties of an Extended Conjugation Bis-
BODIPY Derivative: The above results were motivating, particularly for utilizing 
many chromophores in heavy atom free ISC by only dimerizing them in an 
orthogonal fashion. Consequently, we aimed to surpass the accomplishments of (3) 
and (6) by synthesizing modified orthogonal bis-BODIPYs that will operate at the 
red end of the spectrum and, hence, potentially be better suited for photodynamic 
applications. The well-known modification to red shift λabs, i.e., decrease the energy 
gap between frontier orbitals is, extending208 the π-system of the chromophore core. 
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For this purpose, synthesis of bis-8,2′-distyrylBODIPY derivative shown in figure 76 
was performed. 
Spectroscopic properties of (bis-10a′)  (Figures 77, table 4) was investigated, and an 
emission at 680 nm together with a negligible triplet quantum yield were surprisingly 
observed, contrary to the expectation followed from the computed structural 
orthogonality (interplane angle = 90.1°). These results either suggest that excitation 
characteristics established for (3) and (6) by the CASSCF calculations are not 
complete descriptors for ISC or orthogonality alone does not afford the excited states 
bearing the features of interest. The former seems questionable in light of the reports 
on facile nonadiabatic reactions of related singlet states.209 The latter hypothesis, on 
additional requirements to generate DS-TR S1 states besides orthogonality, was 
tested via CASSCF calculations on the S1 state of (bis-10a′).  
 
Figure 76. Synthesis of (bis-10a’). Copyright © 2012, American Chemical Society. 
Reprinted with permission from ref (227). 
 
Figure 77. Electronic absorption spectrum of (bis-10a’). Copyright © 2012, American 
Chemical Society. Reprinted with permission from ref (227). 
Electronic Structure Calculations on Substituted 8,8′-
and 8,2′-Bis-BODIPYs. Since the disappearance of DS-TR
character was apparently a result of extending the pi framework,
it is desirable to analyze the eﬀect of increasing the size of the
pi-system with a smooth transition from 2 or 3 to bis-10a′. This
will enable us to monitor the cause of the drastic change in
excitation characteristics from DS-TR (bis-4 and bis-4′) to SS
(bis-10a′). Therefore, we ﬁrst generated computational models
where BODIPYs bear only ethenyl/ethynyl substituents on
various positions of the core. Further extension of the pi-system
was performed until SS-S1 character persisted in the dimers.
Also important was searching for any correlations between the
characteristics of S1 states of the bis-BODIPYs and the
monomer electronic structure. Consequently, the set of
monomers given in Scheme 3 and their 8,8′ and/or 8,2′
orthogonal dimers were studied.
Extending the conjugated pi-systems of the monomers
yielded four major sets of BODIPYs possessing the following
substituents neighboring the core; none (4); ethenyl and/or
ethynyl (5 to 8); butadienyl (9); and styryl (10, 11). All these
models preserved an essentially planar geometry within the
monomer, and their dimers were computed to be spatially
orthogonal. Table 1 shows frontier orbital energies of ground
states of all the monomers and dimers as well as the relative
energies of S1 and T1 states of the orthogonal dimers. Excitation
characteristics of the S1 state (DS-TR or SS) of bis-BODIPYs
are also shown.
It is clear from the frontier orbital energy diﬀerences that,
orthogonality dictates formation of two pairs of near-
degenerate orbitals in the dimer that eﬀectively preserve
monomeric character, as supported by orbital isodensity plots.
(Figure S1, Supporting Information). Extension of the pi-system
lowered the HOMO−LUMO gaps as anticipated, and
interestingly, beyond the very ﬁrst double bond added to the
chromophore core; i.e., for set (9 to 11), the DS-TR character
of S1 state disappears. In such cases, S1 MOs were no longer
delocalized on both chromophore cores (Figure S2, Supporting
Information), which is also the case for bis-10a′. The lowering
of the HOMO−LUMO gap and disappearance of DS-TR
character of S1 do correlate; however, it is illusory to conclude
that DS-TR fades with decreased HOMO−LUMO gaps since
the energy gap decrease itself is caused by a structural
perturbation that extends the pi-system. Thus, the fundamental
reason of switching from DS-TR to SS type S1 states needs
further investigation (vide infra). Inspection of the relative
energetic positioning of T1 and S1 states does not provide an
answer since T1 is roughly equally separated from S0 and S1
states for all species and there is no signiﬁcant pattern in favor
of the DS-TR-S1 or SS-S1 possessing species. Incorporation of
functional groups in order to donate or withdraw electron
density as in the series of species 5, 9, 10, and 11 do result in
deviations (from core BODIPY) in the anticipated directions
for frontier MO levels but do not switch the excitation
characteristics of S1. Extension of the pi-system shutting down
Scheme 2
Scheme 3
The Journal of Organic Chemistry Featured Article
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Effect of π-Extension on DS-TR Character of S1:  Since the disappearance of DS-
TR character was apparently a result of extending the π framework, it is desirable to 
analyze the effect of increasing the size of the π -system with a smooth transition 
from (3) or (6) to (bis-10a′). 
Table 4. Photophysical Properties of the Synthesized BODIPY Compounds. 
compound λabsa/nm εmax/M-1 cm-1 λemsa/nm φf τa/nm φΔd 
3 514 119400 527 0.025 2.5a,c 0.51 
6 515 20300 588 0.31 10.9a,b 0.46 
bis-10a’ 661 125300 680 0.06 2.2a,c 0.06 
a In CHCl3. b With respect to Fluorescein in 0.1 M NaOH solution excited at 496 nm. c With 
respect to cresyl violet perchlorate in MeOH excited at 610 nm. d Singlet oxygen quantum 
yield was determined with respect to Methylene Blue (0.57 in Dichloromethane).206  
 
Figure 78. The set of monomers and dimers studied. Copyright © 2012, American Chemical 
Society. Reprinted with permission from ref (227). 
This will enable us to monitor the cause of the drastic change in excitation 
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characteristics from DS-TR (bis-4x) and (bis-4x′) to SS (bis-10a′) where prime (′) 
indicates 8,2′ coupling motif of the monomers, and absence of the prime (′) shows 
8,8′ binding. Therefore, we first generated computational models where BODIPYs 
bear only ethenyl/ethynyl substituents on various positions of the core. Further 
extension of the π –system was performed until SS-S1 character persisted in the 
dimers. Also important was searching for any correlations between the 
characteristics of S1 states of the bis-BODIPYs and the monomer electronic structure. 
Consequently, the set of monomers given in figure 78 and their 8,8′ and/or 8,2′ 
orthogonal dimers were studied. 
Extending the conjugated π-systems of the monomers yielded four major sets of 
BODIPYs possessing the following substituents neighboring the core; none (4x); 
ethenyl and/or ethynyl (5x) to (8); butadienyl (9); and styryl (10), (11). All these 
models preserved an essentially planar geometry within the monomer, and their 
dimers were computed to be spatially orthogonal. Table 5 shows frontier orbital 
energies of ground states of all the monomers and dimers as well as the relative 
energies of S1 and T1 states of the orthogonal dimers. Excitation characteristics of the 
S1 state (DS-TR or SS) of bis-BODIPYs are also shown. 
It is clear from the frontier orbital energy differences that, orthogonality dictates 
formation of two pairs of near degenerate orbitals in the dimer that effectively 
preserve monomeric character. Extension of the π–system lowered the HOMO− 
LUMO gaps as anticipated, and interestingly, beyond the very first double bond 
added to the chromophore core; i.e., for set (9) to (11), the DS-TR character of S1 
state disappears. In such cases, S1 MOs were no longer delocalized on both 
chromophore cores (figure 79), which is also the case for (bis-10a′). The lowering of 
the HOMO− LUMO gap and disappearance of DS-TR character of S1 do correlate; 
however, it is illusory to conclude that DS-TR fades with decreased HOMO−LUMO 
gaps since the energy gap decrease itself is caused by a structural perturbation that 
extends the π-system. Thus, the fundamental reason of switching from DS-TR to SS 
type S1 states needs further investigation (vide infra). Inspection of the relative 
energetic positioning of T1 and S1 states does not provide an answer since T1 is 
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roughly equally separated from S0 and S1 states for all species and there is no 
significant pattern in favor of the DS-TR-S1 or SS-S1 possessing species. 
Incorporation of functional groups in order to donate or withdraw electron density as 
in the series of species (5x), (9), (10), and (11) do result in deviations (from core 
BODIPY) in the anticipated directions for frontier MO levels but do not switch the 
excitation characteristics of S1. Extension of the π-system shutting down the DS-TR 
S1 state seems to be one net conclusion that could be drawn, despite the survival of 
near-degenerate monomer based orbitals for all the dimers considered. Nonetheless, 
from the four sets of models with increasing sizes of conjugated π-systems, the only 
groups with a DS-TR S1 state were (4x) and (5x) to (8), whose π-system extension is 
truncated at the very first C=C double bond. Apparently, one is only allowed to 
slightly modify S0−S1 energy difference without losing the DS-type excitation motif, 
and unfortunately, this does not result in the desired amount of HOMO−LUMO gap 
lowering. 
Table 5. Selected Parameters for Modified BODIPY Cores and Associated Orthogonal Bis-
BODIPYs. 
 
a Prime (′) indicates 8,2′ coupling motif of the monomers, and absence of the prime (′) shows 
8,8′ binding. b DS-TR: Doubly substituted tetraradical. SS: Singly substituted 
HOMO→LUMO-type open-shell singlet state. c Relative energies of T1 and S1 states with 
respect to the ground state S0 of the dimer at the CAS(6,6) level.  
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The rationale of attributing the disappearance of DS-TR character to extension of the 
π-system was further tested by the following computational experiment performed on 
(bis-9′) and (bis-10′). When the extension of π-conjugation is thought to be 
responsible for switching to SS from DS-TR, the DS-TR character of S1 in the dimer 
should reappear if the π–electron density supplied by the substituents, does not 
communicate with the core. 
 
Figure 79. Selected natural orbitals and occupation numbers for (bis-9), (bis-10) and (bis-
10a). Calculations were done at CAS(6,6)/CEP-31G//(U)B3LYP/CEP-31G level. Copyright 
© 2012, American Chemical Society. Reprinted with permission from ref (227). 
Freezing the core coordinates in the optimized structure, we rotated the outermost π-
system, i.e., last ethenyl unit for (bis-9′) and the phenyl for (bis-10′), with respect to 
the core plane as shown in figure 80 and optimized the wave function of the S1 state 
for the conformations generated accordingly. Since planarity is necessary for the 
conjugation of the π-system, any property caused by the extended conjugation should 
be affected by increasing angle θ. In line with the expectations, we observe that DS-
TR is regenerated at large angles where the π-delocalization between the rotated 
units and the rest of the chromophore ceases. NOONs for the conformations tested 
above are close to 2, 1, or 0 at all times in line with SS or DS-TR nature of S1 These 
findings suggest that π-extended bis-chromophores should not possess the target 
electronic structure motif with structural orthogonality alone. This failure encourages 
searching alternative strategies for tuning frontier MO energies; however, before 
moving further, we have to search for any insights provided from the analysis of 
electronic structure of excited singlet states in related heavy atom incorporated 
 S8 
 
Species HOMO-1 NOON HOMO NOON LUMO NOON LUMO+1 NOON 
bis-9 
 
2.0 
 
1.0 1.0 
 
0.0 
bis-10 
 
2.0 1.2 0.8 0.0 
bis-10a 
 
2.0 1.0 1.0 0.0 
Calculations were done at CAS(6,6)/CEP-31G//(U)B3LYP/CEP-31G level. 
 
Figure S2. Selected natural orbitals and occupation numbers for bis-9, bis-10 and bis-10a. 
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systems, that are well-known for facilitated ISC. 
In questioning the rationale of DS-TR to SS switching as a result of π-extension, we 
compared the electron density distribution of frontier MOs of bis-BODIPYs from 
both S1 classes. In the SS cases, contrary to the delocalized SOMOs of DS-TR states, 
MOs were clearly concentrated on a single monomer (figure 79), which implied 
negligible coupling among monomer cores. 
 
Figure 80. Relation of DS-TR character of S1 to the extent of π conjugation in butadienyl- 
and styryl-substituted BODIPY dimers (bis-9′) and (bis-10′). Copyright © 2012, American 
Chemical Society. Reprinted with permission from ref (227). 
This suggests that, the so-called antiferromagnetic coupling of electrons among 
SOMOs weakens with increased size of the π-framework in a SOMO. Such a view 
well agrees with the foundations of electron correlation, which is more of a local 
effect.210 Equivalently, the superexchange path is lost when electrons are more and 
more spread out in space. This difficulty encountered (for relatively largely separated 
electron densities) in obtaining a significant amount of quantum mechanical 
exchange energy is apparently manifested in a relative destabilization of the DS-TR 
with respect to the SS state. 
These results were motivating in investigating DS-TR singlets lying higher than S1 
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for π-extended bis-BODPYs, and we were successful in locating DS-TR singlet 
states for (bis-9), (bis-9′), (bis-10), (bis-10′), (bis-10a), and (bis-10a′) as S2 or S3 
(table 6). Severe convergence problems in the computation of the highlying-excited 
states were encountered, and the quantitative reliability of relative energies may be 
questionable; however, a useful trend of qualitative nature is noteworthy. 
Table 6. Relative Energies (eV) of S2 and S3 States for Selected Species at CAS(6,6)/CEP-
31G level of theory. 
 
It is clear that whenever the S1 state is not computed to be DS-TR as a result of the π-
electron increasing structural perturbation that does not allow a superexchange path 
for vastly spread out SOMO electrons, an Sn  (n  > 1) state with DS-TR character 
exists. Thus, instead of envisioning DS-TR singlet states to disappear with extending 
the conjugation, we should better term this phenomenon as destabilizing the DS-TR 
singlet state as a result of decreasing quantum mechanical exchange stabilization for 
largely spread out spin-orbitals. 
4.1.4. Experimental Details 
General: General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-
400 (operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 
solvent with tetramethylsilane as internal standard. All spectra were recorded at 25oC 
and coupling constants (J values) are given in Hz. Chemical shifts are given in parts 
per million (ppm). Absorption spectra were performed by using a Varian Cary-100 
and Varian Cary 5000 UV-VIS-NIR absorption spectrophotometer. Fluorescence 
measurements were conducted on a Varian Eclipse spectrofluometer. The 
Fluorescence decay measurements were carried out with the Horiba Jobin-Yvon 
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Time-Resolved Fluorometer, Fluorolog FL-1057. The instrument response function 
was measured with an aqueous Ludox solution. Singlet oxygen phosphorescence 
around 1270 nm were determined by using Horiba Jobin-Yvon Fluoremeter with 
Hamamatsu NIR PMT module, model H-10330-75. The decays were analyzed with a 
multiexponential fitting function by iterative reconvolution and chi-square 
minimization. Mass spectra were recorded with Agilent Technologies 6224 TOF 
LC/MS and 6530 Accurate Mass Q-TOF LC/MS. Irradiation of photosensitizers (3), 
(6) and (7) were accomplished at 520 nm by monochromatic light system composed 
of Spectral Products CM 110 1/8m monochromator, ASB-XE-175 Xenon light 
source, Newport Multi Function Optical Meter model 1835-C. Irradiation of bis-10a’ 
was performed using 660 nm LED. Methylene blue was irradiated at 520 nm and 660 
nm. Electrophoretic Light Scattering was performed with Malvern NanoZS zeta 
potential. Reactions were monitored by thin layer chromatography using Merck TLC 
Silica gel 60 F254. Silica gel column chromatography was performed over Merck 
Silica gel 60 (particle size: 0.040-0.063 mm, 230-400 mesh ASTM). 4,4-Difluoro-8-
formyl-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (4)205 and 4,4-Difluoro-8-
formyl-2,6-diethyl-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene (5)205 were 
synthesized according to literature. All other reagents and solvents were purchased 
from suppliers and used without further purification. Micelle has been prepared with 
compound 3 according to the literature.130 In singlet oxygen measurements 1,3-
Diphenylisobenzofuran was used as a singlet oxygen trap in organic solvent 
measurements and was purchased from supplier. 2,2'-(Anthracene-9,10-
diylbis(methylene))dimalonic acid was used a singlet oxygen trap in aqueous solvent 
and was synthesized according to the literature.211 
Computational Details: Geometries were fully optimized with the ab initio 
Complete Active Space Self Consistent Field (CASSCF) methodology and B3LYP 
Density Functional212 employing CEP-31G (SBKJC) and cc-pVDZ basis sets.213 
Harmonic vibrational frequencies were computed to assure that the species did not 
possess any imaginary frequencies and hence correspond to true minima. After a 
number of trial and error the active space in the CASSCF calculations were 
established as 6 electrons distributed over 6 valence orbitals (6,6) for the 8,2’ dimer 
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(3) and 4 electrons distributed over 4 valence orbitals (4,4) for the 8,8’ dimer (6) and. 
Enlarged active spaces up to 12,12 also reproduced the key features presented in the 
main text. For the sake of consistency a 6 electrons in 6 orbitals CAS is used for both 
dimers. Geometries of excited states T1 and S1 were also fully optimized. Natural 
orbitals of the CASSCF wavefunction and configuration state function coefficients 
were analyzed to understand the nature of the electronic state as being a single 
electron HOMO → LUMO type or multiply substituted type. Whereas BODIPY core 
S1 is a clean HOMO → LUMO dominated ππ* state, S1 states of (3) and (6) are 
drastically different and showed a large degree of multi-reference character. 
Gaussian 03214 suite was mainly used for the DFT calculations, CASSCF 
calculations were mainly performed with MOLCAS215, and GAMESS-US216 
programs. For selected species, with no significant multi reference character, TD-
DFT calculations in combination with a polarizable continuum model (PCM) were 
performed to investigate the excitation characteristics. Excited-state MCSCF 
calculations used the state averaged (SA) formalism with equal weights for all the 
states involved. No restrictions on symmetry were imposed.  Computational studies 
were done in Dr. Yavuz Dede group at Gazi University, Department of 
Chemistry, Ankara, Turkey. 
Cell Culture Studies and MTT Assay: K562 human erythroleukemia cells (ATCC) 
were cultured in 25 cm3 culture flasks containing RPMI 1640 medium supplemented 
with heat inactivated 10 % fetal bovine serum, 2 mM L-glutamine,100 units.mL-1 
penicillin G and 100 µg.mL-1 streptomycin at 37oC in a humidified incubator 
containing 5% CO2. Micellar preparation of the sensitizer was dissolved in RPMI 
1640 medium and test concentrations were prepared daily. The 
methlythiazolyltetrazolium (MTT) assay was used to evaluate cell viability. Briefly, 
50 µL cell suspensions containing 4 x 104 K562 cells were seeded in 96-well flat-
bottom plates (Costar, Cambridge, MA) and varying concentrations of Cremophor-
EL solubilized dye (3) (Final concentrations= 41 nM - 164 nM) were added in 50 µL 
into each well. All dye concentrations were tested in triplicate for three times. Then, 
cells were kept either in dark or under illumination with a green (520 nm) LED array 
at 2.5 mW/cm2 fluence rate for a period of 4 h at 37oC in a humidified incubator 
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containing 5% CO2. In order to evaluate the cytotoxicity of dye, 4 h irradiated plates 
were kept in dark for a further 44 h and then MTT solution was added for measuring 
cell viability. In addition, plates kept in dark for 4 h were also incubated for an 
additional 44 h for control. After 48 h, 25 µL of MTT solution (1.0 mg/mL final 
concentration) (Sigma Chemical Co., St. Louis, MO) were added to each well, and 
the plates were incubated for a further 4 h. The formazan precipitate was solubilized 
by adding 80 µL lysing buffer (pH=4.7) composed of 23% SDS (sodium dodecyl 
sulfate) dissolved in a solution of 45% N,N- dimethylformamide. After an overnight 
incubation at 370oC, the absorbances were read at 570 nm using a microplate reader 
(Spectramax Plus, Molecular Devices, Sunnyvale, California, USA). Cells incubated 
in culture medium alone served as a control for cell viability (nontreated wells) either 
in irradiated plate or in plate that was kept in dark. Cell viability (%) was calculated 
as OD of treated wells/OD of nontreated cells x 100. Cell culture and MTT assay 
studies were done in Dicle Guc group at Hacettepe University, Basic Oncology 
Department, Ankara, Turkey. 
Confocal Microscopy Imaging: Confocal microscopic analysis was also performed 
to evaluate cell viability. Briefly, 1500 µL cell suspensions containing 2 x 105 K562 
cells/well were seeded in 24-well plates.  Cells in Control 1 well were incubated in 
dark for 24 hours at 370oC in a humidified incubator containing 5% CO2. Cells in 
Control 2 well were incubated with 500 µL/well Cremophor-EL solubilized dye 3 
(Final dye concentration = 164 nM) and kept in dark for 24 hours in the same 
incubator. Cells in Control 3 well were illuminated for 4 h without dye and incubated 
for a further 20 h in dark at the incubator. Cells in Control 4 well were illuminated 
for 4 h after addition of 164 nM dye (3) and incubated for a further 20 h in dark at 
the incubator. All conditions were studied in duplicate. Cells in wells were collected 
after 24 h and confocal microscopy images were acquired. 
A stock solution of propidium iodide (PI) (Sigma P-4170) was prepared in distilled 
water, and used at a concentration of 0.5 mg/mL. Acridine orange (AO) was 
dissolved in phosphate buffered saline at a concentration of 100 µg/mL. One tablet of 
phosphate buffered saline (PBS) (Amresco) was dissolved in the distilled water to 
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yield a pH=7.4 buffered solution. 
Chromophore-EL solubilisation: Photosensitizer (3) (5 x 10-5 moles) was dissolved 
in THF (1mL) treated with Cremophor EL (CrEL, 150 mg) and sonicated for 30 
mins. THF was removed under reduced pressure, the remaining oil was dissolved in 
phosphate-buffered saline (PBS) (5mL), filtered through a 0.2 µm membrane filter 
and made up to 10 mL with PBS (1X , pH= 7.4). Average size was found to be ca. 90 
nm (figure 81). 
 
Figure 81. Size distribution of compound micellar compound (3). Cremophor EL was used 
for embedding the dye. Copyright © 2011, John Wiley and Sons. Reprinted with permission 
from ref (121). 
Singlet Oxygen Trap Experiments: In singlet oxygen measurements 1,3-
Diphenylisobenzofuran (DPBF) (figure 82) was used as a singlet oxygen trap in 
organic solvent and was purchased from a supplier. 2,2'-(Anthracene-9,10-
diylbis(methylene))dimalonic acid (ADMDA) was used a singlet oxygen trap in 
aqueous solvent and was synthesized according to the literature (figure 83).1 In a 
typical procedure for the detection of singlet oxygen generation by using trap 
molecules, a photosensitizer (~1 µM) and a trap molecule (O.D ~ 1.0) were mixed in 
O2 bubbled solvent. Initially several dark measurements were taken followed by 
irradiation of the mixture at absorption maximum of a sensitizer. Absorbance 
decrease of trap molecules was monitored suggesting singlet oxygen generation in 
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the presence of light and sensitizers. 
Singlet oxygen quantum yields were calculated according to the literature.201 The 
relative quantum yields were calculated with reference to Methylene Blue (MB) in 
dichloromethane as 0.57.206 First, dichloromethane was bubbled with air for 5 
minutes. In UV cuvette absorbance of DPBF was adjusted around 1.0 using air 
bubbled dichloromethane. Then, photosensitizer was added to cuvette and 
photosentizer’s absorbance was adjusted around 0.2-0.3. 
 
Figure 82. Reaction of singlet oxygen with 1,3-Diphenylisobenzofuran. 
 
Figure 83. Reaction of singlet oxygen with 2,2'-(Anthracene-9,10-
diylbis(methylene))dimalonic acid. 
After, taking some measurements in dark, we took cuvette to monochromatic light 
system for irradiation at peak wavelength for 20 seconds. Absorbance was measured 
for several times after each irradiation. The graphics recorded are shown below; 
Figures 84 to 87. Then, slope of absorbance maxima of DPBF at 414 nm versus time 
graph for each photosensitizer were calculated. Singlet oxygen quantum yield were 
calculated according to the equation: where bod and ref designate the orthogonal 
BODIPY photosensitizer and MB respectively. m is the slope of difference in change 
in absorbance of DPBF (414 nm) with the irradiation time, F is the absorption 
correction factor, which is given by F = 1− 10!!"  (OD at the irradiation 
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wavelength), and PF is absorbed photonic flux (µEinstein dm-3 s-1). 
ϕΔ   bod = ϕΔ ref ×m   bodm   ref × F   refF   bod × PF   refPF   𝑏𝑜𝑑  
 
 
Figure 84. Decrease in absorbance of DPBF in dichloromethane in the presence of 
compound (3) in medium. Details are given in singlet oxygen measurements part. Copyright 
© 2011, John Wiley and Sons. Reprinted with permission from ref (121). 
 
 
Figure 85. Decrease in absorbance of DPBF in dichloromethane in the presence of 
compound (6) in medium. Details are given in singlet oxygen measurements part. Copyright 
© 2011, John Wiley and Sons. Reprinted with permission from ref (121). 
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Figure 86. Decrease in absorbance of DPBF in dichloromethane in the presence of 
compound (7) in medium. Details are given in singlet oxygen measurements part. Copyright 
© 2011, John Wiley and Sons. Reprinted with permission from ref (121). 
 
 
Figure 87. Decrease in absorbance of DPBF in dichloromethane in the presence of MB in 
medium. Details are given in singlet oxygen measurements part. Copyright © 2011, John 
Wiley and Sons. Reprinted with permission from ref (121). 
X-ray Crystal Structure Determination: X-ray diffraction data were obtained on 
an Enraf-Nonius CAD4 (κ-geometry) diffractometer operating in ω/2θ scan mode 
using graphite-monochromated MoKα radiation (λ = 0.71073 Å) at room 
temperature.  The lattice parameters and their estimated standard deviations were 
determined by using CAD4 Express. Data reduction was carried out using XCAD4. 
The structures were solved by direct methods and refined by the full-matrix least-
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squares refinement on F2 using the programs SHELXS97 and SHELXL97, 
respectively, in the WinGX package. Atomic scattering factors were taken from the 
International Tables for X-ray Crystallography. Hydrogen atoms bonded to carbon 
were placed on ideal positions and refined with fixed isotropic displacement 
parameters using a riding model. The molecules are held together by weak van der 
Waals interactions. Hydrogen bond and molecular packing geometry of the title 
molecule was calculated with PLATON. The compound has one intermolecular and 
four intramolecular hydrogen bonds. Packing figure (figure 88) are prepared by 
MERCURY program.217 X-ray crystal structure of compound (3) was determined 
in Dr. Leyla Tatar Yildirim group, at Hacettepe University, Department of 
Physics Engineering, Ankara, Turkey. 
 
Figure 88. Packing diagrams of compound (3).  Dashed lines indicate inter H-bond between 
C2 and F4 atoms. Copyright © 2011, John Wiley and Sons. Reprinted with permission from 
ref (121). 
Synthetic Details: 
Synthesis of (1): 250 mL 1,2-dichloroethane was degassed with N2. 2,4-dimethyl 
pyrrole (1 mL, 11.37 mmol), triethylorthoformate (0.95 mL, 5.69 mmol) and POCl3 
(0.58 mL, 6.25 mmol) were added to degassed solvent. Reaction was allowed to stir 
for 2 hours at room temperature. Then 11.55 mL NEt3 and 11.55 mL BF3.OEt2 were 
added. After 1 hour the reaction was washed with water (3x250 mL), the organic 
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layer separated, dried on NaSO4 and evaporated in vacuo. Column chromatography 
with CHCl3 yielded the pure product as reddish solid (400 mg, 28 %). 1H NMR (400 
MHz, CDCl3): δH  7.09 (1H, s, ArH), 6.10 (2H, s, ArH), 2.60 (6H, s, CH3), 2.29 (6H, 
s, CH3); 13C NMR (100 MHz, CDCl3): δC  156.8, 141.3, 133.5, 120.2, 119.1, 14.8, 
11.2 ppm. 
Synthesis of (2): 4 mL of DMF and 4 mL of POCl3 was stirred in an ice bath for 5 
min under argon. Then warmed to room temperature and waited for 30 minutes. To 
this mixture compound (1) (100 mg, 0.328 mmol) was added in dichloroethane (40 
mL). The temperature is raised to 50 ⁰C and stirred for 2 hours. The reaction medium 
was cooled and poured into 150 mL NaHCO3 solution slowly under cool conditions. 
After cooling it was stirred for further 30 min, then washed with water 3 times. The 
organic layers was combined and dried over NaSO4 and evaporated to dryness. The 
compound has been purified by column chromatography by using chloroform as an 
eluant and the compound has been got pure as reddish solid (95 %). 1H NMR  (400 
MHz, CDCl3): δH  10.02 (1H, s, CHO), 7.20 (1H, s, ArH), 6.20 (1H, s, ArH), 2.77 
(3H, s, CH3), 2.58 (3H, s, CH3), 2.48 (3H, s, CH3), 2.28 ppm (3H, s, CH3); 13C NMR 
(100 MHz, CDCl3): δC  185.5, 163.5, 157.2, 145.4, 140.6, 136.4, 131.1, 125.8, 122.0, 
121.5, 15.2, 12.9, 11.5, 10.4 ppm; MS HRMS (TOF- ESI): m/z calcd for 
C14H15BF2N2O+:  275.1246 [M+H]+ ; found: 275.1212[M+H]+,  Δ = 12.3 ppm. 
Synthesis of (3): In N2 bubbled 250 mL dichloromethane, 2,4-Dimethylpyrrole (50 
µL, 0.478 mmol) and (2) (60 mg, 0.217 mmol) were mixed. 1 drop of trifluoroacetic 
acid has been added. The reaction mixture stirred at room temperature overnight. 
Then p-chloranil (49.2 mg, 0.217 mmol) was added to the reaction. After stirring 1 
hours at room temperature, NEt3 (2 mL) and BF3.OEt2 (2 mL) was added and stirred 
again for 1 hour. The reaction was finished by extracting with water (3x250 mL). 
Column chromatography with CHCl3 yielded the pure product (20 %). 1H NMR  
(400 MHz, CDCl3): δH  7.18 (1H, s, ArH), 6.15 (1H, s, ArH), 6.02 (2H, s, ArH), 2.61 
(3H, s, CH3), 2.59 (3H, s, CH3), 2.57 (3H, s, CH3), 2.54 (3H, s, CH3), 2.40 (3H, s, 
CH3), 2.30 (3H, s, CH3), 2.12 (3H, s, CH3), 1.72 ppm (3H, s, CH3); 13C NMR (100 
MHz, CDCl3): δC  160.3, 155.8, 151.5, 143.7, 142.5, 136.6, 134.7, 133.4, 132.3, 
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131.7, 124.2, 121.3, 120.7, 120.5, 14.9, 14.7, 13.9, 12.7, 9.8, 8.7 ppm; MS HRMS 
(TOF-ESI): m/z calcd for C26H28B2F4N4+:  493.2436 [M+H]+ ; found: 493.2417 
[M+H]+,  Δ = 3.9 ppm.  
Synthesis of (6): In N2 bubbled 100 mL dichloromethane 2,4-Dimethylpyrrole (16.2 
µL, 0.12 mmol) and (4) (20 mg, 0.06 mmol) were mixed. 1 drop of trifluoroacetic 
acid has been added. The reaction mixture stirred at room temperature overnight. 
Then p-chloranil (14.8 mg, 0.06 mmol) was added to the reaction. After stirring 1 
hour at room temperature, NEt3 (1 mL) and BF3.OEt2 (1 mL) was added and stirred 
again for 1 hour. The reaction was finished by extracting with water (3x100 mL). 
Column chromatography with CHCl3 yielded the pure product (16 %). 1H NMR  
(400 MHz, CDCl3): δH  6.05 (4H, s, ArH), 2.61 (12H, s, CH3), 1.60 (3H, s, CH3); 13C 
NMR (100 MHz, CDCl3): δC  157.2, 142.6, 121.6, 14.8, 14.3 ppm; MS HRMS (TOF-
APCI): m/z calcd for C26H28B2F4N4: 493.2358 [M-H]- ; 493.2385 found:   [M-H]-,  Δ 
= 5.5 ppm. 
Synthesis of (7): In N2 bubbled 100 mL dichloromethane 2,4-Dimethylpyrrole (14.8 
µL, 0.143 mmol) and (5) (18 mg, 0.065 mmol) were mixed. 1 drop of trifluoroacetic 
acid has been added. The reaction mixture stirred at room temperature overnight. 
Then p-chloranil (16 mg, 0.065 mmol) was added to the reaction. After stirring 1 
hour at room temperature, NEt3 (1 mL) and BF3.OEt2 (1 mL) was added and stirred 
again for 1 hour. The reaction was finished by extracting with water (3x100 mL). 
Column chromatography with CHCl3 yielded the pure product (9 %). 1H NMR  (400 
MHz, CDCl3): δH  2.54 (12H, s, CH3), 2.36 (8H, q, J = 11.3 Hz, CH2,), 1.82 (12H, s, 
CH3), 1.10 (12H, s, CH3); 13C NMR (100 MHz, CDCl3): δC  155.1, 137.8, 134.8, 
133.2, 129.9, 17.1, 14.7, 12.8, 11.6 ppm; MS HRMS (TOF-APCI): m/z calcd for 
C34H43B2F4N4:  605.3610 [M-H]- ; found: 605.3618 [M-H]-,  Δ = 1.3 ppm. 
Synthesis of Bis-8,2′-distyryl-BODIPY Derivative, bis-10a’: Compound (3) (0.121 
mmol, 60.0 mg) and 4-methoxybenzaldehyde (0.728 mmol, 99.2 mg) were added to 
a 100 mL round-bottomed flask containing 50 mL of benzene, and to this solution 
were added piperidine (0.6 mL) and acetic acid (0.6 mL). The mixture was heated 
under reflux using a Dean−Stark trap, and the reaction was monitored by TLC 
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(CHCl3). When all of the starting material had been consumed, the mixture was 
cooled to room temperature and solvent was evaporated. Water (100 mL) was added 
to the residue, and the product was extracted into the chloroform. The organic phase 
dried over Na2SO4 and evaporated, and the residue was purified by silica gel column 
chromatography using CHCl3 as the eluent. Product was separated as a blue solid in 
30% yield (35 mg, 0.0363 mmol). 1H NMR (400 MHz, CDCl3): δH 7.68 (3H, d, J = 
18.8 Hz), 7.65−7.55 (m, 8H), 7.40 (d, 2H, J = 8.9 Hz), 7.35 (d, 1H, J = 15.2 Hz), 
7.22 (d, 2H, J = 15.2 Hz), 7.10 (s, 1H), 7.02−6.93 (m, 6H), 6.86−6.77 (m, 3H), 6.66 
(s, 2H), 3.95−3.85 (9H, m), 3.80 (3H, s), 2.37 (s, 3H), 2.16(s, 3H), 1.85 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δC 160.4, 153.0, 141.5, 141.3, 138.0, 137.2, 136.5, 136.1, 
129.6, 129.5, 129.4, 129.3, 129.2, 129.1, 117.6, 117.3, 116.9, 116.5, 116.2, 114.5, 
114.3, 114.2, 55.4, 55.3, 14.2, 11.5, 9.6 ppm. MS HRMS (TOF-ESI): m/z calcd for 
C58H53B2F4N4O4+ 967.41891 [M+H]+, found 967.41898 [M+H]+, Δ = 0.1 ppm. 
4.1.5. Conclusion 
Our work demonstrated for the first time a practical example of excited state design 
leading to efficient cytotoxic singlet oxygen generation with a potential in 
photodynamic therapy.  With a sound theoretical framework in design, it is only 
natural to expect other photosensitizers to emerge with similar line of reasoning. We 
performed detailed multireference quantum chemical analyses on several electronic 
states of orthogonal bis-BODIPYs. Essentially isolated monomeric states in the 
dimers dictated formation of a pair of (near) degenerate S0 frontier orbitals, which 
yielded four SOMOs in the S1 state. Domination of S1 wave function by doubly 
substituted configurations was utilized as an electronic structure descriptor in 
assessing ISC efficiency. Formation of DS-TR S1 states was not only tied to 
orthogonality but also to a certain degree of truncation in the π-framework of the 
substituents. Bis-BODIPYs with extended π-systems possess destabilized DS-TR 
states, as exchange coupling among unpaired electrons of same spin is significant 
only at small distances. Shifting the absorption wavelength to the red region is 
achieved with π-extension of bis-BODIPYs; however, ISC properties are adversely 
affected for such dimers. Modifications in the chromophore cores are likely to be a 
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more promising research direction. 
4.2. Activatable Heavy Atom Free Sensitizers: Selective 
Enhancement of Photocytotoxicity 
4.2.1. Objective 
Photosensitized generation of reactive oxygen species, particularly singlet oxygen is 
at the core of photodynamic action leading to PDT. “On-off” switching of singlet 
oxygen generation would be highly valuable if it were to be linked to a cancer related 
cellular parameter. A favorite recipe for enhancing ISC in an organic sensitizer has 
been incorporation of heavy atoms. Unfortunately, this comes with price tag of 
increased “dark toxicity”. Building on recent findings related to ISC efficiency, we 
designed dimeric BODIPY dyes with broken symmetry, which is inactive as a 
sensitizer, unless it is activated by a reaction with the intracellular GSH. Modulation 
of charge transfer and DS-TR excited state is an “off-on process” and most 
remarkably, the designed sensitizer can differentiate different concentrations of GSH 
in healthy (normal) and cancer cells, and thus remaining inefficient as a sensitizer 
inside a normal cell, while being transformed into a deadly singlet oxygen source 
inside the cancer cells. This is the first demonstration of such a difference in 
intracellular activity of a sensitizer. 
4.2.2. Introduction 
PDT that is based on the photosensitized generation of singlet oxygen by irradiation 
at the visible-near IR region of the spectrum, has been recognized as a non-invasive 
cancer treatment modality of great potential for some time, however the realization 
of that potential did not take place except for very limited cases of skin lesions and 
always at the initial stages of the diseases.218 It should be in principle possible to 
localize irradiation to the area of the tumor, increasing spatial selectivity, but painful 
oedemia in the patient is a very common side-effect due to photosensitization in an 
unrelated locale inside the body. This situation prompted many in the field to 
propose so-called “activatable sensitizers”, which are to be turned on only when 
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cancerous tissue or cell is uncounted, otherwise staying at a passive state, not-being 
capable of photosensitization, even if the molecule happens to absorb a photon of 
stray light.219  
Earlier examples mostly made use of the pH difference between the tumor 
extracellular pH and the healthy tissues.220 On the other hand, GSH concentration, 
which is reportedly higher in cancer cells,79 was also exploited as a modulator,135 
however no difference in photosensitization activity in cancer cells were shown 
explicitly. Other modulators were caspase,221 this and that, but in all these cases, 
differential sensitization in cancer versus normal cells was not demonstrated. The 
intracellular distinction is important because, extracellular singlet oxygen clearly is 
not as effective cytotoxic agent. 
The other piece of the puzzle is the sensitizer itself. It is possible to attach quencher 
module,130 which is removed by an external agent to restore photosensitization, but 
this bimodular approach makes the activatable sensitizer too large, in some cases 
making it cell impermeable, thus limiting any potential. Extracellular GSH/bio-thiol 
activation reaction is absolutely non-specific and does not really add anything to the 
selectivity of the photosensitization. With these considerations and by using the 
accumulated knowledge of excited state configurations and triplet photosensitization 
(section 4.1), we thus concluded that de novo design of a sensitizer, as opposed to 
tinkering with a porphyrin derivative, seemed more promising.      
4.2.3. Results and Discussion 
In this study, we designed a heavy atom free orthogonal-bis BODIPY sensitizer to 
get activatable, charge transfer (CT) mediated heavy atom free sensitization of PDT 
by modulating excited state characteristics of the sensitizer. Our sensitizer (PS) 
involves an unsubstituted Bodipy core (BOD-1, charge donor), which is linked 
orthogonally to another Bodipy (BOD-2, linker) that is substituted with a methyl 
pyridinium (MP, charge acceptor) moiety (figure 89). Incorporation of methylated 
pyridine unit has four major roles; i) suppressing the DS-TR nature of the BODIPY 
dimer’s excited state via extension of conjugation ii) upon excitation, it is a potential 
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charge acceptor moiety, iii) forming a reaction site for bio-thiols (for instance GSH) 
(iii) improved water solubility. The electronic structure details of (PS) and (actPS) 
were investigated with a combination of DFT, TD-DFT, and CASSCF/CASPT2 
methods before dealing with singlet oxygen generation experiments in order to 
validate our design strategies. 
 
 
Figure 89. Design principles (top) and Orbital energies (eV) and plots of (PS) and (actPS) 
relevant to the CT excitation from BODIPY to methylpyridinium (bottom).  
Initially our sensitizer (PS) is expected to be inactive due to the destabilized DS-TR 
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excited state and non-degenerate HOMO levels of individual BODIPY cores as a 
result of extended conjugation and asymmetric functionalization (section 4.1). In 
addition to that, theoretical calculations show that coplanar arrangement of MP on 
the xy-plane in (PS) generates a LUMO delocalized on the entire MP-BOD-2. On the 
other hand, when conjugation is broken like in the case of (actPS), LUMO is clearly 
local to MP and acts as a spatially separated electron acceptor (figure 89). Frontier 
orbital plots and energies of (PS) and (actPS) are depicted in figure 89. As 
mentioned above, LUMO of (actPS) is mainly the LUMO of cationic 
methylpyridinium moiety. Therefore an S0 → S1 excitation of the HOMO → LUMO 
type is a typical picture of a charge transfer (CT) transition from the unsubstituted 
BOD1 HOMO to the MP LUMO. This (through-space) CT transition is the key point 
in our design for achieving ISC in the case of (actPS). Whenever orbitals taking 
place in a CT excitation are placed on orthogonal and separated donor – acceptor 
moieties (HOMO and LUMO of (actPS) in figure 89) the electronic transition is 
accompanied by a large change in orbital angular momentum that should be 
compensated by a change in the spin angular momentum, hence the reason of singlet-
triplet hop. In line with the requirements on angular momentum change, the donor 
MO lies on the yz-plane and acceptor MO lies on the xy-plane for (actPS) (figure 
89). Our calculations suggest that the 8-phenyl BODIPY is transformed into a spacer 
with the conversion of (PS) to (actPS). The effect of structural spacers on the 
electronics of CT transitions was recently discussed124 where absence of spacers was 
shown to diminish the CT nature of CT in twisted chromophores.  
After obtaining promising theoretical insights, we firstly synthesized a meso-phenyl 
substituted BODIPY derivative according to well-established BODIPY chemistry. 
The formylation of the core at 2-position was performed followed by another 
BODIPY formation reaction to obtain an orthogonal dimer. Then, Knoevenagel 
condensation reaction was performed with 4-pyridine carboxyaldehyde. Finally we 
methylated the pyridine moiety by using excess iodomethane in ethyl acetate and 
methyl pyridinium salt of BODIPY was isolated successfully (figure 90). 
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Figure 90. Synthesis of activatable sensitizer (PS). 
Later, in order to synthesize our activated sensitizer (actPS) by blocking the 
conjugation, we used a simple thiol mercaptoethanol in a proof of principle study. 
Reaction of (PS) with mercaptoethanol in DCM can possibly yield to products; i) 
addition of thiol to double bond or ii) reduction of the double bond under basic 
conditions.222 Literature studies showed that latter product is obtained by a radicalic 
mechanism.222 When we tried the reaction with catalytic amount of potassium 
carbonate in dichloromethane, we isolated the major product as a reduced form 
(actPS) (figure 91). 1H NMR spectrum (figure 91) of (actPS) clearly shows the 
disappearance of the styryl peaks, which are observed at 7.9 and 7.4 ppm in the case 
of compound (PS). Moreover appearance of a new peak at 3.4 ppm that corresponds 
to aliphatic hydrogens, (due to the reduction) can be interpreted as a direct proof of 
the desired adduct (figure 91). Further characterization of the adduct was done by 
mass spectrometry (figure 91) in which we observed a single BODIPY dimer pattern 
with 4.9 ppm precision. 
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Figure 91. Reduction of compound (PS) in the presence of mercaptoethanol. 1H NMR 
spectra of (PS) and (actPS). HR-MS spectrum of (actPS) (Δ (ppm) = 4.9 ppm). 
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Figure 92. Normalized electronic absorption spectra of (dimBDY), (pydimBDY), (PS) and 
(actPS) in DCM. 
Table 7. Photophysical characterization of sensitizers. 
sensitizer λabsa / nm εmaxa / M-1 cm-1 λemsa / nm 
dimBDY 508 140000 530 
pydimBDY 
509 
567 
36000 
30000 
522 
573 
PS 
508 
607 
513b 
590b 
41000 
38000 
34000b 
25000b 
522 
645 
520b 
606b 
actPS 
511 
508b 
119000 
90000b 
535 
533b 
aValues were obtained in DCM. bValues were obtained in 90/10 (HEPES Buffer/ MeCN). 
Fluorescence quantum yield measurements were acquired by using reference compounds 
Rhodamine 6G (water, φf = 0.95, ν = 1.333) and sulphorhodamine (ethanol, φf = 0.90, ν = 
1.362). For all compounds fluorescence quantum yields were found to be almost zero. 
After the synthesis of compounds (PS) and (actPS) and optical characterization, we 
performed series of singlet oxygen (SO) generation experiments by monitoring the 
singlet oxygen formation via 1,3-diphenylisobenzofuran as a SO trap molecule, when 
DCM was used as a solvent and 2,2'-(Anthracene-9,10-diyl)bis(methylene)dimalonic 
acid in the case of aqueous solutions (figure 93). First of all, we investigated the SO 
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generation capacity of compound (dimBDY) by observing the decrease in absorption 
of DPBF in DCM. As expected cytotoxic SO formation was highly efficient in the 
case of (dimPDY). Then SO trap experiment was performed with (PS) in DCM and 
there was no change in absorbance indicating the formation of SS excited state and 
loss of DS-TR state due to the extended conjugation. After that, same experiment 
was repeated in 90:10 / HEPES buffer (pH 7.4):MeCN with water-soluble anthracene 
derivative trap in the presence of (PS). Similarly SO generation could not be 
observed. There are two characteristic absorption peaks for (PS) due to the 
asymmetric arrangement of two different BODIPY cores.   
 
 
Figure 93. Relative 1O2 generation efficiency of top: (dimBDY), (PS) and (actPS) in DCM 
and bottom: (PS) and (actPS) in 90:10 (Hepes buffer, pH 7.2, 20mM : MeCN) detected by 
the absorbance decrease of DPBF at 414 nm and 2'-(Anthracene-9,10 
diylbis(methylene))dimalonic acid (ADMDA) at 378 nm respectively with time. During first 
60 seconds (right) and 15 minutes (left), the samples were kept in the dark. 
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It is important to note that, SO generation is only observed with compounds 
(dimBDY) and (actPS) in both solvents. In the case of (dimBDY), SO generation 
can be detected due to the formation of doubly substituted tetra radical (DS-TR) 
excited state configuration as in the case of our previous studies (section 4.1). On the 
other hand, in (actPS), charge transfer mediated ISC is the reason for SO generation.  
Moreover, remarkable SO generation difference is observed between (PS) and 
(actPS), which is highly important for cancer related activation of sensitizers in PDT 
applications.  
 
 
Figure 94. Left: The T1-Tn transient absorption spectra of (actPS) in argon saturated THF 
and MeCN with laser excitation at 355 nm (the absorbance at 355 nm is 0.402). Right: The 
decay of triplet state T1 of (actPS) at 425 nm in argon saturated THF and MeCN with laser 
excitation at 355 nm (the absorbance at 355 nm is 0.402). The triplet lifetimes are 8.7 µs 
(MeCN) and 27.6 µs (THF). 
As another proof of singlet oxygen generation, we performed nanosecond transient 
absorption analysis of (PS) and (actPS) in MeCN and THF. Figure 94 shows the 
time evolution of the transient absorption (TA) spectra of (actPS), which showed a 
positive peak with the maximum at 420 nm and a negative peak with the minimum at 
510 nm (ground state bleaching) both in MeCN and THF. Both the shape and 
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position are very similar to the T1-Tn absorption spectra of the well-known sensitizer 
iodo-Bodipy derivative.223 This similarity indicates the positive signal of (actPS) is 
also T1-Tn absorption. In the case of (PS), additional peak at around 420 nm could 
not be detected. The following spectral behavior is also typical of the T1-Tn 
absorption. The positive bands are separated from the ground state bleaching with 
well-defined isosbestic points. The triplet lifetime of (actPS) at 425 nm in argon 
saturated acetonitrile THF are 8.76 µs and 27.6 µs receptively, which are long 
enough for singlet oxygen generation reactions. In the case of (PS), transient 
absorption peak at 425 nm cannot be detected in both solvents suggesting an “off” 
state for our sensitizer.  
Table 8. The quantum yields for T1 state formation of (actPS) in different solvents 
--------------------------------------------------------- 
Sample Solvent   ΦT (quantum yield for T1 state formation)* --------------------------------------------------------- 
actPS Hexane-THF(5/1 v/v)  0.47 
actPS THF    0.14 
actPS acetonitrile  0.084 
--------------------------------------------------------- 
*Details are given in experimental part. 
Triplet state quantum yield of (actPS) was calculated224 by using a reference 
compound zinc phthalocyanine (ZnPc)224 in different solvents (table 7). In a nonpolar 
solvent (Hexane-THF (5/1 v/v)) quantum yield was calculated as 0.47, when we 
moved to polar solvents triplet state quantum yield was decreased. This difference is 
due to the fact that the excited dimer undergoes very fast and effective 
intramolecular charge transfer (ICT) in polar solvents, which shutdowns ISC 
pathway, while ICT is almost negligible in nonpolar solvents.223   
After obtaining promising results with SO generation experiments, we wanted to 
show that our sensitizer (PS) is preferentially reacting with GSH rather than other 
two major bio-thiols (Cys&Hcy) in intracellular conditions. To do so, we reacted 
(PS) with three bio-thiols. Thiols are introduced according to their intracellular 
concentrations  (GSH: 5mM, Cys and Hcy: 25 µM). At the end of 12 hours, decrease 
in the absorption peak at 590 nm, which is the sign of thiol reaction, is only observed 
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with GSH (figure 95, left). No changes in absorption spectra were detected with 
other bio-thiols (figure 95, right). 
 
Figure 95. Comparison of electronic absorption spectrum of left: (PS) (30µM) and (PS) 
(30µM)+ GSH (5mM), right: (PS) (25µM) and (PS) (25µM) + Cys (25µM) & Hcy (25µM) 
in 90:10 (Hepes buffer, pH 7.2, 20mM : MeCN). Reaction time is 12 hours in all cases.  
For further demonstration of the singlet oxygen generation capacity and 
photocytotoxicity of our dimers (PS) and (actPS), we carried out a cell culture assay 
with HeLa cell lines. Experimental verification of photocytotoxicity was carried out 
as follows: varying concentrations of the dimeric dyes (PS) and (actPS) were 
incubated with HeLa cells within a standard culture medium at 37oC in a humidified 
incubator containing 5% CO2. Cells were irradiated with a green light-emitting diode 
(LED) source for 4 h, followed by 24 h of incubation in the dark. The control group 
was incubated in the dark under otherwise identical conditions. The cell viabilities 
were determined using a standard MTT assay (Figure 96). Even at very low 
concentrations of pre-activated (actPS), a significant decrease of the cell viability 
was observed (red line in Figure 96, top). In the case of compound (PS), cell death 
was also observed suggesting that (PS) can be activated intracellularly without any 
external stimuli (blue line in Figure 96, top). No statistically significant change was 
observed when the cells were kept in the dark, in the presence of the same 
concentration of the photosensitizers (PS) and (actPS) (Figure 96, bottom). 
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Figure 96. Photocytotoxicity of the sensitizer (PS) (blue) and (actPS) (red) as demonstrated by MTT 
assay. Cells were kept either in the dark (bottom), or under illumination with a green (520 nm) LED 
array (top). 
 
Figure 97. Cytotoxic effects of sample (PS) (blue), (actPS) (red). Cells were incubated with 
(PS), (actPS) for 4 hr and irradiated with green LED. Cytotoxic effects were examined by 
MTT assay. Normal cell lines : NIH 3T3, WI38 VA13, cancer cell lines : HeLa, SK Hep 1.  
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We also conducted additional MTT assay tests to show that designed sensitizer (PS) 
can differentiate different concentrations of GSH in healthy (normal) and cancer 
cells (figure 97). Results were striking such that in the case of healthy cells (NIH 3T3 
and WI38 VA13) survival rate was remained around 80%, however when (PS) is 
incubated with cancer cell lines (HeLa, SK Hep1) survival rate dropped to 40% after 
just 4 hours. These results clearly show that (PS) is able to differentiate 
intracellularly between healthy and cancer cells, which makes (PS) a good candidate 
as an activatable sensitizer. On the other hand, pre-activated (actPS) killed all 
healthy and cancer cells without any selectivity (survival rate is around 10% in all 
cell lines).   
 
Figure 98. The HeLa cells were incubated with (PS), (actPS) for 4 hrs. Cells were irradiated 
with green LED for 30 min and incubated another 3 hrs or kept under dark and stained with 
Annexin V-AF594 (apoptosis marker). Fluorescence images were acquired by confocal 
microscopy. For nucleus stain, 1 µg/ml DAPI costained for 30 min. (a) DAPI (ex. 405 nm, 
em. 430-455 nm), (b) (PS), (actPS) (ex. 473 nm, em. 490-590 nm), (c) Annexin V-AF594 
(ex. 559 nm, em. 575-675 nm),  (d) DIC, (e) Merge. Scale bar: 10 µm 
Confocal microscopy experiments were done in order to investigate the 
photocytotoxic effect and intracellular localization of (PS) and (actPS). The HeLa 
cells were incubated with (PS) and (actPS) for 4 hours. After washing, the cells were 
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irradiated with green LED for 30 min and incubated for another 3 hours or kept 
under dark and stained with DAPI (nucleus stain, blue fluorescence) and Annexin V-
AF594 (apoptosis marker, red fluorescence). Figure 98(b) clearly shows that both 
(PS) and (actPS) were located in the cytosol of the cells. Apoptotic cells were only 
detected upon irradiation (figure 98(c)). Confocal images proved once more that (PS) 
is getting activated intracellularly. Cells incubated with (PS) and (actPS) in the dark 
showed no Annexin V emission. 
Finally, in order to elucidate the conjugation loss (activation) mechanism of (PS) in 
physiological medium (cell culture), we mimicked the (PS) – GSH reaction by 
reacting (PS) with excess mercaptoethanol (simple thiol analogue) in an aqueous 
solution 90:10 (HEPES buffer, pH 7.2, 20mM : MeCN) without adding any base. 
Color of the solution was changed with in a 20 minutes and mass spectrum (figure 
99), which was acquired by taking an aliquot from a reaction mixture showed that 
predominantly Michael addition product was formed. Thus, it is possible to conclude 
that in cell culture medium, formation of Michael adduct is more favorable that 
blocks the conjugation and activates the charge transfer mediated ISC. 
 
 
Figure 99. Michael addition of mercaptoethanol to compound (PS) in the absence of base in 
aqueous solution (90:10 (HEPES buffer, pH 7.2, 20mM : MeCN)). HR-MS spectrum of 
(Michael adduct) (Δ (ppm) = 31.8 ppm). 
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4.2.4. Experimental Details 
General: All chemicals and solvents obtained from suppliers were used without 
further purification in the case of synthetic studies. During the photophysical 
characterizations, all solvents were dried and redistilled before use. Reactions were 
monitored by thin layer chromatography using Merck TLC Silica gel 60 F254. 
Chromatography on silica gel was performed over Merck Silica gel 60 (particle size: 
0.040-0.063 mm, 230-400 mesh ASTM). 
1H NMR and 13C NMR spectra were recorded at room temperature on Bruker DPX-
400 (operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane (TMS) as internal standard. Coupling constants (J values) are given 
in Hz and chemical shifts are reported in parts per million (ppm). Splitting patterns 
are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and p 
(pentet). Electronic absorption spectra in solution were acquired using a Varian 
Cary-100 spectrophotometer and a StellarNet BLACK Comet C-SR diode array 
miniature spectrophotometer connected to deuterium and halogen lamp by optical 
fiber using 1 cm matched quartz cuvettes at room temperature. Fluorescence spectra 
were determined on Varian Eclipse and Edinburgh Instruments FLS920 
fluorospectrometer. Fluorescence lifetime of S1 state was measured by time-
correlated single photon counting method (Edinburgh FLS920 spectrophotometer) 
with excitation at 509 nm by a portable diode laser (150 ps FWHM) and emission 
was monitored at 520 nm. The lifetime values were computed by the F900 software. 
All spectra were corrected for the sensitivity of the photo-multiplier tube. Mass 
spectra were recorded on Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS. 
Fluorescence Measurements: The fluorescence quantum yield (Φf) was computed 
by using; 
2
0 s 0
f f 2
0 s 0
F A
F A
sn
n
Φ =Φ ⋅ ⋅
 
in which F is the integrated fluorescence intensity, A is the absorbance at excitation 
wavelength, n is the refractive index of the solvent used, the subscript 0 stands for a 
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reference compound and s represents samples. A BODIPY monomer in CH2Cl2 was 
used as the reference (Φf =0.80).121 The sample and reference solutions were 
prepared with the same absorbance (Ai) at the excitation wavelength (near 0.050 in a 
1 cm quartz cell). All solutions were air saturated. 
For (actPS), Φf decreases with the increase of solvent polarity. The shape and 
emission maximum of fluorescence spectra is changed very slightly by solvent 
polarity. The decay curves are decreased with the increase of solvent polarity, 
indicating that the percentage of the short-lived emission component is increased 
with the increase of solvent polarity. 
 
Figure 100. The normalized fluorescence emission spectra of (dimBDY), (pydimBDY), and 
(PS) in DCM. 
 
Figure 101. The normalized fluorescence emission spectra of (actPS) in different solvents 
with excitation at 418 nm (absorbance 0.090). 
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Figure 102. Fluorescence decay of (actPS) in EtOH with excitation at 509 nm diode laser 
(150 ps), the emission was monitored at 520 nm, the concentration of dyes is ca. 3.0 µM. 
Table 9. Fluorescence quantum yield (Ff) and lifetime (tf) of (actPS) in different solvents. 
Sample λ em/nm Φ f τ f/ns chi squared  value solvent 
PS 517 0.088 1.60, 5.61(96%) 1.04 THF 
actPS 516 0.19 0.92, 5.95(98%) 1.03 
Hexane-
THF(5:1 v/v) 
actPS 517 0.15 1.35, 5.67(96%) 1.02 THF 
actPS 517 0.089 0.93, 5.89(90%) 1.09 ethanol 
actPS 516 0.073 2.11, 5.79(90%) 1.13 acetonitrile 
actPS 522 0.035 0.77, 2.99(57%), 6.43(31%) 1.14 water 
 
Excited Triplet State Studies: Nanosecond transient absorption measurements were 
obtained using LP920 (Edinburgh Instruments Ltd.). The excitation source was a Q-
switched Nd/YAG laser (BRIO) of 4 ns full width at half maximum with third 
harmonic (355 nm) generation. The 355 nm beam was directed onto one side of a 1 
cm square silica cell containing the sample (absorbance 0.40) after bubbling Ar gas 
during 20 min. The transient transmission variations were monitored at right angles 
to the excitation in a crossbeam arrangement using a 450W xenon flash lamp, a 
monochromator, a photomultiplier and a digitized oscilloscope interfaced with a 
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desktop computer. The power of the incident 355 nm laser pulse in the sample was 
about 5 mJ.  The triplet quantum yield ΦT was obtained by comparing the ΔAT of the 
optically matched sample solution at peak maximum in a 1 cm cuvettes to that of the 
reference using the equation;224 
ZnPc
ZnPc T T
T T ZnPc
T T
ΔA ΔεΦ =Φ
ΔA Δε
⋅ ⋅
 
Where the superscript represents the reference, ΔAT is the absorbance of the triplet 
transient difference absorption spectrum at the selected wavelength, and ZnPc is the 
reference compound (ΦT=0.65 in 1-propanol).224 ΔεT is the triplet state molar 
absorption coefficient, which is obtained by equation given below; 
T
T S
S
A
A
ε ε
Δ
Δ =
Δ  
Where ΔAS and ΔAT are the absorbance change of the triplet transient difference 
absorption spectrum at the minimum of the bleaching band and the maximum of the 
positive band, respectively, and εS is the ground-state molar absorption coefficient at 
the UV-vis absorption band maximum. Both ΔAS and ΔAT were obtained from the 
triplet transient difference absorption spectra. Excited triplet state quantum yield 
calculations were done in Xian-Fu Zhang group at Hebei Normal University of 
Science and Technology, Department of Chemistry, Qinhuangdao, China 
Singlet Oxygen Trap Experiments: In a typical procedure for the detection of 
singlet oxygen generation by using trap molecules, a photosensitizer (~1 µM) and a 
trap molecule (O.D ~ 1.0) were mixed in O2 bubbled solvent. Initially several dark 
measurements were taken followed by irradiation of the mixture at absorption 
maximum of a sensitizer. Absorbance decreases of trap molecules (1,3-
Diphenylisobenzofuran, 2,2'-(Anthracene-9,10-diylbis(methylene))dimalonic acid 
(ADMDA)) were monitored suggesting singlet oxygen generation in the presence of 
light and sensitizers. Irradiation of compounds was accomplished in Horiba Jobin-
Yvon Time-Resolved Fluorometer, Fluorolog FL-1057 by using monochromatic 
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light system. 
 
Figure 103. Decrease in absorbance of DPBF in DCM in the presence of (dimBDY) (1X10-6 
M). Excitation @508 nm. 
 
Figure 104. Decrease in absorbance of DPBF in DCM in the presence of (PS) (1X10-6 M). 
Excitation @508 nm. 
 
Figure 105. Decrease in absorbance of DPBF in DCM in the presence of (PS) (1X10-6 M). 
Excitation @607 nm. 
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Figure 106. Decrease in absorbance of ADMDA in 90:10 (20 mM Hepes buffer:MeCN) in 
the presence of (PS) (1X10-6 M). Excitation @513 nm. 
 
Figure 107. Decrease in absorbance of ADMDA in 90:10 (20 mM Hepes buffer:MeCN) in 
the presence of (PS) (1X10-6 M). Excitation @590 nm. 
 
Figure 108. Decrease in absorbance of DPBF in DCM in the presence of (actPS) (1X10-6 M). 
Excitation @511 nm. 
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Figure 109. Decrease in absorbance of ADMDA in 90:10 (20 mM Hepes buffer:MeCN) in 
the presence of (5r) (1X10-6 M). Excitation @508 nm. 
Computational Details: Computational results are obtained using Density 
Functional Theory (DFT). Hybrid density functional calculations were carried out 
using Gaussian 09. Effective core potentials (ECP), where core electrons up to a 
given shell is treated with pseudopotentials and explicit treatment of the valence 
electrons employed, is used with Stevens-Basch-Krauss split valence, CEP-31G. 
Several other basis sets and various other functionals were previously tested, and this 
level of theory was confirmed to have reliable results compared with the 
experimental data. Spin contaminations were also checked and found to be negligible 
in all cases. Vibrational frequency calculations ensured that Hessian matrix does not 
contain any negative numbers and located geometries correspond to minimum points 
on the potential energy surface. Computational studies were done in Dr. Yavuz 
Dede group at Gazi University, Department of Chemistry, Ankara, Turkey. 
Cell Culture Studies: In the case of MTT assay studies, cells were incubated with 
different concentrations of sensitizers for 4 hrs and irradiated with green LED or kept 
under dark. Cytotoxic effects were examined by MTT assay. NIH 3T3, WI38 VA13 
were used as healthy cell lines and HeLa, SK Hep 1 were used as cancer cell lines. In 
the case of confocal microscopy imaging, HeLa cells were incubated with 5 µg/mL 
of each sensitizers for 3 hrs. After washing with DPBS, the cells were irradiated with 
green LED for 30 min or kept under dark and acquired the images by confocal 
microscopy. For nucleus staining, 1 g/mL DAPI was employed for 30 min. Annexin 
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V-AF594 was used as an apoptotic marker. Excitations were as follows; DAPI (ex. 
405 nm, em. 430-455 nm), Annexin V-AF594 (ex. 559 nm, em. 575-675 nm) and 
(PS), (actPS) (ex. 473 nm, em. 490-590 nm). Cell  studies were done in Dr. Yavuz 
Dede group at Gazi University, Department of Chemistry, Ankara, Turkey. 
Synthetic Details: 
Synthesis of (BDY): To a 1 L round-bottomed flask containing 400 mL argon-
degassed dichloroethane, 2,4-Dimethyl pyrrole (9.56 mmol, 0.924 g) and benzoyl 
chloride (4,34 mmol, 0.611 g) were added. The solution was refluxed for 1 day at 
90oC. After that, 5 mL of Et3N and 5 mL of BF3.OEt2 were successively added and 
after 30 min, the reaction mixture was washed three times with water (3 x 100 mL), 
which was then extracted into the CH2Cl2 (3 x 100 mL) and dried over anhydrous 
Na2SO4. The solvent was evaporated and the residue was purified by silica gel 
column chromatography using (5 Hexane: 1 EtOAc) as the eluent. Red solid (0.631 g, 
45%). 1H NMR (400 MHz, CDCl3): δH 7.51-7.49 (3H, m, ArH), 7.30-7.28 (2H, m, 
ArH), 6.00 (2H, s, ArH), 2.58 (6H, s, CH3), 1.39 (6H, s, CH3). 13C  NMR (100 MHz, 
CDCl3): δC 155.5, 143.3, 141.9, 135.1, 131.5, 129.1, 128.9, 127.9, 121.2, 14.6, 14.4 
ppm. MS (TOF- ESI): m/z: Calcd: 324.1718, Found: 324.1795 [M+H]+, Δ=23.6 
ppm. 
Synthesis of (fBDY): A mixture of DMF (2.5 mL) and POCl3 (2.5 mL) was stirred 
under argon for 5 min in the ice bath. After warming solution up to room 
temperature, it was stirred for additional 30 min. (BDY) (1.24 mmol, 400.0 mg) in 
60 mL dichloroethane was added to the solution and temperature raised to 500C. 
After stirring for 3 hrs, the mixture was cooled to room temperature and then poured 
in to iced cooled saturated aqueous solution of NaHCO3 (150 mL). Then reaction 
mixture was stirred for 30 min after warming solution to rt. After 30 min. the mixture 
was washed with H2O (2x100 mL). The product was extracted into the 
dichloromethane. Organic phase dried over Na2SO4. The solvent was evaporated and 
the residue was purified by silica gel column chromatography using CH2Cl2 as the 
eluent. Reddish-brown solid was obtained (388.0 mg, 89%). 1H NMR  (400 MHz, 
CDCl3, 300K) : δH 10.02 (1H, s, CHO), 7.55-7.53 (3H, m, ArH), 7.30-7.28 (2H, m, 
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ArH), 6.12 (1H, s, ArH), 2.83 (3H, s, CH3), 2.62 (3H, s, CH3), 1.66 (3H, s, CH3), 
1.43 (3H, s, CH3). 13C NMR (100 MHz, CDCl3): δC 186.2, 161.7, 156.7, 147.6, 143.6, 
142.9, 134.2, 129.9, 129.5, 127.7, 126.8, 124.0, 15.1, 14.8, 13.0, 11.6 ppm; MS 
(TOF- ESI): m/z: : Calcd: 352.1668, Found: 352.1710 [M+H]+, Δ=11.9 ppm 
Synthesis of (dimBDY): To a 500 mL round-bottomed flask containing 250 mL 
argon-degassed CH2Cl2, were 2,4-Dimethyl pyrrole (1.87 mmol, 178.3 mg) and 
(fBDY) (0.85 mmol, 0.300 g) were added. The solution was stirred under N2 at room 
temperature for 1 day. After that, 1.5 mL of Et3N and 2 mL of BF3.OEt2 were 
successively added and after 30 min, the reaction mixture was washed three times 
with water (3 x 100 mL), which was then extracted into the CH2Cl2 (3 x 100 mL) and 
dried over anhydrous Na2SO4. The solvent was evaporated and the residue was 
purified by silica gel column chromatography using CH2Cl2 as the eluent. Red solid 
(170.0 mg, 35%). 1H NMR (400 MHz, CDCl3): δH 7.52-7.49 (3H, m, ArH), 7.32-
7.30 (2H, m, ArH), 6.10 (1H, s, ArH), 6.00 (2H, s, ArH), 2.61 (3H, s, CH3), 2.54 
(6H, s, CH3), 2.43 (3H, s, CH3), 1.73 (6H, s, CH3), 1.43 (3H, s, CH3), 1.23 (3H, s, 
CH3). 13C NMR (100 MHz, CDCl3): δC 158.8, 155.7, 150.4, 145.6, 142.5, 142.4, 
138.2, 134.5, 133.7, 132.5, 131.8, 130.9, 129.4, 127.8, 125.6, 122.5, 121.2, 46.6, 
31.7, 22.7, 14.6, 14.1, 13.9, 12.7, 12.1 ppm. MS (TOF- ESI): m/z: Calcd: 568.2822, 
Found: 568.2698 [M]+, Δ=21.8 ppm. 
 Synthesis of (pydimBDY): (dimBDY) (0.26 mmol, 150.0 mg) and 4-
Pyridinecarboxaldehyde (0.79 mmol, 84.6 mg) were added to a 100 mL round-
bottomed flask containing 50 mL benzene and to this solution piperidine (0.20 mL) 
and acetic acid (0.20 mL) were added. The mixture was heated under reflux by using 
a Dean Stark trap and reaction was monitored by TLC (CH2Cl2 : MeOH 95:5). When 
all the starting material had been consumed, the mixture was cooled to room 
temperature and solvent was evaporated. Water (100 mL) added to the residue and 
the product was extracted into the chloroform (3 x 100 mL). Organic phase dried 
over Na2SO4, evaporated and residue was purified by silica gel column 
chromatography using (CH2Cl2: MeOH 95:5) as the eluent. Purple solid was 
obtained (43.0 mg, 25%). 1H NMR (400 MHz, CDCl3): δH 8.69 (2H, s, ArH), 7.92 
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(1H, d, J = 16.2, CH), 7.56-7.54 (5H, m, ArH), 7.36-7.33 (2H, m, ArH), 7.19 (1H, d, 
J = 16.2, CH), 6.73 (1H, s, ArH), 6.02 (2H, s, ArH), 2.55 (6H, s, CH3), 2.50 (3H, s, 
CH3), 1.74 (6H, s, CH3), 1.50 (3H, s, CH3), 1.28 (3H, s, CH3). 13C NMR (100 MHz, 
CDCl3): δC 156.1, 153.9, 151.7, 148.4, 145.3, 143.8, 142.7, 142.2, 140.5, 134.2, 
133.8, 132.7, 132.5, 131.6, 129.7, 129.5, 128.8, 127.7, 127.1, 124.4, 121.8, 121.4, 
118.7, 25.1, 24.7, 14.7, 13.9, 13.1, 12.4. MS (TOF- ESI): m/z: Calcd: 658.3160, 
Found: 658.3164 [M+H]+, Δ=0.6 ppm. 
Synthesis of (PS): (pydimBDY) (0.061 mmol, 40.0 mg) and excess iodomethane 
(0.61 mmol, 87.0 mg) were dissolved in 5 mL ethyl acetate. The reaction mixture 
was stirred for 1 day at room temperature. When all the starting material had been 
consumed, solution was poured in to the cold diethyl ether. Precipitate was filtered 
and dried. Dark blue solid was obtained (36.7 mg, 75%). 1H NMR (400 MHz, 
CDCl3): δH 9.00 (2H, s, ArH), 8.07 (2H, s, ArH), 7.99 (1H, d, J = 16.2, CH), 7.56-
7.54 (3H, m, ArH), 7.49 (1H, d, J = 16.2, CH), 7.34-7.32 (2H, m, ArH), 6.98 (1H, s, 
ArH), 6.02 (2H, s, ArH), 4.55 (3H, s, CH3), 2.54 (6H, s, CH3), 2.50 (3H, s, CH3), 
1.73 (6H, s, CH3), 1.49 (3H, s, CH3), 1.30 (3H, s, CH3). 13C NMR (100 MHz, 
CDCl3): δC 156.1, 153.9, 151.7, 148.4, 145.3, 143.8, 142.7, 142.2, 140.5, 134.2, 
133.8, 132.7, 132.5, 131.6, 129.7, 129.5, 128.8, 127.7, 127.1, 124.4, 121.8, 121.4, 
118.7, 26.6, 25.1, 24.7, 14.7, 13.9, 13.1, 12.4. MS (TOF- ESI): m/z: Calcd: 
672.3322, Found: 672.3236 [M+H]+, Δ=12.8 ppm. 
Synthesis of (actPS): Excess amount of mercaptoethanol (5.0 mmol) and catalytic 
amount of K2CO3 were added on to (PS) (0.024 mmol, 20 mg) in MeCN. Solution 
was stirred for 1 h. After that, the product was separated by silica gel column 
chromatography using (CH2Cl2: MeOH 90:10) as the eluent. Product was obtained as 
orange solid (17.3 mg, 90%). 1H NMR (400 MHz, CDCl3): δH 9.15 (2H, d, J = 6.6, 
ArH), 7.99 (2H, d, J = 6.6, ArH), 7.55-7.52 (3H, m, ArH), 7.34-7.32 (2H, m, ArH), 
6.17 (1H, s, ArH), 6.01 (2H, s, ArH), 4.68 (3H, s, CH3), 3.41 (4H, s, CH2), 2.54 (6H, 
s, CH3), 2.43 (3H, s, CH3), 1.73 (6H, s, CH3), 1.44 (3H, s, CH3), 1.25 (3H, s, CH3). 
13C NMR (100 MHz, CDCl3): δC 161.5, 156.6, 156.0, 152.8, 145.4, 144.9, 143.9, 
142.3, 140.4, 134.1, 132.9, 131.7, 129.6, 129.5, 128.2, 127.9, 126.7, 121.4, 120.8, 
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60.6, 49.0, 41.6, 34.7, 28.1, 14,7 14.6, 14.0, 12.9, 12.3. MS (TOF- ESI): m/z: Calcd: 
674.3479, Found: 674.3511 [M]+, Δ=4.9 ppm.  
4.2.5. Conclusion 
All in all, our work for the first time demonstrated an activatable heavy atom free 
BODIPY sensitizer as an efficient singlet oxygen generator for PDT applications. 
Modulations of excited state of the sensitizer through DS-TR and charge transfer 
configurations via cancer related input are the key for the selectivity of this 
therapeutic design. The electronic structure details are investigated with a 
combination of DFT, TD-DFT, and CASSCF/CASPT2 methods in order to validate 
our design principles. Chemical singlet oxygen trap experiments, transient absorption 
signals and detailed cell culture studies revealed that our sensitizer is getting 
activated only in the presence of high amount of GSH. Further investigations showed 
that we are able to differentiate healthy and cancer cells during the PDT action. This 
study is the first example of such differentiation.     
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CHAPTER 5 
 
5. Axially Chiral BODIPY Derivatives 
This work is partially described in the following publication: 
 
Kolemen, S.; Cakmak, Y.; Kostereli, Z.; Akkaya, E. U. Org. Lett., 2014, 16, 660.  
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5.1. Objective 
A dissymetrically substituted orthogonal BODIPY dimer and an orthogonal 
BODIPY trimer exist as two stable conformers, which are in fact atropisomeric 
enantiomers.  The racemic mixture can be separated by HPLC using a chiral 
stationary phase.  These enantiomeric derivatives hold great potential as chiral agents 
in asymmetric synthesis, fluorogenic/chromogenic sensing and biological 
applications. 
5.2. Introduction 
BODIPY dyes, once considered to be yet another class of fluorophores with 
applications limited to laser dyes and biological labeling, continue to flourish as their 
rich chemistry24,29 unravels and a multitude of new potential applications keep 
pouring in.54,85,225,226 It is remarkable that all positions on the parent 
boradiazaindacene ring including the boron bridge can be functionalized using 
straightforward procedures, resulting in a large family of chromophores with 
impressive diversity of photophysical and photochemical properties. Case in point, 
the parent compound has a very small intersystem crossing rate,202 but on heavy 
atom functionalization of the 3,5-positions, BODIPY derivatives are transformed 
into effective singlet oxygen generators with a potential in photodynamic therapy.123 
In our attempts to find an alternative to heavy atom substitution protocol, we 
discovered that orthogonal BODIPY dimers have a remarkable excited state feature, 
which makes them very efficient in intersystem crossing.227  
At that point, we recognized the potential of this compound for atropisomerism. 
Axial chirality in atropisomeric compounds is the result of non-planar arrangement 
of different groups on both sides of the chiral plane and enantiopure products can be 
isolated because of the restricted rotation of a single bond on that chiral axis. Most 
extensively used and studied atropisomeric molecules are bi-naphthyl derivatives 
with various applications.146 On the other hand, chiral BODIPY derivatives were also 
previously reported in a few, chirality is generated by the tethered chiral prosthetic 
groups,23,149,151,228-230 and in one recent example, by the asymmetrically substituted 
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boron bridge.148 Nevertheless, chirality based on rotationally hindered BODIPY 
cores was not previously proposed or explored. 
5.3. Results and Discussion 
In the case of dimer (3), there is still a symmetry plane, however a single 
dissymmetric substitution would remove that. To carry out that operation chemically, 
we formylated the dimer (3).  The reaction takes place essentially exclusively in the 
meso-functionalized ring.  To further increase the complexity, we wanted to generate 
another BODIPY unit, where the formyl carbon would then supply the meso-carbon 
for the nascent third BODIPY ring.  The latter reaction was carried out following 
highly established procedures for BODIPY synthesis while the pyrrole rings were 
supplied by 2,4-dimethylpyrrole (figure 110).   
 
Figure 110. Synthesis of the atropisomeric BODIPY derivative (4) and (5). As expected, (4) 
and (5) are produced as racemates. For both (4) and (5) (R) enantiomers are depicted. 
Copyright © 2014, American Chemical Society. Reprinted with permission from ref (150). 
It should be also noted here that the formyl group is highly useful precursor for other 
functionalities.  For both the formyl derivative (4) and the trimer (5), purification (as 
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the racemic mixture) was through silica gel chromatography using dichloromethane / 
methanol (95% / 5%) and only dichloromethane as the eluent solvents, respectively.  
The racemates were then subjected to chiral HPLC purification. The conditions had 
to be carefully optimized to affect efficient separation of the both enantiomeric 
couples. 
 
Figure 111. HPLC separation of compound (4) to (4a) (20.3 min) and (4b) (33.4 min), (95% 
/ 5 %, heptane / IPA, detection @270 nm) (top), and compound (5) to (5a) (18.5 min) and 
(5b) (20.6 min),  (98% / 2%, heptane / ethanol, detection @510 nm) (bottom). Copyright © 
2014, American Chemical Society. Reprinted with permission from ref (150). 
Analytical and preparative HPLC separations of racemic mixtures of compound (4) 
and (5) were performed using cellulose based Chiralcel-OD columns. For analytical 
and preparative resolutions, racemic mixture of the compounds were dissolved in an 
isocratic eluent of isopropyl alcohol or ethanol/heptane, filtered and injected to the 
column. HPLC chromatograms are shown in figure 111.  Racemic compound (4) 
yielded easily resolvable peaks under these conditions, but the resolution for (5) was 
somewhat more challenging.  Separated enantiomers were checked for their optical 
spectra (figure 112, 113, 114) / mass / NMR (see experimental details) and were 
found to be identical as expected.  
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Figure 112. Electronic absorption (red) and emission (blue) spectra of (4) (left) and (5) 
(right). Ext @ 500 nm for (4) and 510 nm for (5). Copyright © 2014, American Chemical 
Society. Reprinted with permission from ref (150). 
 
Figure 113. Electronic absorption (red) and emission (blue) spectra of (4a)(left) and (4b) 
(right). Ext @ 500 nm. Copyright © 2014, American Chemical Society. Reprinted with 
permission from ref (150). 
 
Figure 114. Electronic absorption (red) and emission (blue) spectra of (5a) (left) and (5b) 
(right). Ext @ 510 nm. Copyright © 2014, American Chemical Society. Reprinted with 
permission from ref (150). 
Circular dichroism data (Figures 115 and 116) clearly demonstrate successful 
separation of the two enantiomers.  While the racemic mixture (4) resulted in an 
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essentially flat line indicative of achirality, enantiomer (4a) and the enantiomer (4b) 
show the mirror image spectra.  Same is true for (5), (5a) and (5b).  The peaks on the 
visible region are related to sharp S0-S1 transition of the BODIPY core. 
 
Figure 115. Circular dichroism spectra of racemic mixture (4) and the two enantiomers 
following resolution using Chiralcel-OD columns via preparative HPLC.  The structures 
shown on the figure are the energy-minimized structures (employing the MM method as 
implemented in Spartan 08) and the assignment is arbitrary. Copyright © 2014, American 
Chemical Society. Reprinted with permission from ref (150). 
 
Figure 116. Circular dichroism spectra of racemic mixture (5) and the two enantiomers 
following resolution using Chiralcel-OD columns via preparative HPLC. The structures 
shown on the figure are the energy-minimized (employing the MM method as implemented 
in Spartan 08) structures and the assignment is arbitrary. Copyright © 2014, American 
Chemical Society. Reprinted with permission from ref (150). 
The compound (4) has a major absorption band in the visible region (λmax=505 nm, 
ε = 78000 M-1cm-1). Only weak fluorescence emission (quantum yield < 1%) is 
observed with a peak at 520 nm. The trimer on the other hand, has a stronger 
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absorption at 514 nm (ε= 162000 M-1cm-1).  This compound also has a low quantum 
yield of emission (quantum yield < 1%) (Figure 117, Table 9). 
 
Figure 117.  Electronic absorption (solid line) and emission (dashed line) spectra of 
compounds (4) and (5). Copyright © 2014, American Chemical Society. Reprinted with 
permission from ref (150). 
Table 10. Photophysical characterization of compound (4) and (5). 
dye λabsa/nm εmax/M-1 cm-1 λemsa/nm Φ fb τfa/ns 
 
4 
 
505 
 
78000 
 
520 
 
0.0078 
 
3.14 
 
5 
 
514 
 
162000 
 
528 
 
0.0075 
 
3.72 
a Data acquired in CH2Cl2. b in reference to fluorescein in 0.1 M NaOH solution, excited at 
495 nm. 
5.4. Experimental Details 
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane (TMS) as internal standard. All spectra were recorded at 25oC and 
coupling constants (J values) are given in Hz. Chemical shifts were reported in parts 
per million (ppm). Absorption spectra were performed by using a Varian Cary-100. 
Fluorescence measurements were conducted on a Varian Eclipse Spectrofluometer. 
The fluorescence decay measurements were carried out with the Horiba Jobin-Yvon 
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Time-Resolved Fluorometer, Fluorolog FL-1057. The instrument response function 
was measured with an aqueous ludox solution. Mass spectra were recorded with 
Agilent Technologies 6224 TOF LC/MS and 6530 Accurate Mass Q-TOF LC/MS. 
High performance liquid chromatography (HPLC) separations were performed by 
using Agilent Technologies HPLC-1200 Series with multi-wavelength detector 
(MWD) and Agilent Technologies Preparative HPLC-1200 Series with diode array 
detector (DAD). Circular dichroism (CD) measurements were conducted with Jasco 
J-815 CD Spectrometer. Reactions were monitored by thin layer chromatography 
using Merck TLC Silica gel 60 F254. Silica gel column chromatography was 
performed over Merck Silica gel 60 (particle size: 0.040-0.063 mm, 230-400 mesh 
ASTM). Compounds (1), (2), and (3) were synthesized according to our pervious 
study.121 All other reagents and solvents were purchased from suppliers and used 
without further purification. 
HPLC Separation: Analytical and preparative HPLC separation of racemic 
mixtures of compound (4) and (5) were performed on Agilent Technologies HPLC-
1200 Series with multi-wavelength detector (MWD) and Agilent Technologies 
Preparative HPLC-1200 Series with diode array detector (DAD). In both cases, 
cellulose based Chiralcel-OD columns were used.  
For analytical resolution, racemic mixture of compound (4) was dissolved in an 
isocratic eluent of (5%/95% isopropyl alcohol/heptane), filtered and injected to the 
column. The flow rate was 1 mL/min and UV detection wavelength was 270 nm. 
This separation was performed on a 250 x 4.6 mm column. One injection was done 
(10μL). In the case of preparative resolution of (4), again it was dissolved in an 
isocratic eluent of (5%/95% isopropyl alcohol/hexane), filtered and injected to the 
column. The flow rate was adjusted as 12 mL/min and UV detection wavelength was 
270 nm. This separation was performed on a 250 x 10 mm column. In preparative 
separation 5 injections were done (5 mg/injections, 2000μL/injections), in order to 
get reasonable amounts of (4a) (12.0 mg) and (4b) (8.0 mg). 
For analytical resolution, racemic mixture of compound (5) was dissolved in an 
isocratic eluent of (2%/98% ethanol/heptane), filtered and injected to the column. 
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The flow rate was 0.8 mL/min and UV detection wavelength was 510 nm. This 
separation was performed on a 250 x 4.6 mm column. One injection was done 
(10μL). In the case of preparative resolution of (5), again it was dissolved in an 
isocratic eluent of (2%/98% ethanol/hexane), filtered and injected to the column. The 
flow rate was adjusted as 8 mL/min and UV detection wavelength was 510 nm. This 
separation was performed on a 250 x 10 mm column. In preparative separation 5 
injections were done (2 mg/injections, 2000μL/injections), in order to get reasonable 
amounts of (5a) (4.3 mg) and (5b) (2.6 mg). 
Synthetic Details: 
Synthesis of (4): 1 mL of DMF and 1 mL of POCl3 was stirred in an ice bath for 5 
min under argon. Then warmed to room temperature and waited for 30 minutes. To 
this mixture compound (3) (200 mg, 0.405 mmol) was added in dichloroethane (60 
mL). The temperature was raised to 500C and stirred for 2 hours. The reaction 
medium was cooled and poured into 150 mL of ice cooled NaHCO3 solution slowly. 
After that it was stirred for further 30 min, then washed with water 3 times. The 
organic layers was combined and dried over Na2SO4 and evaporated to dryness. The 
compound has been purified by column chromatography by using DCM / MeOH 
(95%/5%) as an eluent and the compound has been got pure as reddish solid (95 %). 
1H NMR (400 MHz, CDCl3): δH 10.05 (1H, s, CHO), 7.21 (1H, s, ArH), 6.20 (1H, d, 
J= 3.64 Hz, ArH), 2.83 (3H, s, CH3), 2.62 (3H, s, CH3), 2.60 (3H, s, CH3), 2.41 (3H, 
s, CH3), 2.35 (3H, s, CH3), 2.12 (3H, s, CH3), 2.02 (3H, s, CH3), 1.75 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3): δC 185.8, 161.9, 161.6, 156.7, 150.1, 146.6, 144.5, 
142.2, 135.8, 135.6, 135.2, 134.7, 132.1, 129.9, 126.4, 124.2, 122.9, 121.0, 120.8, 
15.1, 14.9, 14.4, 13.1, 12.6, 11.2, 10.8, 9.8 ppm. MS HRMS (TOF-ESI): m/z calcd: 
522.239; found: 522.237 [M-H]-,  Δ = 3.8 ppm. Retention time of (4a) and (4b) are 
20.3 min and 33.4 min respectively. 
1H NMR and HRMS results for compound (4a): (400 MHz, CDCl3): δH 10.05 (1H, s, 
CHO), 7.20 (1H, s, ArH), 6.18 (1H, d, J= 3.72 Hz, ArH), 2.81 (3H, s, CH3), 2.62 
(3H, s, CH3), 2.58 (3H, s, CH3), 2.40 (3H, s, CH3), 2.32 (3H, s, CH3), 2.12 (3H, s, 
CH3), 2.02 (3H, s, CH3), 1.75 (3H, s, CH3). MS HRMS (TOF-ESI): m/z calcd: 
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522.239; found: 522.236 [M+H]-,  Δ = 5.7 ppm. 
1H NMR and HRMS results for compound (4b): (400 MHz, CDCl3): δH 10.03 (1H, s, 
CHO), 7.19 (1H, s, ArH), 6.20 (1H, d, J= 3.48 Hz, ArH), 2.80 (3H, s, CH3), 2.62 
(3H, s, CH3), 2.58 (3H, s, CH3), 2.39 (3H, s, CH3), 2.31 (3H, s, CH3), 2.11 (3H, s, 
CH3), 2.02 (3H, s, CH3), 1.75 (3H, s, CH3). MS HRMS (TOF-ESI): m/z calcd: 
522.239; found: 522.247 [M+H]-,  Δ = 15.3 ppm. 
CD result for compound (4a): [λ, nm] {Δε, M-1 cm-1}: [510] {-7298.56}, [378] 
{785.52}, [300] {-821.75}, [235] {-44751.24}. 
CD result for compound (4b): [λ, nm] {Δε, M-1 cm-1}: [510] {11592.04}, [378] {-
2686.81}, [300] {2039.80}, [235] {31716.42}. 
Synthesis of (5): In N2 bubbled 250 mL dichloromethane, 2,4-Dimethylpyrrole (145 
μL, 1.408 mmol) and (4) (336.6 mg, 0.646 mmol) were mixed. 2 drops of 
trifluoroacetic acid has been added. The reaction mixture stirred at room temperature 
overnight. Then p-chloranil (159 mg, 0.646 mmol) was added to the reaction. After 
stirring 1 hour at room temperature, NEt3 (5 mL) and BF3.OEt2 (5 mL) were added 
and stirred again for additional 1 hour. The reaction was finished by extracting with 
water (3x250 mL). Column chromatography with CH2Cl2 yielded the pure product 
(20 %). 1H NMR (400 MHz, CDCl3): δH 7.18 (1H, s, ArH), 6.18 (1H, s, ArH), 6.12 
(1H, s, ArH), 6.01 (2H, d, J= 12.04 Hz, ArH), 2.53 (3H, s, CH3), 2.52 (3H, s, CH3), 
2.51 (6H, s, CH3), 2.41 (3H, s, CH3), 2.38 (3H, s, CH3), 2.25 (3H, s, CH3), 2.13 (3H, 
s, CH3), 1.75 (3H, s, CH3), 1.71 (6H, s, CH3), 1.53 (3H, s, CH3); 13C
 NMR (100 MHz, 
CDCl3): δC 161.4, 159.0, 156.1, 155.5, 150.9, 150.3, 144.8, 144.2, 142.5, 142.0, 
137.6, 135.6, 135.1, 134.4, 133.5, 133.0, 132.1, 131.9, 131.7, 131.0, 130.8, 128.8, 
125.7, 123.4, 122.6, 121.5, 121.1, 120.8, 120.7, 31.9, 29.7, 22.7, 15.0, 14.8, 14.6, 
14.1, 13.8, 13.7, 12.7, 12.5, 11.5, 11.3, 9.7 ppm; MS HRMS (TOF-ESI): m/z calcd: 
740.358; found: 740.3585 [M-H]-,  Δ = 0.68 ppm. Retention time of (5a) and (5b) are 
18.5 min and 20.6 min respectively. 
1H NMR and HRMS results for compound (5a): (400 MHz, CDCl3): δH 7.19 (1H, s, 
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ArH), 6.18 (1H, s, ArH), 6.11 (1H, s, ArH), 6.02 (2H, d, J= 12.04 Hz, ArH), 2.55 
(3H, s, CH3), 2.53 (3H, s, CH3), 2.51 (6H, s, CH3), 2.41 (3H, s, CH3), 2.38 (3H, s, 
CH3), 2.25 (3H, s, CH3), 2.11 (3H, s, CH3), 1.74 (3H, s, CH3), 1.71 (6H, s, CH3), 1.54 
(3H, s, CH3); MS HRMS (TOF-ESI): m/z calcd: 740.358; found: 740.366 [M+H]-,  Δ 
= 10.8 ppm. 
1H NMR and HRMS results for compound (5b): (400 MHz, CDCl3): δH 7.18 (1H, s, 
ArH), 6.19 (1H, s, ArH), 6.12 (1H, s, ArH), 6.03 (2H, d, J= 12.04 Hz, ArH), 2.56 
(3H, s, CH3), 2.52 (3H, s, CH3), 2.51 (6H, s, CH3), 2.41 (3H, s, CH3), 2.38 (3H, s, 
CH3), 2.25 (3H, s, CH3), 2.13 (3H, s, CH3), 1.75 (3H, s, CH3), 1.71 (6H, s, CH3), 1.53 
(3H, s, CH3); MS HRMS (TOF-ESI): m/z calcd: 740.358; found: 740.367 [M+H]-,  Δ 
= 12.2 ppm. 
CD result for compound (5a): [λ, nm] {Δε, M-1 cm-1}: [521] {-6402.25}, [505] 
{1617.65}, [474] {674.13}. 
CD result for compound (5b): [λ, nm] {Δε, M-1 cm-1}: [521] {7900.20}, [505] {-
2768.80}, [474] {-1212.90}. 
5.5. Conclusion 
In summary, we present the first example of atropisomeric BODIPY derivatives with 
persistent chirality due to multiple methyl group clashes.  The orthogonally linked 
BODIPY compounds have been demonstrated to have interesting photophysical 
properties but now, we show that they can be isolated as atropisomeric chiral 
compounds.  Their large extinction coefficients and large anisotropy factors (g> 
5x10-3) would mean that similar compounds may find practical applications as 
chiroptical fluorogenic/chromogenic sensors, and as highly selective chiral 
photosensitizers in a therapeutic context, among other potential fields.   
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6.1. Objective 
In this project, our primary goal is to deliver the principal cytotoxic agent of 
photodynamic therapy, singlet oxygen, directly by thermal decomposition of 
otherwise stable endoperoxides. To that end, endoperoxide derivative is conjugated 
to the gold nanorod. Irradiation of gold nanorod with near-IR laser light causes 
temperature increase on the surface of nanoparticle, which triggers the thermal 
decomposition of the endoperoxide that yield singlet and molecular oxygen. This 
project, which is a radical rewriting of the photodynamic therapy concept, is poised 
to revamp photodynamic therapy, offering potential solutions for major problems 
(light penetration depth and hypoxia) hitherto blocking broader clinical application. 
6.2. Introduction  
Photodynamic therapy is a useful methodology for the treatment of various 
cancers.112 However, its applicability is severely limited by two factors, the 
requirement for external excitation of the photosensitizer, and hypoxia (low oxygen 
concentration) in tumor tissues.  Mammalian tissue is transparent only in the optimal 
spectral region, the so-called therapeutic window (600-950 nm).  This means that a 
photosensitizer in living organism will be excited efficiently only if it has absorption 
maximum at this interval. Most tumor tissues and cells, as a result rapid outgrowth of 
their blood supply, are hypoxic. The other major requirement is the presence of 
dissolved molecular oxygen for sensitization. This reduced oxygen concentration not 
only inhibits efficiency of photodynamic therapy, but also reduces responsiveness of 
the cancer cells to traditional chemotherapy, allowing further progression of the 
cancer. Thus, it is highly desired to design PDT agents, which can produce both 
molecular and cytotoxic singlet oxygen upon near-IR irradiation. Traditional PDT 
sensitizers are only capable of generating singlet after series of photophysical steps 
including ISC. It is also possible to deliver singlet oxygen chemically at sufficient 
concentrations to induce apoptotic and/or necrotic cell deaths.  
It is very well known that the chemical reactivity of singlet oxygen is different than 
the triplet ground state oxygen.  It can undergo addition reactions to form 
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endoperoxides.152 Most endoperoxides (EPOs) are not stable; they thermally (or 
photochemically) decompose, in some cases generating singlet oxygen.  Many 
polycyclic aromatic compounds can trap singlet oxygen, and some of these resulting 
endoperoxides exhibit an interesting feature, which is the release of oxygen in the 
excited state on warming.  Most of these endoperoxides themselves are prepared by 
photosensitized oxygenation, which involves [4+2] cycloaddition of 1O2. In the 
dissociation of EPOs, in principle there are two primary pathways, cycloreversion, 
leading to the substrate and O2 (in either triplet or singlet state) and homolytic 
cleavage of the peroxide bond, which is often accompanied by rearrangements or 
decomposition to hydroxyketones or quinones.  
Gold nanoparticles attracted considerable attention in recent years mostly due to their 
plasmonic properties.165 Surface plasmon confers absorption properties to the 
nanoparticles depending on their size, state of aggregation, and surrounding 
dielectric medium.  Absorption of light causes heating, and this was once considered 
an undesirable property, a nuisance, which has to be minimized in applications such 
as imaging.  Within the last decade however, this nanoscale heating proved to be 
valuable in the therapeutic context.182 Typical gold nanospheres have absorption 
bands in the visible region of the spectrum, but gold nanorods (GNRs) may have 
strong absorptions in the therapeutically relevant red to near IR region, depending on 
their aspect ratios. Since the absorption peak can be pushed into near IR in the case 
of gold nanorods, plasmonic heating can be obtained by relatively more penetrating 
red-to-near IR light sources.  Cell death in tissues heated to 41-47oC displays signs of 
apoptosis, but at temperatures above 50oC, it is mostly due to necrosis.182 While 
hyperthermia induced in this way is interesting and getting the attention that it 
deserves in many research groups worldwide, the therapeutic potential in vivo and in 
clinical studies needs to be further evaluated.  
Once appropriate EPOs are synthesized and characterized chemically, the delivery of 
the singlet oxygen to the targeted tumor region can be reduced to a problem of safe 
systemic transport of an endoperoxide, followed by decomposition (cycloreversion) 
at the target region. However, the temperature inside the human body is very well 
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regulated by homeostasis, it wouldn’t be reasonable to expect significant temperature 
differences in any part of the body to yield differential decomposition rates. At that 
point, gold nanorods are quite useful to achieve this goal, as they have strong and 
tunable absorption peaks in their absorption spectra, and this phenomenon is being 
exploited to generate localized heating in the vicinity of these particles. Combination 
of gold nanoparticles with aromatic endoperoxides has not been utilized for PDT 
action until very recently. During the preparation of this thesis Branda et al. reported 
an anthracene endoperoxide derivative, which is conjugated to gold nanospheres 
(organic solvent soluble) for the purpose of singlet oxygen generation on gold 
nanoparticles. In their design excitation of gold nanospheres at 500 nm increase the 
temperature on nanoparticles that triggers the thermal decomposition of conjugated 
anthracene derivative to yield singlet oxygen. However, near-IR irradiation and 
water dispersion of the conjugate, which are highly significant for therapeutic 
applications, could not be introduced.  
In this study, we are introducing PEGlyated anthracene endoperoxide derivative, 
which is conjugated to gold nanorods with SPR peak around 800 nm in order to 
realize the control singlet and molecular oxygen generation by irradiating the 
nanorods with near-IR laser (figure 118). Once laser irradiation is applied on to the 
nanorod-EPO conjugate, local temperature increases on the nanorods trigger the 
thermal decomposition of EPO and produce both singlet (cytotoxic) and molecular 
oxygen. 
 
Figure 118. Therapeutic design. 
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6.3. Results and Discussion  
The shape of gold nanoparticles has critical role in governing their optical and 
chemical properties. Dramatic changes can be seen in many characteristics of gold 
nanocrystals when you shift from spherical to nonspherical nanoparticles. Among the 
nonspherical gold NPs, gold nanorods have attracted much interest. They have been 
widely used in optical devices, biochemical sensors and nanomedicine applications. 
Most featured property of Au nanorods is their tunable and intense localized surface 
plasmon resonance (LSPR) bands at visible and near-IR region of the 
electromagnetic spectrum. Also, GNRs have the ability of converting absorbed light 
to heat (photothermal conversion). In addition to that there are many well-established 
growth methods for this rod-like NPs, which all of them offering high yields, 
improved aspect ratios, shape and uniformity control. With all these advantages, we 
thought that Au nanorods might be a good candidate for our design. Our first attempt 
was to synthesize GNRs with LSPR peak at longer wavelengths (around 800 nm). 
Various studies in literature show that short rods (~40 nm) with aspect ratio of 4 
satisfy our needs.173 We synthesized the GNRs with seed-mediated growth technique 
according to El-Sayed procedure.173 It is the most applied wet chemical, bottom-up 
method. In a typical procedure, first of all small Au nanoparticle seed (~1-2 nm) 
were prepared by the reduction of HAuCl4 with borohydride in 
cetyltrimethylammonium bromide (CTAB) solution. CTAB is a surfactant and is 
used to prevent the aggregation and more importantly it directs the longitudinal 
growth of the Au nanoparticles by forming micelles around the Au NPs. After the 
preparation of so-called seed solution, growth was accomplished by the reduction of 
additional HAuCl4 (Au (III)) by ascorbic acid to Au (I) and further reduction of Au 
(I) to Au (0) with the help of gold seeds synthesized in the previous step. One of the 
important contributors to the growth is the AgNO3. Detailed studies reveal that Ag 
(I) ions selectively bind to energetic {110} sides of Au NPs and diminish the growth 
rate at that position. Thus Au atoms choose to deposit on {100} sides that results in 
longitudinal growth of Au NPs to form rod-like shapes. 
Figure 119 shows the TEM images of gold nanorods that were synthesized with 
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respect to El-Sayed seed-mediated growth technique. TEM images (Figure 119) 
clearly represents the highly uniform rods with acceptable yield. Size of the rods is 
40 nm with an aspect ratio of 4. Surface plasmon resonance peaks were observed by 
acquiring the electronic absorption spectrum (Figure 119). 
Figure 119. TEM images of gold nanorods (~40 nm) and electronic absorption spectrum of 
GNRs in HEPES buffer (pH 7.2, 20 mM). 
GNRs exhibit mainly two surface plasmon modes; (i) longitudinal mode corresponds 
to electron oscillations along the length direction and the (ii) transverse mode 
associated with the transverse electron oscillations. In our spectrum we observed 
these two well-known modes at around 500 nm (transverse) and 800 nm 
(longitudinal). Since the path of the electron movements is longer at length direction, 
the longitudinal peak is red-shifted. One should note that aspect ratio could be varied 
from 2.4 to 8.5 in GNRs that directly affects the longitudinal plasmon wavelength. 
 
Figure 120. Reaction scheme for the target compound. 
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After obtaining GNRs, the next step was to synthesize a water-soluble anthracene 
endoperoxide derivative with thiolated end group for GNRs conjugation (figure 120). 
We started with 4-formylboronic acid and oxidized it to carboxylic acid with 
KMnO4. Then methyl ester derivative was synthesized in MeOH with catalytic 
amount of concentrated sulfuric acid. This esterification was crucial because Suzuki 
coupling could not be done with 4-carboxyphenylboronic acid, most probably due to 
the de-activation of the palladium catalyst. On the other hand, we did mono Suzuki 
coupling between commercial 9,10-dibromoanthracene and phenylboronic acid. 
After that we repeated the coupling with compound (5) and methyl ester derivative 
of boronic acid (3) successfully. Hydrolysis of ester to acid was achieved by LiOH in 
MeOH. At that point, we synthesized the endoperoxide. Methylene blue and our 
anthracene derivative were irradiated with a water-cooled 400W Hg arc lamp by 
bubbling 3O2 in cosolvent (DCM/dry THF). Finally DCC coupling was applied in 
dry THF with NH2-(PEG)3400-SH and the carboxylated anthracene endoperoxide (8) 
to get the water-soluble, thiolated target endoperoxide (9). 
 
 
 
 
 
 
 
 
 
 
Figure 121. Top: Absorption spectra that is taken during the endoperoxide formation 
reaction. Bottom: Thermolysis of endoperoxide (8) to parent compound (7).  
Endoperoxide formation (compound (8)) was further observed and followed by the 
electronic absorption spectrum during the reaction (Figure 121, top). As the reaction 
precedes absorption peaks at 352, 375, and 395 nm of the parent anthracene 
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decreases due to the disturbed aromaticity, which is the result of reaction with 1O2, 
produced by methylene blue. 
It is a typical [4+2] cycloaddition reaction. At the end of two hours, reaction was 
completed with almost no absorbance at corresponding wavelengths as expected.  On 
the other hand, we also checked the reappearance of absorbance bands (regained 
aromaticity) of the parent anthracene upon heating in DMF solution. Figure 121, 
bottom clearly confirms the release of oxygen followed by thermal decomposition of 
our compound (8). 
Next we tried to show thermal decomposition of our target compound (9). For that 
purpose, (9) in DMSO solution was heated in a closed system. The time of heating 
was 1 hour for all selected temperatures. As in the case of compound (8), 
reappearance of absorbance bands was followed at 352, 375, and 395 nm. Release 
was finished after 9 hours at 140oC (Figure 122). Additionally (9) was heated at 95oC 
for six hours, which resulted in efficient thermolysis. On the other hand, when we 
heated (9) at 37oC (body temperature), anthracene absorption cannot be detected, 
suggesting that our singlet oxygen carrier is stable under physiological conditions 
(figure 123).  We also studied the oxygen release from compound (9) in aqueous 
solution (Figure 124). Thermolysis in aqueous medium is important for practical 
applications such as cell culture studies. (9) was heated in double-distilled water for 
1 hour at 100oC in a closed system. Reappearance of absorbance was observed 
indicating the decomposition of endoperoxide. 
 
Figure 122. Left: Thermolysis of 5x10-5 M (9) in DMSO at different temperature. Right: 
Absorbance vs. temperature graph of the thermolysis. The time of heating was 30 min for all 
selected temperatures. 
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Figure 123. Thermolysis of 5x10-5 M (9) in DMSO at 95oC for 6 hours. Inset: Absorbance of 
5x10-5 M (9) in DMSO at 37oC. Sample was heated for 6 hours. 
 
 
 
 
 
Figure 124. Thermolysis of 1x10-5 M (9) at 100oC for 1 hr in HEPES buffer (pH 7.2, 20 mM). 
It is known that thermolysis of polycyclic aromatic endoperoxides yield both 
molecular (3O2) and singlet oxygen (1O2). So, remaining important task is to show 
the presence of singlet oxygen. In order to prove that, we used a singlet oxygen trap 
molecule, diphenylisobenzofuran (DPBF). Upon production of 1O2, it reacts with 
DPBF and decomposes the trap molecule that causes a decrease in absorbance at 414 
nm. Thus, we arranged the absorbance of DPBF to around O.D~1 and mixed it with 
1x10-5 M (9) in DMSO. Then mixture was heated at 70oC for 150 minutes. In every 
30 minutes, aliquots were taken and electronic absorption spectra acquired. In the 
first 30 min, dramatic decrease in DPBF absorbance was seen indicating the effective 
production of singlet oxygen. After 90 min, we started to see reappearance 
absorbance bands of anthracene. Decrease in trap absorbance was observed in the 
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course of 150 minutes heating (Figure 125). 
 
Figure 125. Decrease in absorbance of DPBF in DMSO in the presence of 1x10-5 M upon 
heating at 70oC (9) and the reappearance of parent anthracene absorbance bands. 
After obtaining promising results, we conjugated the compound (9) with GNRs. 
TEM images of GNRs after conjugation are given in figure 126. LSPR maximum of 
the GNRs are slightly red shifted prior to conjugation both in buffer and DMSO 
(figure 126). 
 
Figure 126. Left: TEM image of GNR-(9) conjugate. Right: Normalized electronic 
absorption spectra of CTAB-GNR, (9)-GNR(in HEPES (pH 7.2, 20 mM) and (9)-GNR in 
DMSO. 
Following the conjugation, we mixed the conjugate with trap molecule in DMSO and 
heated the mixture in an oil bath. Decrease in absorption of trap clearly showed the 
singlet oxygen generation as well as successful conjugation of gold nanorods and (9) 
(figure 127). We further conducted several singlet oxygen generation experiments 
with our gold nanorod-(9) conjugate (GNR-(9)) via laser irradiation. We dispersed 
the GNR-(9) in DMSO and irradiated the conjugate with laser light (830 nm) in the 
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presence of singlet oxygen trap (DPBF). 
 
Figure 127. Decrease in absorbance of DPBF at 414 nm in DMSO in the presence of (9)-
GNR upon heating in oil bath. 
 
Figure 128. Decrease in absorbance of DPBF at 414 nm in DMSO in the presence of (9)-
GNR. Excitation @830 nm.  
Decrease in the absorption spectrum of DPBF clearly showed that our conjugate is 
generating singlet oxygen (figure 128). This is the result of local temperature 
increase on the surface of gold nanorod upon excitation at its surface plasmon peak 
(830 nm), which triggers the thermal decomposition of compound (9). On the other 
hand, when we irradiated the solution, which contains gold nanorod only, there was 
no decrease in trap absorbance (figure 129). Relative absorbance decrease difference 
of GNR-EPO and GNR with respect to time is given in figure 130. 
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Figure 129. Absorbance of DPBF in DMSO in the presence of GNRs only (0.125 nM). 
Excitation @830 nm. 
 
Figure 130. Relative 1O2 generation efficiency of (9)-GNR and GNR only in DMSO 
detected by the absorbance decrease of DPBF @414 nm with time. During first 4 min the 
samples were kept in the dark. 
6.4. Experimental Details 
General: 1H NMR and 13C NMR spectra were recorded on Bruker DPX-400 
(operating at 400 MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 with 
tetramethylsilane (TMS) as internal standard. All spectra were recorded at 25oC and 
coupling constants (J values) are given in Hz. Chemical shifts were reported in parts 
per million (ppm). Absorption spectra were performed by using a Varian Cary-100. 
Mass spectra were recorded with Agilent Technologies 6224 TOF LC/MS and 6530 
Accurate Mass Q-TOF LC/MS. TEM images were acquired by using FEI Technai 
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G2 F30 high-resolution transmission electron microscope and carbon grid. Reactions 
were monitored by thin layer chromatography using Merck TLC Silica gel 60 F254. 
Silica gel column chromatography was performed over Merck Silica gel 60 (particle 
size: 0.040-0.063 mm, 230-400 mesh ASTM). All other reagents and solvents were 
purchased from suppliers and used without further purification.  
Singlet Oxygen Trap Experiments: In singlet oxygen measurements 1,3-
Diphenylisobenzofuran (DPBF) was used as a singlet oxygen trap in DMSO. In a 
typical procedure for the detection of singlet oxygen generation by using trap 
molecules, (9)-GNR conjugate and a trap molecule were mixed in DMSO. Initially 
several dark measurements were taken followed by irradiation of the conjugate at 
absorption maximum of GNR. Absorbance decrease of trap molecules was 
monitored suggesting singlet oxygen generation in the presence of light and 
conjugate. Irradiation of the conjugate was accomplished by using Tsunami, 
SpectraPhysics, USA laser system in combination with Spectrum Analyzer, 
SpectraSuite, Ocean Optics, USA. Excitation wavelength was adjusted to 830 nm 
(1W/cm2) and 11 mm lens (Thorlabs) was used in order to focus the incoming light. 
Laser irradiation was performed in Dr. Bulend Ortac group at UNAM, Bilkent 
University, Ankara, Turkey.  
Synthetic Details: 
Synthesis of (2): A solution of 4-formylboronic acid (1.0 g, 6.67 mmol) in aqueous 
sodium hydroxide solution (5.4 mL of a 2.5 M solution) was diluted with distilled 
water (40 mL) just before the addition of a freshly prepared solution of KMnO4 (246 
mg, 1.56 mmol, 0.23 eq.) in water (7.5 mL). This addition was repeated twice at 1-
hour intervals. After stirring over night, ethanol (3 mL) was added and the mixture 
stirred at 50oC for 10 min. After cooling and filtrating over celite, the filtrate was 
acidified to pH 2.5 with 0.5 M HCl. Finally filtration of the precipitate gave the pure 
product as a white solid (90%). 1H NMR (400 MHz, DMSO-d6): δH 8.30 (2H, s), 
7.80 (4H, s); 13C NMR (100 MHz, DMSO-d6): δC 194.0, 167.9, 134.9, 134.5, 132.4, 
128.7, 128.5 ppm. MS HRMS (TOF-ESI): m/z calcd: 164.040; found: 164.037 [M-
H]-,  Δ = 17.0 ppm.   
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Synthesis of (3): (2) (1.0 gr, 6.02 mmol) was dissolved in 25 mL MeOH, then 5 
drops of conc. H2SO4 was added. The mixture was stirred at reflux for 1 day. After 
that solvent was evaporated under vacuum. Then aqueous Na2CO3 was added and the 
mixture was extracted in to the ethyl acetate. Organic phase was washed with water 
and the solvent was removed. Recrystallization from toluene gave the pure product 
as a white solid (60%). 1H NMR (400 MHz, DMSO-d6): δH 8.20 (2H, s), 7.80 (4H, 
s), 3.75 (3H, s); 13C NMR (100 MHz, DMSO-d6): δC 164.8, 132.6, 129.1, 126.3, 
50.4 ppm. MS HRMS (TOF-ESI): m/z calcd: 178.056; found: 178.053 [M-H]-,  Δ = 
13.2 ppm.   
Synthesis of (5): 9,10-Dibromoanthracene (1.68 g, 5 mmol), phenylboronic acid 
(0.61 g, 5 mmol), Pd(PPh3)4 (0.58 mg, 0.5 mmol) and 2 M Na2CO3 were mixed in 
degassed toluene (30 mL), ethanol (10 mL) and distilled water (12 mL). Reaction 
was heated for 3 hours at 100oC. The mixture is extracted with ethyl acetate and the 
organic phase dried over anhydrous Na2SO4. Solvent was evaporated in vacuo and 
compound was purified by silica gel FCC using hexane as the eluent. A white solid 
was obtained (35%). 1H NMR (400 MHz, CDCl3): δH 8.61 (2H, d, J = 8.8 Hz), 7.71-
7.62 (2H, m), 7.60-7.53 (5H, m), 7.45-7.30 (4H, m); 13C NMR (100 MHz, CDCl3): 
δC 138.4, 137.8, 131.1, 131.0, 130.0, 128.4, 127.8, 127.7, 127.4, 126.9, 125.5 ppm. 
MS HRMS (TOF-ESI): m/z calcd: 332.020; found: 332.022 [M],  Δ = 5.7 ppm. 
Synthesis of (6): (5) (0.15 g, 0.44 mmol), (3) (0.080 g, 0.44 mmol), Pd(PPh3)4 (0.061 
g, 0.044 mmol) and 2 M Na2CO3 were mixed in degassed toluene (6 mL), ethanol (2 
mL) and distilled water (3 mL). Reaction was heated for 3 hours at 100oC. The 
mixture is extracted with ethyl acetate and the organic phase dried over anhydrous 
Na2SO4. Solvent was evaporated in vacuo and compound was purified by silica gel 
FCC using 3:1 (DCM: hexane) as the eluent. A white solid was obtained (53%). 1H 
NMR (400 MHz, CDCl3): δH 8.32 (2H, d, J = 1.8 Hz), 7.78-7.73 (2H, m), 7.69-7.60 
(7H, m), 7.55 (2H, d, J = 1.3 Hz), 7.39-7.32 (4H, m), 4.05 (3H, s); 13C NMR (100 
MHz, CDCl3): δC 167.1, 144.4, 138.9, 137.8, 135.8, 131.6, 131.5, 131.3, 129.9, 
129.7, 129.5, 128.5, 127.6, 127.1, 126.5, 125.4, 125.1, 52.3 ppm. MS HRMS (TOF-
ESI): m/z calcd: 388.146; found: 388.149 [M],  Δ = 6.1 ppm. 
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Synthesis of (7): (6) (80 mg, 0.21 mmol) was dissolved in 5 mL MeOH. To this 
solution 2M LiOH in 1 mL water was added. The mixture was stirred for 3 hours at 
60oC then the solution was acidified to pH 2.0 followed by precipitation in water. 
Filtrate was collected and dried (48%). 1H NMR (400 MHz, CDCl3): δH 8.22 (2H, d, 
J = 8.0 Hz), 7.71-7.62 (2H, m), 7.60-7.55 (5H, m), 7.53-7.48 (2H, m), 7.47-7.37 (6H, 
m); 13C NMR (100 MHz, CDCl3): δC 167.8, 143.5, 138.5, 137.8, 136.1, 131.8, 
131.3, 130.7, 130.1, 129.6, 129.4, 129.2, 128.3, 126.9, 126.5, 126.3, 126.0 ppm. MS 
HRMS (TOF-ESI): m/z calcd: 373.123; found: 373.121 [M-H]-,  Δ = 5.6 ppm. 
Synthesis of (8): (7) (50 mg, 0.13 mmol) was dissolved in co-solvent DCM-THF (10 
mL-5mL) and cooled to -78oC. Methylene blue (0.013 mmol) was added to the 
solution. The mixture was stirred under O2 atmosphere for 3 hours. Water-cooled 
400W Hg arc lamp (white light) irradiation was performed during the reaction. 
Solvent was evaporated in vacuo, and compound was purified by silica gel FCC 
using 95:5 (DCM: MeOH) as the eluent (55%). 1H NMR (400 MHz, CDCl3): δH 
8.25 (2H, d, J = 1.5 Hz), 7.78 (2H, d, J = 1.7 Hz), 7.71 (2H, d, J = 1.5 Hz), 7.68-7.59 
(3H, m), 7.35-7.29 (4H, m), 7.11-7.02 (4H, m); 13C NMR (100 MHz, CDCl3): δC 
140.1, 139.8, 139.5, 132.6, 130.1, 129.1, 128.5, 127.9, 127.5, 127.2, 123.6, 123.4 
ppm. MS HRMS (TOF-ESI): m/z calcd: 407.129; found: 407.118 [M-H]-,  Δ = 25.7 
ppm. 
Synthesis of (9): (8) (50 mg, 0.12 mmol), H2N-PEG-SH (292 mg, 0.086 mmol, MW: 
3400 g/mol) were dissolved in 5 mL dry THF. DCC (26 mg, 0.12 mmol) and DMAP 
(11 mg, 0.15 mmol) were added to the solution. Reaction mixture was stirred for 2 
hours and precipitate formation was observed. Precipitate was filtered and cold 
diethyl ether was added to the solution in order to precipitate the product. Pure 
product was filtered (42%). 1H NMR (400 MHz, CDCl3): δH 8.12 (2H, d, J = 8.2 
Hz), 7.78 (2H, d, J = 8.2 Hz), 7.71-7.60 (5H, m), 7.21-7.12 (6H, m), 7.11-7.07 (2H, 
m), 3.78-3.49 (m, PEG), 2.90 (2H, t, J = 6.5), 1.22 (2H, s), 0.90 (1H, s). 13C NMR 
(100 MHz, CDCl3): δC 167.0, 157.2, 140.9, 140.4, 140.1, 139.9, 136.0, 134.5, 132.9, 
128.3, 127.7, 127.3, 127.2, 123.5, 123.2, 70.4, 70.3, 70.2, 70.0, 69.9, 69.5, 66.9, 
38.5, 33.8, 25.6, 24.9 ppm. 
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Synthesis of Gold Nanorod:  
Preparation of Seed Solution: Firstly CTAB solution (5.0 mL, 0.20 M) was mixed 
with HAuCl4 solution (5.0 mL, 0.00050 M). To the stirred solution, ice-cold NaBH4 
(0.60 mL, 0.010 M) was added, which yields brownish yellow solution. The mixture 
was vigorously stirred for 2 min. It was stored at room temperature. 
Growth of Nanorods with LSPR band around 800 nm: CTAB solution (5.0 mL, 0.20 
M) was added to AgNO3 (0.20 mL, 0.0040 M) solution at 25oC. To this mixture, 
HAuCl4 (5.0 mL, 0.0010 M) was added and after gently mixing, ascorbic acid (70.0 
µL, 0.0788 M) was added. Addition of ascorbic acid changed the color of solution 
from dark yellow to colorless. Finally, 12.0 mL of the seed solution was added to the 
growth solution at 27-30oC. The color of the solution changed to purple within 10-20 
min. The temperature of the growth medium was kept at 27-30oC for 12 hours. In 
order to remove excess CTAB, the solution was centrifuged at 6000 rpm for 10 min 
and dispersed in distilled water. With this experimental method, 1.8E+10 nps/mL, 
0.060 mg/mL GNRs were obtained. 
Synthesis of EPO decorated GNRs: GNR solution was centrifuged at 14000 rpm 
just before the conjugation for further removal of CTAB. Then, equi-volume 
solutions of GNR (O.D~1.0, ~0.25 nM) and (9) are mixed under vigorous stirring 
and sonicated for 1 min. After that the mixture was left to react for 2 hours. Excess, 
unreacted (9) were removed by centrifugation at 7000 rpm for 10 min and (9)-GNR 
was dispersed in buffer or DMSO. 
6.5. Conclusion 
To sum up, in this study water-soluble anthracene endoperoxide derivative was 
combined with gold nanorod in order to achieve light induced thermal decomposition 
of endoperoxide that yields cytotoxic singlet oxygen. Thermal decomposition and 
singlet oxygen generation were observed in detail. Since this project is addressing 
major problems of PDT, we are confident that, this new approach will definitely be a 
breakthrough in PDT designs.  
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CHAPTER 7 
 
7. CONCLUSION 
 
This thesis covers mainly three topics, which are selective fluorescence sensing of 
GSH, finding out alternative pathways for the generation of cytotoxic singlet oxygen 
for PDT applications and synthesis of axially chiral BODIPY fluorophores. Almost 
all of these studies gave novel and/or interesting results such as (i) use of two 
modulation sides for the fluorescent detection of the glutathione for the first time and 
selective intracellular GSH detection and monitoring (ii) first example of an 
orthogonal, heavy atom-free BODIPY designs that generate singlet oxygen 
efficiently (iii) detailed computational studies about heavy atom-free sensitization of 
PDT (iv) first example of an activatable heavy atom free BODIPY sensitizer for 
targeted PDT action (v) first synthesis of atropisomeric Bodipy derivatives and (v) 
addressing long-standing issues related to PDT by utilization of nanoparticles. 
In the first part (chapter 3), we performed the selective fluorescent detection of one 
of the most significant bio-thiol, glutathione. The main obstacle in designing GSH 
selective chemosensor is that; conventional reactions that are mostly used for the 
detection of other bio-thiols (Cys and Hcy) namely Michael addition, cyclization and 
disulfide bond breakage are not well suited for GSH due to its different, larger and 
bulkier chemical structure. Thus some additional approaches were needed. In this 
study, we thought that selectivity towards GSH could be achieved by incorporating 
an additional recognition site, such as azacrown ethers for the terminal ammonium 
group found in GSH in addition to Michael acceptor site for thiol end. In addition to 
that remarkable turn-on response upon addition of GSH was detected at pH 6.0, 
mimicking the pH of cancer cells where GSH concentration is elevated. This was 
obtained by judicious modulation of PeT process. Cancer cell culture studies and 
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GSH inhibition experiments were revealed that our novel probe is able to detect 
intracellular level of GSH in cancer cells selectively. The design principle 
represented here, which includes two binding sides approach, will pave the way for 
similar design methodologies. 
In chapter 4, we addressed the heavy atom mediated dark toxicity conflict of PDT 
sensitizers by designing and introducing a new concept on BODIPY dyes. This was 
achieved by engineering the excited state of the BODIPY leading to efficient 
cytotoxic singlet oxygen generation. We synthesized series of orthogonal BODIPY 
dimers without incorporating any heavy atoms. In the light of computational studies 
we defined a new excited state configuration for our dimers named as doubly 
substituted tetra radical state (DS-TR), which was shown to be essential for obtaining 
ISC. Chemical singlet oxygen trap experiments, singlet oxygen phosphorescence 
signals and cell culture studies proved the formation of SO. For further investigation 
of this novel excited state configuration and in order to check its applicability in 
near-IR absorbing BODIPY dimers, we conducted additional detailed computational 
studies. Shifting the absorption wavelength to the red region is achieved with π-
extension of bis-BODIPYs; however, ISC properties are adversely affected for such 
dimers. Modifications in the chromophore cores are likely to be a more promising 
research direction rather than simple π-extension. In the second part of chapter 4, we 
enlarged the excited state modulation by combining DS-TR and charge transfer 
concepts in order to get an activatable heavy atom free sensitizer. Singlet oxygen trap 
experiments, transient absorption signals and detailed cell culture studies revealed 
that our sensitizer is getting activated only in the presence of high amount of GSH, 
which is a well known cancer marker. Further investigations showed that we are able 
to differentiate healthy and cancer cells during the PDT action. This is the first 
example of such differentiation, where GSH is used as a targeting agent. 
In chapter 5, we recognized the potential of our dimeric BODIPY derivatives for 
atropisomerism, while dealing with them for PDT applications. In this manner, we 
introduced the axially chiral BODIPY derivatives for the first time in this chapter. 
Analytical and preparative HPLC separations of racemic mixtures of target 
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compounds were performed using cellulose based Chiralcel-OD columns and 
circular dichroism studies clearly demonstrated successful separation of the two 
enantiomers. In summary, we presented the first example of atropisomeric BODIPY 
derivatives with persistent chirality due to multiple methyl group clashes.  The 
orthogonally linked BODIPY compounds have been demonstrated to have 
interesting photophysical properties (chapter 4) but also we showed that they could 
be isolated as atropisomeric chiral compounds. Similar compounds may find 
practical applications and hold great promise as chiroptical fluorogenic/chromogenic 
sensors, and as highly selective chiral photosensitizers in a therapeutic context, 
among other potential applications. 
In chapter 6, we addressed the major problems of PDT concept hitherto blocking 
broader clinical application. These restrictions are mainly incorporation of heavy 
atoms, which was mentioned in chapter 4, restricted light penetration depth through 
tissues and hypoxia (molecular oxygen deficiency). To do so, we combined water-
soluble anthracene derivative endoperoxide with near-IR absorbing gold nanorods. In 
this study heating itself is not the therapeutic action as in the case of photothermal 
therapy, but it is a trigger. On the other hand hypoxia is not an issue; generation of 
singlet oxygen in current practice of PDT is dependent on the presence of dissolved 
oxygen. As mentioned previously, the process of singlet oxygen generation through 
photosensitization itself depletes cellular oxygen very fast, so that the dose of 
irradiation has to be carefully adjusted and the light has to be introduced in pulses. 
Endoperoxides decompose along a few different pathways, but in any case for 
cycloreversion, the product is either triplet molecular oxygen (3O2) or singlet oxygen 
(1O2). Singlet oxygen generation capacity of our conjugate was observed upon 
irradiation with laser light via singlet oxygen trap experiments.  
There is no doubt that today interdisciplinary research efforts are the key in solving 
complicated problems. As a chemist our starting point is the design of intelligent 
molecular structures with multiple properties. Accordingly, in this thesis, I combined 
organic&nanoparticle synthesis with supramolecular chemistry, photochemistry, 
biochemistry and materials science in order to touch on the challenges in the field of 
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fluorescence sensing, PDT and chiral fluorophores.     
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9. APPENDIX 
 
A.1. Selective Fluorescence Sensing of Glutathione Using a 
Bifunctional Probe 
A.1.1. 1H and 13C NMR Spectra 
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A.1.2. Mass Spectra 
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A.2. Activatable Heavy Atom Free Sensitizers for Photodynamic 
Therapy Application 
A.2.1. Singlet Oxygen Generation by Using Heavy Atom Free Orthogonal 
BODIPY Derivatives 
A.2.1.1. 1H NMR and 13C NMR Spectra 
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A.2.2. Singlet Oxygen Generation by Using Heavy Atom Free Orthogonal 
BODIPY Derivatives 
A.2.2.1. 1H NMR and 13C NMR Spectra 
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A.2.2.2. Mass Spectra 
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A.3. Axially Chiral BODIPY Derivatives 
A.3.1. 1H and 13C NMR Spectra 
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1H NMR Spectrum of (4b) 
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1H NMR Spectrum of (5a) 
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A.3.2. Mass Spectra 
 
 
 
1H NMR Spectrum of (5b) 
HR-MS Spectrum of (4) 
  215 
 
 
 
 
 
 
 
HR-MS Spectrum of (4a) 
HR-MS Spectrum of (4b) 
HR-MS Spectrum of (5) 
  216 
 
 
 
 
A.4. Controlled Singlet Oxygen Generation on Gold Nanorods: 
Advancing Photodynamic Therapy  
A.4.1. 1H and 13C NMR Spectra 
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